日本臨牀　別冊　循環器症候群（第3版）III

出版社： 日本臨牀社
発行日： 2019-11-30
分野： 臨床医学：一般  >  雑誌
ISSN： 00471852
雑誌名：
特集： 循環器症候群（第3版）III―その他の循環器疾患を含めて―
電子書籍版： 2019-11-30 （第3版第1刷）
書籍・雑誌
≪全国送料無料でお届け≫
取寄せ目安：8～14営業日

19,800 円(税込)

購入する
電子書籍
章別単位での購入はできません
ブラウザ、アプリ閲覧

19,800 円(税込)

購入する

目次

  • 特集　循環器症候群（第3版）III―その他の循環器疾患を含めて―

    IX．不整脈
    1．不整脈の分類とメカニズム
    2．Adams-Stokes症候群
    3．頸動脈洞過敏症・頸動脈洞症候群
    4．洞不整脈
    5．異所性心房調律, 移動性ペースメーカ
    6．房室接合部調律
    7．固有心室調律(心室自動性調律)
    8．心室副収縮
    9．洞頻脈
    10．洞不全症候群
    11．洞房ブロック
    12．心房停止，心房静止
    13．心房間・心房内ブロック
    14．房室ブロック
    15．発作性房室ブロック
    16．房室解離
    17．進行性心臓伝導障害(PCCD)・家族性房室ブロック
    18．右脚ブロック
    19．左脚ブロック
    20．2束ブロック，3束ブロック
    21．心室内伝導障害，心室内変行伝導
    22．房室結節亢進伝導
    23．過常興奮と過常伝導
    24．補充収縮
    25．心房期外収縮・房室接合部期外収縮
    26．心室期外収縮
    27．副収縮
    28．発作性上室頻拍
    29．洞結節リエントリー性頻拍
    30．二重房室結節伝導路
    31．Slow-fast型房室結節リエントリー性頻拍
    32．稀有型房室結節リエントリー性頻拍
    33．早期興奮症候群(WPW症候群）
    34．房室回帰性頻拍
    35．潜在性WPW症候群
    36．Lown-Ganong-Levine症候群
    37．Coumel's tachycardia(permanent form of junctional reciprocating tachycardia)
    38．Long RP' tachycardia
    39．異所性心房頻拍
    40．多源性心房頻拍
    41．心房内リエントリー性頻拍
    42．心房細動
    43．心房粗動
    44．Regular wide QRS tachycardia
    45．Brugada症候群
    46．早期再分極症候群
    47．QT短縮症候群
    48．先天性QT延長症候群
    50．二次性QT延長症候群
    51．急性心臓死，心臓突然死
    52．致死性不整脈
    53．心室頻拍の分類
    54．単形性・多形性心室頻拍
    55．左室起源特発性心室頻拍
    56．右室起源特発性心室頻拍
    57．家族性心室頻拍
    58．カテコラミン誘発多形性心室頻拍
    58．脚枝間リエントリー性頻拍
    59．不整脈原性右室心筋症
    60．倒錯型心室頻拍
    61．心室細動
    62．再灌流不整脈
    63．胎児不整脈
    64．小児の不整脈
    65．先天性不整脈
    66．心臓手術後不整脈
    67．透析患者にみられる不整脈
    68．薬物による不整脈
    69．薬物抵抗性不整脈
    70．ペースメーカ症候群
    71．ペースメーカ不全
    72．無限旋回環頻拍

    X．突然死
    1．突然死の定義・疫学・分類
    2．突然死のスクリーニング
    3．突然死の予防
    4．突然死ハイリスク群の薬物治療
    5．突然死ハイリスク群のデバイス治療
    6．心原性失神
    7．エコノミークラス症候群
    8．心臓振盪
    9．心停止後症候群
    10．致死性不整脈の分類
    11．無脈性電気活動（PEA)
    12．電気的な嵐
    13．心不全に伴う突然死
    14．心筋梗塞に伴う突然死
    15．心筋症に伴う突然死
    16．心臓サルコイドーシス・心臓アミロイドーシスに伴う突然死
    17．遺伝性不整脈症候群と突然死
    18．向精神薬に関連する突然死
    19．周産期における突然死
    20．薬剤に伴う突然死
    21．電解質異常に伴う突然死
    22．心臓移植後の突然死
    23．透析患者の突然死
    24．アスリートの突然死
    25．小児の突然死
    26．若年者の突然死
    27．高齢者の突然死

    XI．心臓腫瘍
    1．心臓腫瘍の疫学と分類
    2．心粘液腫
    3．乳頭状線維弾性腫
    4．心臓横紋筋腫、心臓横紋筋肉腫
    5．心血管腫，心血管肉腫
    6．心臓線維腫/心孤在性線維性腫瘍
    7．心脂肪腫・心脂肪肉腫
    8．脂肪腫様過形成・心房間脂肪腫
    9．心中皮腫・心膜中皮腫[良性，悪性]
    10．転移性心腫瘍・心膜腫瘍
    11．心臓原発悪性リンパ腫
    12．心嚢内リンパ管腫（嚢胞性リンパ管奇形）
    13．Caltified amorphous tumor

この書籍の参考文献

参考文献のリンクは、リンク先の都合等により正しく表示されない場合がありますので、あらかじめご了承下さい。

本参考文献は電子書籍掲載内容を元にしております。

IX 不整脈

P.11 掲載の参考文献
1) 池田隆徳 : 不整脈の種類と分類. 不整脈-診断と治療の進歩. 日本内科学会雑誌 95 : 196-202, 2006.
 
2) 池田隆徳 : 不整脈症候群と呼ばれる新しいカテゴリー. 不整脈症候群-遺伝子変異から不整脈治療を捉える (池田隆徳, ほか編), p2-5, 南江堂, 2015.
 
3) Peters NS, et al : Arrhythmogenic mechanisms : Automaticity, triggered activity, and reentry. In : Cardiac Electrophysiology : From Cell to Bedside, 3rd ed (ed by Zipes DP, Jalife J), p345-355, WB Saunders, Philadelphia, 2000.
 
4) 池田隆徳 : spiral waveとリエントリー. 新不整脈学 (井上博編) : 医学書院, pp106-110, 2003.
 
5) Janse MJ : Mechanisms of atrial fibrillation. In : Cardiac Electrophysiology : From Cell to Bedside, 3rd ed (ed by Zipes DP, Jalife J), p476-481, WB Saunders, Philadelphia, 2000.
 
P.15 掲載の参考文献
1) Edvardsson N, et al : Use of an implantable loop recorder to increase the diagnostic yield in unexplained syncope : results from the PICTURE registry. Europace 13 : 262-269, 2011.
PubMed
2) 日本循環器学会, ほか : 循環器病の診断と治療に関するガイドライン (2011年度合同研究班報告). 失神の診断・治療ガイドライン (2012年改訂版), 2012. [http://www.j-circ.or.jp/guideline/pdf/JCS2012_inoue_h.pdf] (2019年8月閲覧)
 
3) Steinberg JS, et al : 2017 ISHNE-HRS expert consensus statement on ambulatory ECG and external cardiac monitoring/telemetry. Ann Noninvasive Electrocardiol 22. doi : 10.1111/anec.12447,2017.
 
4) Soteriades ES, et al : Incidence and prognosis of syncope. N Engl J Med 347 : 878-885, 2002.
PubMed
P.18 掲載の参考文献
1) Shen WK, et al : 2017 ACC/AHA/HRS Guideline for the Evaluation and Management of Patients With Syncope : A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol 70 : e39-e110, 2017.
 
2) Brignole M, et al : 2018 ESC Guidelines for the diagnosis and management of syncope. Eur Heart J 39 : 1883-1948, 2018.
PubMed
3) Kerr SRJ, et al : Carotid sinus hypersensitivity in asymptomatic older persons : Implications for diagnosis of syncope and falls. Arch Intern Med 166 : 515-520, 2006.
 
4) Brignole M, et al : Guidelines on management (diagnosis and treatment) of syncope-update 2004. Executive Summary. Eur Heart J 25 : 2054-2072, 2004.
PubMed
5) McIntosh SJ, et al : Clinical characteristics of vasodepressor, cardioinhibitory, and mixed carotid sinus syndrome in the elderly. Am J Med 95 : 203-208, 1993.
PubMed
6) Parry SW, et al : Diagnosis of carotid sinus hypersensitivity in older adults : carotid sinus massage in the upright position is essential. Heart 83 : 22-23, 2000.
PubMed
7) Puggioni E, et al : Results and complications of the carotid sinus massage performed according to the "method of symptoms". Am J Cardiol 89 : 599-601, 2002.
 
8) 日本循環器学会, ほか : 循環器病の診断と治療に関するガイドライン (2011年度合同研究班報告). 失神の診断・治療ガイドライン (2012年改訂版), 2012. [http://www.j-circ.or.jp/guideline/pdf/JCS2012_inoue_h.pdf] (2019年8月閲覧)
 
9) Lopes R, et al : The role of pacemaker in hypersensitive carotid sinus syndrome. Europace 13 : 572-575, 2011.
PubMed
10) McLeod CJ, et al : Method of pacing does not affect the recurrence of syncope in carotid sinus syndrome. Pacing Clin Electrophysiol 35 : 827-833, 2012.
 
11) Sheldon R, et al : Effect of dual-chamber pacing with automatic rate-drop sensing on recurrent neurally mediated syncope. Am J Cardiol 81 : 158-162, 1998.
PubMed
P.21 掲載の参考文献
1) Brown SJ, et al : Cardiac vagal control and respiratory sinus arrhythmia during hypercapnia in humans. J Physiol Sci 57 : 337-342, 2007.
PubMed
2) Stein PK, et al : Heart rate variability : a measure of cardiac autonomic tone. Am Heart J 127 : 1376-1381, 1994.
 
3) Neff RA, et al : Respiratory sinus arrhythmia : endogenous activation of nicotinic receptors mediates respiratory modulation of brainstem cardioinhibitory parasympathetic neurons. Circ Res 93 : 565-572, 2003.
PubMed
4) Hayano J, Yasuma F : Hypothesis : respiratory sinus arrhythmia is an intrinsic resting function of cardiopulmonary system. Cardiovasc Res 58 : 1-9, 2003.
PubMed
5) Yasuma F, Hayano J : Respiratory sinus arrhythmia : why does the heartbeat synchronize with respiratory rhythm? Chest 125 : 683-690, 2004.
PubMed
P.26 掲載の参考文献
1) Hancock EW : Coronary sinus rhythm in sinus venosus defect and persistent left superior vena cava. Am J Cardiol 14 : 608-615, 1964.
PubMed
2) Higuchi S, et al : A Unique Ectopic Atrial Rhythm : Where Is the Origin? Pacing Clin Electrophysiol 40 : 323-325, 2017.
PubMed
3) Mirowski M : Left atrial rhythm ; diagnostic criteria and differentiation from nodal arrhythmias. Am J Cardiol 17 : 203-210, 1966.
PubMed
4) Kistler PM, et al : P-wave morphology in focal atrial tachycardia : development of an algorithm to predict the anatomic site of origin. J Am Coll Cardiol 48 : 1010-1017, 2006.
PubMed
5) Yamane T, et al : Morphological characteristics of P waves during selective pulmonary vein pacing. J Am Coll Cardiol 38 : 1505-1510, 2001.
PubMed
6) Inoue D, Hartigan PM : Wandering pacemaker. Chest 98 : 1542, 1990.
PubMed
7) Bjornstad H, et al : Electrocardiographic findings in athletic students and sedentary controls. Cardiology 79 : 290-305, 1991.
PubMed
8) Borgia JF, et al : Wandering atrial pacemaker associated with repetitive respiratory strain. Cardiology 69 : 70-73, 1982.
PubMed
9) Nizet PM, et al : Wandering atrial pacemaker (prevalence in French hornists). J Electrocardiol 9 : 51-52, 1976.
PubMed
10) Izumi K : Atrial parasystolic trigeminy with sinus node echoes during wandering sinus node pacemaker in a patient with malignant lymphoma and hypertrophic cardiomyopathy. J Electrocardiol 25 : 59-64, 1992.
 
11) Gomes JA, Winters SL : The origins of the sinus node pacemaker complex in man : demonstration of dominant and subsidiary foci. J Am Coll Cardiol 9 : 45-52, 1987.
PubMed
12) SippensGroenewegen A, et al : Body surface mapping during pacing at multiple sites in the human atrium : P-wave morphology of ectopic right atrial activation. Circulation 97 : 369-380, 1998.
PubMed
13) Piccolo E, et al : Wandering pacemaker-a vectorcardiographic study. Cardiology 55 : 69-78, 1970.
PubMed
P.28 掲載の参考文献
1) Spodick DH : Normal sinus heart rate : sinus tachycardia and sinus bradycardia redefined. Am Heart J 124 : 1119-1121, 1992.
PubMed
2) Thery C, et al : Pathology of sinoatrial node. Correlations with electrocardiographic findings in 111 patients. Am Heart J 93 : 735-740, 1977.
PubMed
3) Dobrzynski H, et al : Structure, function and clinical relevance of the cardiac conduction system, including the atrioventricular ring and outflow tract tissues. Pharmacol Ther 139 : 260-288, 2013.
PubMed
4) Chua K, et al : High-resolution mapping of the triangle of Koch : Spatial heterogeneity of fast pathway atrionodal connections. Heart Rhythm 15 : 421-429, 2018.
PubMed
5) Rodriguez RD, Schocken DD : Update on sick sinus syndrome, a cardiac disorder of aging. Geriatrics 45 : 26-30, 33-36, 1990.
 
6) Hauptman PJ, Kelly RA : Digitalis. Circulation 99 : 1265-1270, 1999.
PubMed
7) Kelly RA, Smith TW : Recognition and management of digitalis toxicity. Am J Cardiol 69 : 108G-118G ; disc. 118G-119G, 1992.
 
8) Antman EM, et al : Treatment of 150 cases of life-threatening digitalis intoxication with digoxinspecific Fab antibody fragments. Final report of a multicenter study. Circulation 81 : 1744-1752, 1990.
PubMed
9) Tuohy S, et al : Catheter ablation as a treatment of atrioventricular block. Heart Rhythm 15 : 90-96, 2018.
PubMed
10) Kim D, et al : Calcium dynamics and the mechanisms of atrioventricular junctional rhythm. J Am Coll Cardiol 56 : 805-812, 2010.
PubMed
11) Semelka M, et al : Sick sinus syndrome : a review. Am Fam Physician 87 : 691-696, 2013.
PubMed
12) Trappe HJ : Tachyarrhythmias, bradyarrhythmias and acute coronary syndromes. J Emerg Trauma Shock 3 : 137-142, 2010.
PubMed
13) Romhilt DW, et al : Prevalence and significance of arrhythmias in long-term survivors of cardiac transplantation. Circulation 66 : 1219-222, 1982.
 
P.33 掲載の参考文献
1) Surawicz B, Knilans TK : Ventricular arrhythmias. In : Chou's Electrocardiography in Clinical Practice, 6th ed, p405-439, Saunders, Philadelphia, 2008.
 
2) Schamroth L : Idioventricular tachycardia. J Electrocardiol 1 : 205-212, 1968.
PubMed
3) Lichstein E, et al : Incidence and description of accelerated ventricular rhythm complicating acute myocardial infarction. Am J Med 58 : 192-198, 1975.
PubMed
4) Hiss RG, et al : Electrocardiographic findings in 67,375 asymptomatic subjects. III. Ventricular rhythms. Am J Cardiol 6 : 96-107, 1960.
PubMed
5) Denes P, et al : Prevalence, characteristics and significance of ventricular premature complexes and ventricular tachycardia detected by 24-hour continuous electrocardiographic recording in the Cardiac Arrhythmia Suppression Trial. CAST Investigators. Am J Cardiol 68 : 887-896, 1991.
PubMed
6) Hasdemir C, et al : Tachycardia-induced cardiomyopathy in patients with idiopathic ventricular arrhythmias : the incidence, clinical and electrophysiologic characteristics, and the predictors. J Cardiovasc Electrophysiol 22 : 663-668, 2011.
PubMed
7) Crosson JE, et al : PACES/HRS expert consensus statement on the evaluation and management of ventricular arrhythmias in the child with a structurally normal heart. Heart Rhythm 11 : e55-78, 2014.
PubMed
8) Tsuji A, et al : Long-term follow-up of idiopathic ventricular arrhythmias in otherwise normal children. Jpn Circ J 59 : 654-662, 1995.
PubMed
P.37 掲載の参考文献
1) Scherf D, et al : Parasystole. Am J Cardiol 12 : 527-538, 1963.
PubMed
2) Jalife J, Moe GK : Effect of electrotonic potentials on pacemaker activity of canine Purkinje fibers in relation to parasystole. Circ Res 39 : 801-808, 1976.
PubMed
3) Jalife J, et al : A biologic model of parasystole. Am J Cardiol 43 : 761-772, 1979.
PubMed
4) Jalife J, et al : The case for modulated parasystole. Pacing Clin Electrophysiol 5 : 911-926, 1982.
PubMed
5) Nau GJ, et al : Modulation of parasystolic activity by nonparasystolic beats. Circulation 66 : 462-469, 1982.
PubMed
6) Takayanagi K, et al : Strong modulation of ectopic focus as a mechanism of repetitive interpolated ventricular bigeminy with heart rate doubling. Heart Rhythm 10 : 1433-1440, 2013.
PubMed
7) Castellanos A, et al : A search for modulation in intermittent ventricular parasystole. Pacing Clin Electrophysiol 3 : 73-83, 1980.
 
8) Antzelevitch C, et al : Parasystole, reentry, and tachycardia : a canine preparation of cardiac arrhythmias occurring across inexcitable segments of tissue. Circulation 68 : 1101-1115, 1983.
PubMed
9) Jalife J, et al : Excitation, conduction, and reflection of impulses in isolated bovine and serum cardiac purkinje fibers. Circ Res 49 : 233-247, 1981.
PubMed
10) Castellanos A, et al : Annihilation, entrainment and modulation of ventricular parasystolic rhythms. Am J Cardiol 54 : 317-322, 1984.
PubMed
11) Jalife J, Antzelevitch C : Phase resetting and annihilation of pacemaker activity in cardiac tissue. Science 206 : 695-697, 1979.
PubMed
12) Haissaguerre M, et al : Mapping and ablation of idiopathic ventricular fibrillation. Circulation 106 : 962-967, 2002.
PubMed
P.39 掲載の参考文献
1) Page RL, et al : 2015 ACC/AHA/HRS Guideline for the Management of Adult Patients With Supraventricular Tachycardia : A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. Circulation 133 : e506-574, 2016.
 
P.42 掲載の参考文献
1) 日本循環器学会, ほか : 日本循環器学会/日本不整脈心電学会合同ガイドライン. 不整脈非薬物治療ガイドライン (2018年改訂版), 2019.
 
P.49 掲載の参考文献
1) John RM, Kumar S : Sinus Node and Atrial Arrhythmias. Circulation 133 : 1892-1900, 2016.
PubMed
2) Kottkamp H, et al : Catheter ablation of atrial fibrillation : how to modify the substrate? J Am Coll Cardiol 65 : 196-206, 2015.
PubMed
3) 関口守衛 : 心房心筋症と心房性不整脈. 心電図 19 : 250-254, 1999.
Medical*Online
4) Makita N, et al : Congenital atrial standstill associated with coinheritance of a novel SCN5A mutation and connexin 40 polymorphisms. Heart Rhythm 2 : 1128-1134, 2005.
PubMed
5) 稲葉茂樹, ほか : Persistent atrial standstill. 呼吸と循環 36 : 361-369, 1988.
 
6) Khan IA : Atrial stunning : determinants and cellular mechanisms. Am Heart J 145 : 787-794, 2003.
PubMed
7) Woolliscroft J, Tuna N : Permanent atrial standstill : the clinical spectrum. Am J Cardiol 49 : 2037-2041, 1982.
PubMed
P.54 掲載の参考文献
1) Bachmann G : The Inter-auricular time interval. Am J Physiol 41 : 309-320, 1916.
 
2) Conde D, et al : Bayes' syndrome : the association between interatrial block and supraventricular arrhythmias. Expert Rev Cardiovasc Ther 13 : 541-550, 2015.
PubMed
3) Bayes de Luna A, et al : Diagnosis of interatrial block. J Geriatr Cardiol 14 : 161-165, 2017.
PubMed
4) Bayes de Luna A, et al : Electrocardiographic and vectorcardiographic study of interatrial conduction disturbances with left atrial retrograde activation. J Electrocardiol 18 : 1-13, 1985.
PubMed
5) Bayes de Luna A, et al : Interatrial blocks. A separate entity from left atrial enlargement : a consensus report. J Electrocardiol 45 : 445-451, 2012.
PubMed
6) Gialafos E, et al : Prevalence of interatrial block in young healthy men < 35 years of age. Am J Cardiol 100 : 995-997, 2007.
PubMed
7) Asad N, Spodick DH : Prevalence of interatrial block in a general hospital population. Am J Cardiol 91 : 609-610, 2003.
 
8) Ariyarajah V, et al : Interatrial block : pandemic prevalence, significance, and diagnosis. Chest 128 : 970-975, 2005.
PubMed
9) Legato MJ, et al : Atrial ultrastructure in patients with fixed intra-atrial block. Chest 65 : 252-261, 1974.
PubMed
10) Ariyarajah V, et al : Potential factors that affect electrocardiographic progression of interatrial block. Ann Noninvasive Electrocardiol 12 : 21-26, 2007.
PubMed
11) Mizuno R, et al : Atrial conduction abnormalities in patients with systemic progressive sclerosis. Eur Heart J 18 : 1995-2001, 1997.
PubMed
12) Rocken C, et al : Atrial amyloidosis : an arrhythmogenic substrate for persistent atrial fibrillation. Circulation 106 : 2091-2097, 2002.
PubMed
13) Song J, et al : Effect of diuresis on P-wave duration and dispersion. Pharmacotherapy 22 : 564-568, 2002.
 
14) Roithinger FX, et al : Use of electroanatomic mapping to delineate transseptal atrial conduction in humans. Circulation 100 : 1791-1797, 1999.
PubMed
15) Markides V, et al : Characterization of left atrial activation in the intact human heart. Circulation 107 : 733-739, 2003.
PubMed
16) Mitrofanova L, et al : Anatomy of the inferior interatrial route in humans. Europace 7 (Suppl 2) : 49-55, 2005.
 
17) Lewis T, et al : The excitatory process in the dog's heart. Part I. The auricles. Phil Trans Roy Soc Lond 205 : 375-426, 1914.
 
18) Frisella ME, Spodick DH : Confirmation of the prevalence and importance of a 12-lead investigation for diagnosis of interatrial block [corrected]. Am J Cardiol 96 : 696-697, 2005.
PubMed
19) Bayes de Luna A, et al : Interatrial conduction block and retrograde activation of the left atrium and paroxysmal supraventricular tachyarrhythmia. Eur Heart J 9 : 1112-1118, 1988.
PubMed
20) Agarwal YK, et al : Association of interatrial block with development of atrial fibrillation. Am J Cardiol 91 : 882, 2003.
PubMed
21) Zaman AG, et al : Angiotensin-converting enzyme inhibitors as adjunctive therapy in patients with persistent atrial fibrillation. Am Heart J 147 : 823-827, 2004.
PubMed
22) Kitkungvan D, Spodick DH : Interatrial block : is it time for more attention? J Electrocardiol 42 : 687-692, 2009.
PubMed
23) Fogari R, et al : Effect of valsartan and ramipril on atrial fibrillation recurrence and P-wave dispersion in hypertensive patients with recurrent symptomatic lone atrial fibrillation. Am J Hypertens 21 : 1034-1039, 2008.
PubMed
24) Celik T, et al : The comparative effects of telmisartan and ramipril on P-wave dispersion in hypertensive patients : a randomized clinical study. Clin Cardiol 28 : 298-302, 2005.
 
25) Daubert C, et al : [Permanent atrial resynchronization by synchronous bi-atrial pacing in the preventive treatment of atrial flutter associated with high degree interatrial block]. Arch Mal Coeur Vaiss 87 : 1535-1546, 1994.
PubMed
26) Becker R, et al : Suppression of atrial fibrillation by multisite and septal pacing in a novel experimental model. Cardiovasc Res 54 : 476-481, 2002.
 
27) Saksena S, et al : Improved suppression of recurrent atrial fibrillation with dual-site right atrial pacing and antiarrhythmic drug therapy. J Am Coll Cardiol 40 : 1140-1150 ; discussion l151-1152, 2002.
 
28) Ding L, et al : Improvement of P wave dispersion after cardiac resynchronization therapy for heart failure. J Electrocardiol 42 : 334-338, 2009.
PubMed
P.60 掲載の参考文献
1) Kerola T, et al : Risk Factors Associated With Atrioventricular Block. JAMA Netw Open 2 : e194176, 2019.
PubMed
2) James TN, et al : Apoptosis as a possible cause of gradual development of complete heart block and fatal arrhythmias associated with absence of the AV node, sinus node, and internodal pathways. Circulation 93 : 1424-1438, 1996.
PubMed
3) Nery PB, et al : Atrioventricular block as the initial manifestation of cardiac sarcoidosis in middle-aged adults. J Cardiovasc Electrophysiol 25 : 875-881, 2014.
PubMed
4) Aro AL, et al : Prognostic significance of prolonged PR interval in the general population. Eur Heart J 35 : 123-129, 2014.
PubMed
5) Crisel RK, et al : First-degree atrioventricular block is associated with heart failure and death in persons with stable coronary artery disease : data from the Heart and Soul Study. Eur Heart J 32 : 1875-1880, 2011.
PubMed
6) 日本循環器学会, ほか : 日本循環器学会/日本不整脈心電学会合同ガイドライン. 不整脈非薬物治療ガイドライン (2018年改訂版), 2019. [http://www.j-circ.or.jp/guideline/pdf/JCS2018_kurita_nogami.pdf] (2019年8月閲覧)
 
P.64 掲載の参考文献
1) Aste M, Brignole M : Syncope and paroxysmal atrioventricular block. J Arrhythm 33 : 562-567, 2017.
PubMed
2) Brignole M, et al : Syncope and Idiopathic (Paroxysmal) AV Block. Cardiol Clin 33 : 441-447, 2015.
PubMed
3) Brignole M, et al : Lack of correlation between the responses to tilt testing and adenosine triphosphate test and the mechanism of spontaneous neurally mediated syncope. Eur Heart J 27 : 2232-2239, 2006,
PubMed
4) McAnulty JH, et al : Natural history of "high-risk" bundle-branch block : final report of a prospective study. N Engl J Med 307 : 137-143, 1982.
PubMed
5) Blanc JJ, Le Dauphin C : Syncope associated with documented paroxysmal atrioventricular block reproduced by adenosine 5' triphosphate injection. Europace 16 : 923-927, 2014.
PubMed
6) Brignole M, et al : Adenosine-induced atrioventricular block in patients with unexplained syncope : the diagnostic value of ATP testing. Circulation 96 : 3921-3927, 1997.
PubMed
7) 日本循環器学会, ほか : 日本循環器学会/日本不整脈心電学会合同ガイドライン. 不整脈非薬物治療ガイドライン (2018年改訂版), 2019. [http://www.j-circ.or.jp/guideline/pdf/JCS2018_kurita_nogami.pdf] (2019年8月閲覧)
 
8) Flammang D, et al : Treatment of unexplained syncope : a multicenter, randomized trial of cardiac pacing guided by adenosine 5'-triphosphate testing. Circulation 125 : 31-36, 2012.
PubMed
P.67 掲載の参考文献
1) Pick A : AV Dissociation. A proposal for a comprehensive classification and consistent terminology. Am Heart J 66 : 147-150, 1963.
PubMed
2) Phibbs B : Interference, dissociation, and semantics. A plea for rational nomenclature. Am Heart J 65 : 283-285, 1963.
PubMed
3) Marriott HJL, Menendez MM : A-V dissociation revisited. Prog Cardiovasc Dis 8 : 522-538, 1966.
 
4) Marriott HJL, et al : A-V dissociation : a reappraisal. Am J Cardiol 2 : 586-605, 1958.
 
5) Harrigan RA, et al : Atrioventricular dissociation. Am J Emerg Med 19 : 218-222, 2001.
 
P.70 掲載の参考文献
1) Katritsis DG : Chapter 105. Progressive conduction system disease. In : Cardiac Electrophysiology : From Cell to Bedside, 7th ed (ed by Zipes DP, et al), p996-1000, Elsevier, Philadelphia, 2017.
 
2) Lenegre J : [Chronic complete auriculo-ventricular blocks. Study of causes and lesions apropos of 37 cases]. Mal Cardiovasc 3 : 311-343, 1962.
PubMed
3) Brink PA, et al : Gene for progressive familial heart block type I maps to chromosome 19q13. Circulation 91 : 1633-1640, 1995.
PubMed
4) Schott JJ, et al : Cardiac conduction defects associate with mutations in SCN5A. Nat Genet 23 : 20-21, 1999.
PubMed
5) Priori SG, et al : Executive summary : HRS/EHRA/APHRS expert consensus statement on the diagnosis and management of patients with inherited primary arrhythmia syndromes. Heart Rhythm 10 : e85-108, 2013.
PubMed
6) 蒔田直昌 : 厚生労働科学研究費補助金難治性疾患克服研究事業 進行性心臓伝導障害の病態診断と遺伝子基盤に関する研究班, 平成23年度総括・分担報告書, 2012.
 
7) Watanabe H, et al : Electrocardiographic abnormalities and risk of complete atrioventricular block. Int J Cardiol 155 : 462-464, 2012.
PubMed
8) Schott JJ, et al : Congenital heart disease caused by mutations in the transcription factor NKX2-5. Science 281 : 108-111, 1998.
PubMed
9) Fatkin D, et al : Missense mutations in the rod domain of the lamin A/C gene as causes of dilated cardiomyopathy and conduction-system disease. N Engl J Med 341 : 1715-1724, 1999.
PubMed
10) Basson CT, et al : The clinical and genetic spectrum of the Holt-Oram syndrome (heart-hand syndrome). N Engl J Med 330 : 885-891, 1994.
PubMed
11) Hayashi H, et al : Association between Progressive Intraventricular Conduction Disturbance and Cardiovascular Events. PLoS ONE 11 : e0157412, 2016.
PubMed
12) Kawaguchi T, et al : Prognostic implications of progressive cardiac conduction disease. Circ J 77 : 60-67, 2013.
PubMed
13) Hao X, et al : TGF-β1-mediated fibrosis and ion channel remodeling are key mechanisms in producing the sinus node dysfunction associated with SCN5A deficiency and aging. Circ Arrhythm Electrophysiol 4 : 397-406, 2011.
 
P.75 掲載の参考文献
1) 井川修 : 心不全に伴う不整脈を理解するために必要な心臓解剖. 日本臨牀 77 (増刊 : 心不全 (第2版) 下) : 144-156, 2019.
 
2) 井川修 : 臨床心臓構造学-不整脈診療に役立つ心臓解剖-, p49-55, 医学書院, 2011.
 
3) Willems JI, et al : Criteria for intraventricular conduction disturbances and pre-excitation. World Health Organization/International Society and Federation for Cardiology Task Force Ad Hoc. J Am Coll Cardiol 5 : 1261-1275, 1985.
 
4) 厚生労働省 第5次循環器疾患基礎調査 (平成12年), 2000. [https://www.mhlw.go.jp/toukei/kouhyo/indexkk_18_1.html] (2019年10月閲覧)
 
5) Brugada P, et al : Right bundle branch block, persistent ST segment elevation and sudden cardiac death : a distinct clinical and electrocardiographic syndrome. A multicenter report. J Am Coll Cardiol 20 : 1391-1396, 1992.
PubMed
6) Antzelevitch C, et al : Brugada syndrome : 1992-2002 : a historical perspective. J Am Coll Cardiol 41 : 1665-1671, 2003.
PubMed
P.81 掲載の参考文献
1) 井川修 : 臨床心臓構造学-不整脈診療に役立つ心臓解剖-, p49-55, 医学書院, 2011.
 
2) 井川修 : 心不全に伴う不整脈を理解するために必要な心臓解剖. 日本臨牀 77 (増刊 : 心不全 (第2版) 下) : 144-156, 2019.
 
3) James TN, Sherf L : Fine structure of the His bundle. Circulation 44 : 9-28, 1971.
PubMed
4) Wyndham CR, et al : Epicardial activation of the intact human heart without conduction defect. Circulation 59 : 161-168, 1979.
PubMed
5) Nikoo MH, et al : LBBB : State-of-the-Art Criteria. Int Cardiovasc Res J 7 : 39-40, 2013.
PubMed
6) Lenegre J : Etiology and Pathology of Bilateral Bundle Branch Block in Relation to Complete Heart Block. Prog Cardiovasc Dis 6 : 409-444, 1964.
PubMed
7) Lev M : The Pathology of Complete Atrioventricular Block. Prog Cardiovasc Dis 6 : 317-326, 1964.
PubMed
8) Sgarbossa EB, et al : Electrocardiographic diagnosis of evolving acute myocardial infarction in the presence of left bundle-branch block. GUSTO-1 (Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries) Investigators. N Engl J Med 334 : 481-487, 1996.
 
9) Dillon JC, et al : Echocardiographic manifestations of left bundle branch block. Circulation 49 : 876-880, 1974.
PubMed
10) Hirzel HO, et al : Thallium-201 scintigraphy in complete left bundle branch block. Am J Cardiol 53 : 764-769, 1984.
PubMed
11) MH Ellestad : Rhythm and conduction disturbances in stress testing. In : Stress Testing : Principles and Practice, 4th ed (ed by Ellestad MH), p309-311, FA Davis, Philadelphia, 1996.
 
12) Vijayaraman P, et al : Permanent His bundle pacing is an excellent alternative to cardiac resynchronization therapy. Heart Rhythm 13 : S39-S40, 2016.
 
P.86 掲載の参考文献
1) Kawaguchi T, et al : Prognostic implications of progressive cardiac conduction disease. Circ J 77 : 60-67, 2013.
PubMed
2) 日本循環器学会, ほか : 循環器病の診断と治療に関するガイドライン (2010年度合同研究班報告). 臨床心臓電気生理検査に関するガイドライン (2011年改訂版), 2011.
 
3) 日本循環器学会, ほか : 日本循環器学会/日本不整脈心電学会合同ガイドライン. 不整脈非薬物治療ガイドライン (2018年改訂版), 2019.
 
4) McAnulty JH, et al : A prospective study of sudden death in "high-risk" bundle-branch block. N Engl J Med 299 : 209-215, 1978.
PubMed
5) McAnulty JH, et al : Natural history of "high-risk" bundle-branch block : final report of a prospective study. N Engl J Med 307 : 137-143, 1982.
PubMed
P.91 掲載の参考文献
1) Haataja P, et al : Prevalence of ventricular conduction blocks in the resting electrocardiogram in a general population : the Health 2000 Survey. Int J Cardiol 167 : 1953-1960, 2013.
 
2) Baldasseroni S, et al : Intraventricular conduction defects in patients with congestive heart failure : left but not right bundle branch block is an independent predictor of prognosis. A report from the Italian Network on Congestive Heart Failure (IN-CHF database). Ital Heart J 4 : 607-613, 2003.
 
3) Kawaguchi T, et al : Prognostic implications of progressive cardiac conduction disease. Circ J 77 : 60-67, 2013.
PubMed
4) Coumel P, Attuel P : Reciprocating tachycardia in overt and latent preexcitation. Influence of functional bundle branch block on the rate of the tachycardia. Eur J Cardiol 1 : 423-436, 1974.
PubMed
5) Braunschweig F, et al : New York Heart Association functional class, QRS duration, and survival in heart failure with reduced ejection fraction : implications for cardiac resychronization therapy. Eur J Heart Fail 19 : 366-376, 2017.
 
6) 日本循環器学会, ほか : 日本循環器学会/日本不整脈心電学会合同ガイドライン. 不整脈非薬物治療ガイドライン (2018年改訂版), 2019.
 
P.95 掲載の参考文献
1) Gallagher JJ, et al : Multiple accessory pathways in patients with the pre-excitation syndrome. Circulation 54 : 571-591, 1976.
PubMed
2) Benditt DG, et al : Characteristics of atrioventricular conduction and the spectrum of arrhythmias in lown-ganong-levine syndrorne. Circulation 57 : 454-465, 1978.
PubMed
3) Wiener I : Syndromes of Lown-Ganong-Levine and enhanced atrioventricular nodal conduction. Am J Cardiol 52 : 637-639, 1983.
PubMed
4) James TN : Morphology of the human atrioventricular node, with remarks pertinent to its electrophysiology. Am Heart J 62 : 756-771, 1961.
PubMed
5) Lown B, et al : The syndrome of short P-R interval, normal QRS complex and paroxysmal rapid heart action. Circulation 5 : 693-706, 1952.
 
6) Ometto R, et al : Enhanced A-V nodal conduction (Lown-Ganong-Levine syndrome) by congenitally hypoplastic A-V node. Eur Heart J 13 : 1579-1584, 1992.
 
7) Josephson ME, Kastor JA : Supraventricular tachycardia in Lown-Ganong-Levine syndrome : atrionodal versus intranodal reentry. Am J Cardiol 40 : 521-527, 1977.
PubMed
8) Bauernfeind RA, et al : Analysis of anterograde and retrograde fast pathway properties in patients with dual atrioventricular nodal pathways : observations regarding the pathophysiology of the Lown-Ganong-Levine syndrome. Am J Cardiol 49 : 283-290, 1982.
PubMed
9) Jackman WM, et al : Reevaluation of enhanced atrioventricular nodal conduction : evidence to suggest a continuum of normal atrioventricular nodal physiology. Circulation 67 : 441-448, 1983.
PubMed
10) Castellanos A, et al : Syndrome of short P-R, narrow QRS and repetitive supraventricular tachyarrhythmias : the possible occurrence of the R-on-T phenomenon and the limits of this syndrome. Eur J Cardiol 2 : 337-342, 1975.
 
11) Myerburg RJ, et al : Ventricular tachycardia and ventricular fibrillation in patients with short P-Rintervals and narrow QRS complexes. Pacing Clin Electrophysiol 2 : 568-578, 1979.
 
12) Benditt DG, et al : AV node bypass tracts and enhanced AV conduction : Relation to ventricular preexcitation. In : Cardiac Pre-excitation Syndromes (ed by Benditt DG, et al), p225, Martinus Nijhoff, Boston, 1986.
 
13) Moro C, Cosio FG : Electrophysiologic study of patients with short P-R interval and normal QRS complex. Eur J Cardiol 11 : 81-90, 1980.
 
P.100 掲載の参考文献
1) Lewis T : The Mechanism and Graphic Registration of the Heart Beat, 3rd ed, p116-122, Shaw & Sons, London, 1925.
 
2) Adrian ED, Lucas K : On the summation of propagated disturbances in nerve and muscle. J Physiol (Lond) 44 : 68-124, 1912.
 
3) Orias O, et al : Excitability of the mammalian ventricle throughout the cardiac cycle. Am J Physiol 163 : 272-282, 1950.
PubMed
4) Wiggers CJ, Wegria R : Ventricular fibrillation due to single, localized induction and condenser shocks applied during the vulnerable phase of ventricular systole. Am J Physiol 128 : 500-505, 1940.
 
5) Van Dam RT, et al : The excitability cycle of the dog's left ventricle determined by anodal, cathodal, and bipolar stimulation. Circ Res 4 : 196-204, 1956.
PubMed
6) Gotoh M, et al : Cellular graded responses and ventricular vulnerability to reentry by a premature stimulus in isolated canine ventricle. Circulation 95 : 2141-2154, 1997.
PubMed
7) Lujan HL et al : A single electrical pulse within the protective zone of each cardiac cycle prevented reperfusion-induced ventricular tachycardia in conscious mice. Physiol Rep 6. doi : 10.14814/phy2.13578, 2018.
 
8) McHenry PL, et al : The Wolff-Parkinson-White (WPW) syndrome with supernormal conduction through the anomalous BYPASS. Circulation 34 : 734-739, 1966.
PubMed
9) Childers RW, et al : Supernormality in Bachmann's bundle. An in vitro and in vivo study in the dog. Circ Res 22 : 363-370, 1968.
 
10) Merideth J, et al : Electrical excitability of atrioventricular nodal cells. Circ Res 23 : 69-85, 1968.
PubMed
11) Suguta M, et al : Retrograde supernormal conduction in concealed accessory atrioventricular pathway following catheter ablation. J Cardiovasc Electrophysiol 8 : 1291-1295, 1997.
PubMed
12) Damato AN, et al : Gap phenomena : Antegrade and retrograde. In : the Conduction System of the Heart. Structure, Function and Clinical Implications (ed by Wellens HJJ, et al), P504-528, HE Stenfert Kroese, Leiden, 1976.
 
13) Rosenbaum MB, et al : Paroxysmal atrioventricular block related to hypopolarization and spontaneous diastolic depolarization. Chest 63 : 678-688, 1973.
PubMed
14) Saihara S, et al : Summation of excitation with a single conditioning stimulus in the canine heart. Pacing Clin Electrophysiol 13 : 52-58, 1990.
PubMed
15) Sohns C, et al : Supraventricular tachycardia with 'A-A-V' response upon ventricular entrainment and transient 2 : 1 AV conduction block. Clin Res Cardiol 102 : 927-929, 2013.
 
P.109 掲載の参考文献
1) Tasaki H, et al : Longitudinal age-related changes in 24-hour total heart beats and premature beats and their relationship in healthy elderly subjects. Int Heart J 47 : 549-563, 2006.
PubMed
2) Conen D, et al : Premature atrial contractions in the general population : frequency and risk factors. Circulation 126 : 2302-2308, 2012.
PubMed
3) Bjerregaard P : Premature beats in healthy subjects 40-79 years of age. Eur Heart J 3 : 493-503, 1982.
PubMed
4) Binici Z, et al : Excessive supraventricular ectopic activity and increased risk of atrial fibrillation and stroke. Circulation 121 : 1904-1911, 2010.
PubMed
5) Larsen BS, et al : Excessive Atrial Ectopy and Short Atrial Runs Increase the Risk of Stroke Beyond Incident Atrial Fibrillation. J Am Coll Cardiol 66 : 232-241, 2015.
PubMed
6) Murakoshi N, et al : Prognostic impact of supraventricular premature complexes in community-based health checkups : the Ibaraki Prefectural Health Study. Eur Heart J 36 : 170-178, 2015.
PubMed
7) Inohara T, et al : Long-term outcome of healthy participants with atrial premature complex : a 15-year follow-up of the NIPPON DATA 90 cohort. PLoS ONE 8 : e80853, 2013.
PubMed
8) Suzuki S, et al : Usefulness of frequent supraventricular extrasystoles and a high CHADS2 score to predict first-time appearance of atrial fibrillation. Am J Cardiol 111 : 1602-1607, 2013.
 
9) Kochhauser S, et al : Supraventricular premature beats and short atrial runs predict atrial fibrillation in continuously monitored patients with cryptogenic stroke. Stroke 45 : 884-886, 2014.
PubMed
10) Gladstone DJ, et al : Atrial premature beats predict atrial fibrillation in cryptogenic stroke : results from the EMBRACE trial. Stroke 46 : 936-941, 2015.
PubMed
11) Cardiac Arrhythmia Suppression Trial (CAST) Investigators : Preliminary report : effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction. N Engl J Med 321 : 406-412, 1989.
 
P.114 掲載の参考文献
1) Kostis JB, et al : Premature ventricular complexes in the absence of identifiable heart disease. Circulation 63 : 1351-1356, 1981.
PubMed
2) Ruberman W, et al : Ventricular premature beats and mortality after myocardial infarction. N Engl J Med 297 : 750-757, 1977.
PubMed
3) Bikkina M, et al : Asymptomatic ventricular arrhythmias and mortality risk in subjects with left ventricular hypertrophy. J Am Coll Cardiol 22 : 1111-1116, 1993.
PubMed
4) Jouven X, et al : Long-term outcome in asymptomatic men with exercise-induced premature ventricular depolarizations. N Engl J Med 343 : 826-833, 2000.
PubMed
5) Lin CY, et al : Long-term outcome of multiform premature ventricular complexes in structurally normal heart. Int J Cardiol 180 : 80-85, 2015.
 
6) Kennedy HL, et al : Long-term follow-up of asymptomatic healthy subjects with frequent and complex ventricular ectopy. N Engl J Med 312 : 193-197, 1985.
PubMed
7) Echt DS, et al : Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial. N Engl J Med 324 : 781-788, 1991.
 
P.119 掲載の参考文献
1) Nakahara S, et al : Catheter ablation of ventricular parasystole. J Arrhythm 27 : 83-86, 2011.
 
2) Takayanagi K, Sakai Y : Mechanism of ventricular premature contraction showing interpolated bigeminy-Strong modulation hypothesis-. J Arrhythm 25 : 177-192, 2009.
 
3) Steinfurt J, et al : Fascicular parasystole and recurrent syncope-a case report. Eur Heart J Case Rep 2 : yty020, 2018.
PubMed
4) Wang H, Wang L : Ablation ofunmappable ventricular parasystole originating from the right ventricular outflow tract : a case report. BMC Cardiovasc Disord 19 : 3, 2019.
 
P.123 掲載の参考文献
1) Murakawa Y, et al : A brief report on the nationwide survey of catheter ablation in Japan/the Japanese Catheter Ablation Registry (JCAR). J Arrhythm 28 : 122-126, 2012.
 
2) Orejarena LA, et al : Paroxysmal supraventricular tachycardia in the general population. J Am Coll Cardiol 31 : 150-157, 1998.
PubMed
3) Katritsis DG, et al : Left Septal Slow Pathway Ablation for Atrioventricular Nodal Reentrant Tachycardia. Circ Arrhythm Electrophysiol 11 : e005907, 2018.
PubMed
4) Stavrakis S, et al : Slow/Fast Atrioventricular Nodal Reentrant Tachycardia Using the Inferolateral Left Atrial Slow Pathway. Circ Arrhythm Electrophysiol 11 : e006631, 2018.
PubMed
5) Kaneko Y, et al : Atypical Fast-Slow Atrioventricular Nodal Reentrant Tachycardia Incorporating a "Superior" Slow Pathway : A Distinct Supraventricular Tachyarrhythmia. Circulation 133 : 114-123, 2016.
PubMed
6) Rujirachun P, et al : Paroxysmal supraventricular tachycardia and risk of ischemic stroke : A systematic review and meta-analysis. J Arrhythm 35 : 499-505, 2019.
PubMed
7) 日本循環器学会, ほか : 循環器病の診断と治療に関するガイドライン (2008年度合同研究班報告). 不整脈薬物治療に関するガイドライン (2009年改訂版), 2009.
 
8) Appelboam A, et al : Postural modification to the standard Valsalva manoeuvre for emergency treatment of supraventricular tachycardias (REVERT) : a randomised controlled trial. Lancet 386 : 1747-1753, 2015.
 
9) 日本循環器学会, ほか : 日本循環器学会/日本不整脈心電学会合同ガイドライン. 不整脈非薬物治療ガイドライン (2018年改訂版), 2019.
 
P.129 掲載の参考文献
1) Josephson ME : Supraventricular tachycardias. In : Clinical Cardiac Electrophysiology, Techniques and Interpretations, 2nd ed, p181-274, Lea & Febiger, Philadelphia, 1993.
 
2) Gomes JA, et al : Sinus node reentrant tachycardia. Pacing Clin Electrophysiol 18 : 1045-1057, 1995.
PubMed
3) Blaufox AD, et al : Sinoatrial node reentrant tachycardia in infants with congenital heart disease. Am J Cardiol 88 : 1050-1054, 2001.
PubMed
4) Jalife J : Mutual entrainment and electrical coupling as mechanisms for synchronous firing of rabbit sino-atrial pace-maker cells. J Physiol (Lond) 356 : 221-243, 1984.
 
5) Kalman JM, et al : Radiofrequency catheter modification of sinus pacemaker function guided by intracardiac echocardiography. Circulation 92 : 3070-3081, 1995.
PubMed
6) Kay GN, et al : Radiofrequency ablation for treatment of primary atrial tachycardias. J Am Coll Cardiol 21 : 901-909, 1993.
PubMed
7) Kirchhof CJ, et al : Sinus node reentry : Fact or fiction? In : Cardiac Arrhythmias : Where To Go From Here? (ed by Brugada P, Wellens HJ), p53, Futura, Mt. Kisco, 1987.
 
8) Allessie MA, Bonke FI : Direct demonstration of sinus node reentry in the rabbit heart. Circ Res 44 : 557-568, 1979.
PubMed
9) Childers RW, et al : Sinus nodal echoes. Clinical case report and canine studies. Am J Cardiol 31 : 220-231, 1973.
PubMed
10) Bleeker WK, et al : Functional and morphological organization of the rabbit sinus node. Circ Res 46 : 11-22, 1980.
PubMed
11) Gomes JA, et al : Sustained symptomatic sinus node reentrant tachycardia : incidence, clinical significance, electrophysiologic observations and the effects of antiarrhythmic agents. J Am Coll Cardiol 5 : 45-57, 1985.
PubMed
12) Engelstein ED, et al : Mechanism-specific effects of adenosine on atrial tachycardia. Circulation 89 : 2645-2654, 1994.
PubMed
13) Goya M, et al : Radiofrequency catheter ablation for sinoatrial node reentrant tachycardia : electrophysiologic features of ablation sites. Jpn Circ J 63 : 177-183, 1999.
PubMed
14) Sanders WE Jr, et al : Catheter ablation of sinoatrial node reentrant tachycardia. J Am Coll Cardiol 23 : 926-934, 1994.
PubMed
P.134 掲載の参考文献
1) Rosenblueth A : Ventricular echoes. Am J Physiol 195 : 53-60, 1958.
PubMed
2) Denes P, et al : Demonstration of dual A-V nodal pathways in patients with paroxysmal supraventricular tachycardia. Circulation 48 : 549-555, 1973.
 
3) Sheahan RG, et al : Atrioventricular node reentry with'smooth'AV node function curves : a different arrhythmia substrate? Circulation 93 : 969-972, 1996.
PubMed
4) Lockwood DJ, et al : Electrophysiological characteristics of atrioventricular nodal reentrant tachycardia : implications for the reentrant circuits. In : Cardiac Electrophysiology : From Cell to Bedside, 6th ed (ed by zipes DP, Jalife J), p767-787, Elsevier, Philadelphia, 2014.
 
5) Chen YJ, et al : Dual AV node pathway physiology in patients with Wolff-Parkinson-White syndrome. Int J Cardiol 56 : 275-281, 1996.
PubMed
6) Markowitz SM, Lerman BB : A contemporary view of atrioventricular nodal physiology. J Interv Card Electrophysiol 52 : 271-279, 2018.
PubMed
7) Inoue S, Becker AE : Posterior extensions of the human compact atrioventricular node : a neglected anatomic feature of potential clinical significance. Circulation 97 : 188-193, 1998.
PubMed
8) George SA, et al : At the Atrioventricular Crossroads : Dual Pathway Electrophysiology in the Atrioventricular Node and its Underlying Heterogeneities. Arrhythm Electrophysiol Rev 6 : 179-185, 2017.
PubMed
9) Kurian T, et al : Anatomy and electrophysiology of the human AV node. Pacing Clin Electrophysiol 33 : 754-762, 2010.
PubMed
10) Katritsis DG, et al : Atrial activation during atrioventricular nodal reentrant tachycardia : studies on retrograde fast pathway conduction. Heart Rhythm 3 : 993-1000, 2006.
PubMed
11) Engelstein ED, et al : Posterior fast atrioventricular node pathways : implications for radiofrequency catheter ablation of atrioventricular node reentrant tachycardia. J Am Coll Cardiol 27 : 1098-1105, 1996.
PubMed
P.138 掲載の参考文献
1) Orejarena LA, et al : Paroxysmal supraventricular tachycardia in the general population. J Am Coll Cardiol 31 : 150-157, 1998.
PubMed
2) Porter MJ, et al : Influence of age and gender on the mechanism of supraventricular tachycardia. Heart Rhythm 1 : 393-396, 2004.
PubMed
3) Inoue S, Becker AE : Posterior extensions of the human compact atrioventricular node : a neglected anatomic feature of potential clinical significance. Circulation 97 : 188-193, 199&
 
4) Gonzalez-Torrecilla E, et al : Independent predictive accuracy of classical electrocardiographic criteria in the diagnosis of paroxysmal atrioventricular reciprocating tachycardias in patients without pre-excitation. Europace 10 : 624-628, 2008.
PubMed
5) Page RL, et al : 2015 ACC/AHA/HRS Guideline for the Management of Adult Patients With Supraventricular Tachycardia : A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol 67 : e27-e115, 2016.
 
P.144 掲載の参考文献
1) Porter MJ, et al : Influence of age and gender on the mechanism of supraventricular tachycardia. Heart Rhythm 1 : 393-396, 2004.
PubMed
2) Inoue S, Becker AE : Posterior extensions of the human compact atrioventricular node : a neglected anatomic feature of potential clinical significance. Circulation 97 : 188-193, 1998.
PubMed
3) Lockwood D, et al : Electrophysiologic characteristics of atrioventricular nodal reentrant tachycardia : implications for the reentrant circuits. In : Cardiac Electrophysiology : From Cell to Bedside, 5th ed (ed by Zipes DP, Jalife J), p615-646, Saunders, Philadelphia, 2009.
 
4) Nawata H, et al : Heterogeneity of anterograde fast-pathway and retrograde slow-pathway conduction patterns in patients with the fast-slow form of atrioventricular nodal reentrant tachycardia : electrophysiologic and electrocardiographic considerations. J Am Coll Cardiol 32 : 1731-1740, 1998.
PubMed
5) Kaneko Y, et al : Atypical Fast-Slow Atrioventricular Nodal Reentrant Tachycardia Incorporating a "Superior" Slow Pathway : ADistinct Supraventricular Tachyarrhythmia. Circulation 133 : 114-123, 2016.
 
6) Iesaka Y, et al : Adenosine-sensitive atrial reentrant tachycardia originating from the atrioventricular nodal transitional area. J Cardiovasc Electrophysiol 8 : 854-864, 1997.
PubMed
P.149 掲載の参考文献
1) Wolff L, et al : Bundle-branch block with short P-R interval in healthy young people prone to paroxysmal tachycardia. Am Heart J 5 : 685-704, 1930.
 
2) Vidaillet HJ, et al : Familial occurrence of accessory atrioventricular pathways (preexcitation syndrome). N Engl J Med 317 : 65-69, 1987.
PubMed
3) Klein GJ, et al : Ventricular fibrillation in the Wolff-Parkinson-White syndrome. N Engl J Med 301 : 1080-1085, 1979.
PubMed
4) Kugler JD, et al : Radiofrequency catheter ablation for paroxysmal supraventricular tachycardia in children and adolescents without structural heart disease. Pediatric EP Society, Radiofrequency Catheter Ablation Registry. Am J Cardiol 80 : 1438-1443, 1997.
PubMed
5) Durrer D, et al : Pre-excitation revisited. Am J Cardiol 25 : 690-697, 1970.
PubMed
6) Tung R, et al : An unusual form of preexcitation : fasciculoventricular bypass tract. Heart Rhythm 5 : 1767-1768, 2008.
PubMed
7) Zipes DP : Preexcitation syndrome. In : Braunwald's Heart Disease : A Textbook of Cardiovascular Medicine (ed by Braunwald E), 5th ed, p667-675, WB Saunders, Philadelphia, 1997.
 
8) 日本循環器学会, ほか : 日本循環器学会/日本不整脈心電学会合同ガイドライン. 不整脈非薬物治療ガイドライン (2018年改訂版), 2019.
 
9) Obeyesekere MN, et al : Risk of arrhythmia and sudden death in patients with asymptomatic preexcitation : a meta-analysis. Circulation 125 : 2308-2315, 2012.
PubMed
10) Pappone C, et al : Wolff-Parkinson-White syndrome in the era of catheter ablation : insights from aregistry study of 2169 patients. Circulation 130 : 811-819, 2014.
 
11) Pediatric and Congenital Electrophysiology Society (PACES), et al : PACES/HRS expert consensus statement on the management of the asymptomatic young patient with a Wolff-Parkinson-White (WPW, ventricular preexcitation) electrocardiographic pattern : developed in partnership between the Pediatric and Congenital Electrophysiology Society (PACES) and the Heart Rhythm Society (HRS). Endorsed by the governing bodies of PACES, HRS, the American College of Cardiology Foundation (ACCF), the American Heart Association (AHA), the American Academy of Pediatrics (AAP), and the Canadian Heart Rhythm Society (CHRS). Heart Rhythm 9 : 1006-1024, 2012.
 
12) Wackel P, et al : Risk stratification in Wolff-Parkinson-White syndrome : the correlation between noninvasive and invasive testing in pediatric patients. Pacing Clin Electrophysiol 35 : 1451-1457, 2012.
PubMed
P.154 掲載の参考文献
1) Hirano K, et al : Para-Hisian pacing. A new method for differentiating retrograde conduction over an accessory AV pathway from conduction over the AV node. Circulation 94 : 1027-1035, 1996.
 
P.159 掲載の参考文献
1) De la Fuente D, et al : Conduction through a narrow isthmus in isolated canine atrial tissue. A model of the W-P-W syndrome. Circulation 44 : 803-809, 1971.
 
2) Katoh T, et al : Non-invasive diagnosis of concealed Wolff-Parkinson-White syndrome by detection of concealed anterograde pre-excitation. Jpn Circ J 65 : 367-370, 2001.
PubMed
3) Kawabata M, et al : The impact of B-type natriuretic peptide levels on the suppression of accompanying atrial fibrillation in Wolff-Parkinson-White syndrome patients after accessory pathway ablation. J Cardiol 68 : 485-491, 2016.
PubMed
4) Lee A, et al : Spontaneous transformation of a concealed to manifest posteroseptal accessory pathway requiring epicardial ablation. J Arrhythm 34 : 312-314, 2018.
PubMed
5) Swissa M, et al : Cryotherapy ablation of parahisian accessory pathways in children. Heart Rhythm 12 : 917-925, 2015.
PubMed
P.163 掲載の参考文献
1) Derejko P, et al : Atrial fibrillation in patients with Wolff-Parkinson-White syndrome : role of pulmonary veins. J Cardiovasc Electrophysiol 23 : 280-286, 2012.
PubMed
2) Lown B, et al : The syndrome of short P-R interval, normal QRS complex and paroxysmal rapid heart action. Circulation 5 : 693-706, 1952.
 
3) Burch GE, Kimball JL : Notes on the similarity of QRS complex configurations in the Wolff-Parkinson-White syndrome. Am Heart J 32 : 560-570, 1946.
PubMed
4) James TN : Morphology of the human atrioventricular node, with remarks pertinent to its electrophysiology. Am Heart J 62 : 756-771, 1961.
PubMed
5) Brechenmacher C, et al : [Histological study of abnormal conduction pathways in the Wolff-Parkinson-White syndrome and Lown-Ganong-Levine syndrome]. Arch Mal Coeur Vaiss 67 : 507-519, 1974.
PubMed
6) Josephson ME, Kastor JA : Supraventricular tachycardia in Lown-Ganong-Levine syndrome : atrionodal versus intranodal reentry. Am J Cardiol 40 : 521-527, 1977.
PubMed
7) Shabanian R, et al : Lown-Ganong-Levine syndrome in a 3-month-old infant with isolated left ventricular noncompaction. Pediatr Cardiol 31 : 274-276, 2010.
 
8) Chou TC : Wolff-Parkinson-White syndrome and its variants. In : Electrocardiography in Clinical Practice : Adult and Pediatric, 4th ed (ed by Chou TC), WB Saunders, Philadelphia, 1996.
 
9) Moller P : Letter : Criteria for the LGL syndrome. Am Heart J 91 : 539-541, 1976.
PubMed
10) Jackman WM, et al : Reevaluation of enhanced atrioventricular nodal conduction : evidence to suggest a continuum of normal atrioventricular nodal physiology. Circulation 67 : 441-448, 1983.
PubMed
11) Wiener I : Syndromes of Lown-Ganong-Levine and enhanced atrioventricular nodal conduction. Am J Cardiol 52 : 637-639, 1983.
PubMed
12) Ward DE, et al : Re-entrant tachycardia using two bypass tracts and excluding AV node in short PR interval, normal QRS syndrome. Br Heart J 40 : 1127-1133, 1978.
PubMed
13) Zipes DP, et al : Unusual properties of accessory pathways. Circulation 49 : 1200-1211, 1974.
PubMed
14) Benditt DG, et al : Characteristics of atrioventricular conduction and the spectrum of arrhythmias in lown-ganong-levine syndrome. Circulation 57 : 454-465, 1978.
PubMed
15) Durrer D, et al : Pre-excitation revisited. Am J Cardiol 25 : 690-697, 1970.
PubMed
16) Caracta AR, et al : Electrophysiologic studies in the syndrome of short P-R interval, normal QRS complex. Am J Cardiol 31 : 245-253, 1973.
 
17) Bauernfeind RA, et al : Cycle length in atrioventricular nodal reentrant paroxysmal tachycardia with observations on the Lown-Ganong-Levine syndrome. Am J Cardiol 45 : 1148-1153, 1980.
PubMed
P.169 掲載の参考文献
1) Coumel P : Junctional reciprocating tachycardias. The permanent and paroxysmal forms of A-V nodal reciprocating tachycardias. J Electrocardiol 8 : 79-90, 1975.
 
2) Gallagher JJ, Sealy WC : The permanent form of junctional reciprocating tachycardia : further elucidation of theunderlying mechanism. Eur J Cardiol 8 : 413-430, 1978.
 
3) Dorostkar PC, et al : Clinical course of persistent junctional reciprocating tachycardia. J Am Coll Cardiol 33 : 366-375, 1999.
PubMed
4) Kang KT, et al : Permanent junctional reciprocating tachycardia in children : a multicenter experience. Heart Rhythm 11 : 1426-1432, 2014.
PubMed
5) Kuck KH, et al : Sites of conduction block in accessory atrioventricular pathways. Basis for concealed accessory pathways. Circulation 82 : 407-417, 1990.
PubMed
6) Aguinaga L, et al : Long-term follow-up in patients with the permanent form of junctional reciprocating tachycardia treated with radiofrequency ablation. Pacing Clin Electrophysiol 21 : 2073-2078, 1998.
PubMed
7) Gaita F, et al : Catheter ablation of permanent junctional reciprocating tachycardia with radiofrequency current. J Am Coll Cardiol 25 : 648-654, 1995.
 
8) Sun Y, et al : Coronary sinus-ventricular accessory connections producing posteroseptal and left posterior accessory pathways : incidence and electrophysiological identification. Circulation 106 : 1362-1367, 2002.
PubMed
9) Tseng ZH, Scheinman M : Persistent Long R-P Tachycardia. Card Electrophysiol Clin 2 : 225-229, 2010.
 
10) Ticho BS, et al : Variable location of accessory pathways associated with the permanent form of junctional reciprocating tachycardia and confirmation with radiofrequency ablation. Am J Cardiol 70 : 1559-1564, 1992.
PubMed
11) Guarnieri T, et al : The nonpharmacologic management of the permanent form of junctional reciprocating tachycardia. Circulation 69 : 269-277, 1984.
PubMed
12) Jackman WM, et al : Localization of left free-wall and posteroseptal accessory atrioventricular pathways by direct recording of accessory pathway activation. Pacing Clin Electrophysiol 12 : 204-214, 1989.
 
13) Packer DL, et al : Tachycardia-induced cardiomyopathy : a reversible form of left ventricular dysfunction. Am J Cardiol 57 : 563-570, 1986.
PubMed
P.174 掲載の参考文献
1) 日本循環器学会, ほか : 日本循環器学会/日本不整脈心電学会合同ガイドライン. 不整脈非薬物治療ガイドライン (2018年改訂版), 2019.
 
2) Maruyama M, et al : Analyses of the Mode of Termination During Diagnostic Ventricular Pacing to Differentiate the Mechanisms of Supraventricular Tachycardias. JACC Clin Electrophysiol 3 : 1252-1261, 2017.
PubMed
3) Wathen M, et al : An Anatomically Guided Approach to Atrioventricular Node Slow Pathway Ablation. Am J Cardiol 70 : 886-889, 1992.
PubMed
4) Haissaguerre M, et al : Elimination of atrioventricular nodal reentrant tachycardia using discrete slow potentials to guide application of radiofrequency energy. Circulation 85 : 2162-2175, 1992.
PubMed
5) Meiltz A, et al : Permanent form of junctional reciprocating tachycardia in adults : peculiar features and results of radiofrequency catheter ablation. Europace 8 : 21-28, 2006.
PubMed
6) Yagishita A, et al : Differentiation of atrial tachycardia from other long RP tachycardias by electrocardiographic characteristics. J Arrhythm 30 : 376-381, 2014.
 
7) Roberts-Thomson KC, et al : Focal atrial tachycardia II : management. Pacing Clin Electrophysiol 29 : 769-778, 2006.
PubMed
8) Iesaka Y, et al : Adenosine-Sensitive Atrial Reentrant Tachycardia Originating from the Atrioventricular Nodal Transitional Area. J Cardiovasc Electrophysiol 8 : 854-864, 1997.
PubMed
9) Sarkozy A, et al : A novel pacing manoeuvre to diagnose atrial tachycardia. Europace 10 : 459-466, 2008.
PubMed
10) Maruyama M, et al : The VA relationship after differential atrial overdrive pacing : a novel tool for the diagnosis of atrial tachycardia in the electrophysiologic laboratory. J Cardiovasc Electrophysiol 18 : 1127-1133, 2007.
PubMed
P.176 掲載の参考文献
1) Poutiainen AM, et al : Prevalence and natural course of ectopic atrial tachycardia. Eur Heart J 20 : 694-700, 1999.
PubMed
2) von Bernuth G, et al : Atrial automatic tachycardia in infancy and childhood. Eur Heart J 13 : 1410-1415, 1992.
PubMed
3) Roberts-Thomson KC, et al : Atrial tachycardia : mechanisms, diagnosis, and management. Curr Probl Cardiol 30 : 529-573, 2005.
PubMed
4) Salerno JC, et al : Clinical course of atrial ectopic tachycardia is age-dependent : results and treatment in children < 3 or ≧ 3 years of age. J Am Coll Cardiol 43 : 438-444, 2004.
 
5) Kalman JM, et al : "Cristal tachycardias" : origin of right atrial tachycardias from the crista terminalis identified by intracardiac echocardiography. J Am Coll Cardiol 31 : 451-459, 1998.
PubMed
6) Kistler PM, et al : Focal atrial tachycardia from the ostium of the coronary sinus : electrocardiographic and electrophysiological characterization and radiofrequency ablation. J Am Coll Cardiol 45 : 1488-1493, 2005.
PubMed
7) Lai LP, et al : Clinical, electrophysiological characteristics, and radiofrequency catheter ablation of atrial tachycardia near the apex of Koch's triangle. Pacing Clin Electrophysiol 21 : 367-374, 1998.
 
8) Kistler PM, et al : Electrophysiological and electrocardiographic characteristics of focal atrial tachycardia originating from the pulmonary veins : acute and long-term outcomes of radiofrequency ablation. Circulation 108 : 1968-1975, 2003.
PubMed
9) Iesaka Y, et al : Adenosine-sensitive atrial reentrant tachycardia originating from the atrioventricular nodal transitional area. J Cardiovasc Electrophysiol 8 : 854-864, 1997.
PubMed
10) Kistler PM, et al : P-wave morphology in focal atrial tachycardia : development of an algorithm to predict the anatomic site of origin. J Am Coll Cardiol 48 : 1010-1017, 2006.
PubMed
11) Kubala M, et al : P-wave morphology and multipolar intracardiac atrial activation to facilitate nonpulmonary vein trigger localization. J Cardiovasc Electrophysiol 30 : 865-876, 2019.
PubMed
12) Rosso R, Kistler PM : Focal atrial tachycardia. Heart 96 : 181-185, 2010.
PubMed
13) Ge H, et al : Predictors of Pharmacological Therapy of Ectopic Atrial Tachycardia in Children. Pediatr Cardiol 38 : 289-295, 2017.
PubMed
14) Schaffer MS, et al : Mortality following radiofrequency catheter ablation (from the Pediatric Radiofrequency Ablation Registry). Participating members of the Pediatric Electrophysiology Society. Am J Cardiol 86 : 639-643, 2000.
PubMed
15) Nerheim P, et al : Heart failure and sudden death in patients with tachycardia-induced cardiomyopathy and recurrent tachycardia. Circulation 110 : 247-252, 2004.
PubMed
P.180 掲載の参考文献
1) Bisset GS, et al : Chaotic atrial tachycardia in childhood. Am Heart J 101 : 268-272, 1981.
PubMed
2) Shine KI, et al : Multifocal atrial tachycardia. Clinical and electrocardiographic features in 32 patients. N Engl J Med 279 : 344-349, 1968.
PubMed
3) Bradley DJ, et al : The clinical course of multifocal atrial tachycardia in infants and children. J Am Coll Cardiol 38 : 401-408, 2001.
 
4) Kones RJ, et al : Mechanism and management of chaotic atrial mechanism. Cardiology 59 : 92-101, 1974.
PubMed
5) McCord J, Borzak S : Multifocal atrial tachycardia. Chest 113 : 203-209, 1998.
PubMed
6) Farooki ZQ, Green EW : Multifocal atrial tachycardia in two neonates. Br Heart J 39 : 872-874, 1977.
PubMed
7) Levine JH, et al : Multifocal atrial tachycardia : a toxic effect of theophylline. Lancet 1 : 12-14, 1985.
PubMed
8) Oner T, et al : Multifocal atrial tachycardia caused by risperidone. Int J Cardiol 203 : 855-857, 2016.
PubMed
9) Gouin S, Ali S : A patient with chaotic atrial tachycardia. Pediatr Emerg Care 19 : 95-98, 2003.
 
10) Habibzadeh MA : Multifocal atrial tachycardia : a 66 month follow-up of 50 patients. Heart Lung 9 : 328-335, 1980.
PubMed
11) Custer AM, Lappin SL : Multifocal Atrial Tachycardia (MAT). StatPearls [Internet], Treasure Island, 2019.
 
12) McCord JK, et al : Usefulness of intravenous magnesium for multifocal atrial tachycardia in patients with chronic obstructive pulmonary disease. Am J Cardiol 81 : 91-93, 1998.
PubMed
13) Kouvaras G, et al : The effective treatment of multifocal atrial tachycardia with amiodarone. Jpn Heart J 30 : 301-312, 1989.
PubMed
14) Hsieh MY, et al : Multifocal atrial tachycardia in 2 children. J Chin Med Assoc 69 : 439-443, 2006.
 
P.184 掲載の参考文献
1) Saoudi N, et al : Classification of atrial flutter and regular atrial tachycardia according to electrophysiologic mechanism and anatomic bases : a statement from a joint expert group from the Working Group of Arrhythmias of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. J Cardiovasc Electrophysiol 12 : 852-866, 2001.
 
2) Markowitz SM, et al : Atrial Tachycardias and Atypical Atrial Flutters : Mechanisms and Approaches to Ablation. Arrhythm Electrophysiol Rev 8 : 131-137, 2019.
PubMed
3) Takigawa M, et al : Revisiting anatomic macroreentrant tachycardia after atrial fibrillation ablation using ultrahigh-resolution mapping : Implications for ablation. Heart Rhythm 15 : 326-333, 2018.
PubMed
4) Yamashita S, et al : Pulmonary vein-gap re-entrant atrial tachycardia following atrial fibrillation ablation : an electrophysiological insight with high-resolution mapping. Europace 21 : 1039-1047, 2019.
PubMed
5) Knight BP, et al : A technique for the rapid diagnosis of atrial tachycardia in the electrophysiology laboratory. J Am Coll Cardiol 33 : 775-781, 1999.
PubMed
6) Kadish AH, Morady F : The response of paroxysmal supraventricular tachycardia to overdrive atrial and ventricular pacing : can it help determine the tachycardia mechanism? J Cardiovasc Electrophysiol 4 : 239-252, 1993.
PubMed
P.188 掲載の参考文献
1) Odutayo A, et al : Atrial fibrillation and risks of cardiovascular disease, renal disease, and death : systematic review and meta-analysis. BMJ 354 : i4482, 2016.
PubMed
2) Haissaguerre M, et al : Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N Engl J Med 339 : 659-666, 1998.
PubMed
3) Pathak RK, et al : Aggressive risk factor reduction study for atrial fibrillation and implications for the outcome of ablation : the ARREST-AF cohort study. J Am Coll Cardiol 64 : 2222-2231, 2014.
PubMed
4) 日本循環器学会, ほか : 日本循環器学会/日本不整脈心電学会合同ガイドライン. 不整脈非薬物治療ガイドライン (2018年改訂版), 2019.
 
5) Friberg L, et al : Catheter ablation for atrial fibrillation is associated with lower incidence of stroke and death : data from Swedish health registries. Eur Heart J 37 : 2478-2487, 2016.
PubMed
6) Boriani G, et al : Asymptomatic atrial fibrillation : clinical correlates, management, and outcomes in the EORP-AF Pilot General Registry. Am J Med 128 : 509-518.e2, 2015.
 
7) Bunch TJ, et al : The Impact of Age on 5-Year Outcomes After Atrial Fibrillation Catheter Ablation. J Cardiovasc Electrophysiol 27 : 141-146, 2016.
PubMed
8) Marrouche NF, et al : Catheter Ablation for Atrial Fibrillation with Heart Failure. N Engl J Med 378 : 417-427, 2018.
PubMed
9) Verma A, et al : Approaches to catheter ablation for persistent atrial fibrillation. N Engl J Med 372 : 1812-1822, 2015.
PubMed
10) Kumagai K, et al : A new approach for complete isolation of the posterior left atrium including pulmonary veins for atrial fibrillation. J Cardiovasc Electrophysiol 18 : 1047-1052, 2007.
PubMed
11) Nademanee K, et al : A new approach for catheter ablation of atrial fibrillation : mapping of the electrophysiologic substrate. J Am Coll Cardiol 43 : 2044-2053, 2004.
PubMed
12) Rolf S, et al : Tailored atrial substrate modification based on low-voltage areas in catheter ablation of atrial fibrillation. Circ Arrhythm Electrophysiol 7 : 825-833, 2014.
PubMed
13) Kumagai K, et al : Effects of additional ablation of low-voltage areas after box isolation for persistent atrial fibrillation. J Arrhythm 35 : 197-204, 2019.
PubMed
14) He X, et al : Left atrial posterior wall isolation reduces the recurrence of atrial fibrillation : a meta-analysis. J Interv Card Electrophysiol 46 : 267-274, 2016.
PubMed
15) Sakata K, et al : Not all rotors, effective ablation targets for nonparoxysmal atrial fibrillation, are included in areas suggested by conventional indirect indicators of atrial fibrillation drivers : ExTRa Mapping project. J Arrhythm 34 : 176-184, 2018.
PubMed
P.196 掲載の参考文献
1) Olshansky B, et al : Atrial flutter-update on the mechanism and treatment. Pacing Clin Electrophysiol 15 : 2308-2335, 1992.
PubMed
2) Wells JL Jr, et al : Characterization of atrial flutter. Studies in man after open heart surgery using fixed atrial electrodes. Circulation 60 : 665-673, 1979.
PubMed
3) Tai CT, et al : Conduction properties of the crista terminalis in patients with typical atrial flutter : basis for a line of block in the reentrant circuit. J Cardiovasc Electrophysiol 9 : 811-819, 1998.
PubMed
4) Saffitz JE, et al : Tissue-specific determinants of anisotropic conduction velocity in canine atrial and ventricular myocardium. Circ Res 74 : 1065-1070, 1994.
PubMed
5) Tai CT, et al : Characterization of low right atrial isthmus as the slow conduction zone and pharmacological target in typical atrial flutter. Circulation 96 : 2601-2611, 1997.
PubMed
P.201 掲載の参考文献
1) Benditt DG, et al : Spectrum of regular tachycardias with wide QRS complexes in patients with accessory atrioventricular pathways. Am J Cardiol 42 : 828-838, 1978.
PubMed
2) Benson DW, et al : Mechanisms of regular, wide QRS tachycardia in infants and children. Am J Cardiol 49 : 1778-1788, 1982.
PubMed
3) Wellens HJ, et al : The value of the electrocardiogram in the differential diagnosis of a tachycardia with a widened QRS complex. Am J Med 64 : 27-33, 1978.
PubMed
4) Kindwall KE, et al : Electrocardiographic criteria for ventricular tachycardia in wide complex left bundle branch block morphology tachycardias. Am J Cardiol 61 : 1279-1283, 1988.
PubMed
5) Brugada P, et al : A new approach to the differential diagnosis of a regular tachycardia with a wide QRS complex. Circulation 83 : 1649-1659, 1991.
 
6) Antunes E, et al : The differential diagnosis of a regular tachycardia with a wide QRS complex on the 12-lead ECG : ventricular tachycardia, supraventricular tachycardia with aberrant intraventricular conduction, and supraventricular tachycardia with anterograde conduction over an accessory pathway. Pacing Clin Electrophysiol 17 : 1515-1524, 1994.
PubMed
7) Steurer G, et al : The differential diagnosis on the electrocardiogram between ventricular tachycardia and preexcited tachycardia. Clin Cardiol 17 : 306-308, 1994.
PubMed
8) Akhtar M, et al : Wide QRS complex tachycardia. Reappraisal of a common clinical problem. Ann Intern Med 109 : 905-912, 1988.
PubMed
9) Kremers MS, et al : Effect of preexisting bundle branch block on the electrocardiographic diagnosis of ventricular tachycardia. Am J Cardiol 62 : 1208-1212, 1988.
PubMed
10) Miler JM, et al : Ventricular tachycardia versus supraventricular tachycardia with aberration : electrocardiographic distinctions. In : Cardiac Electrophysiology : from Cell to Bedside, 3rd ed (ed by Zipes DP, Jalife J), P696-705, WB Saunders, Philadelphia, 1995.
 
11) Alberca T, et al : Evaluation of the specificity of morphological electrocardiographic criteria for the differential diagnosis of wide QRS complex tachycardia in patients with intraventricular conduction defects. Circulation 96 : 3527-3533, 1997.
PubMed
12) Vereckei A, et al : New algorithm using only lead aVR for differential diagnosis of wide QRS complex tachycardia. Heart Rhythm 5 : 89-98, 2008.
PubMed
13) Wellens HJ : Electrophysiology : Ventricular tachycardia : diagnosis of broad QRS complex tachycardia, Heart 86 : 579-585, 2001.
PubMed
14) 櫻田春水 : 12 誘導心電図からみた持続性心室頻拍の診断-Wide QRS頻拍の鑑別診断-. 心電図 22 (Suppl 2) : 5-25, 2002.
 
P.205 掲載の参考文献
1) Brugada P, Brugada J : Right bundle branch block, persistent ST segment elevation and sudden cardiac death : a distinct clinical and electrocardiographic syndrome. A multicenter report. J Am Coll Cardiol 20 : 1391-1396, 1992.
PubMed
2) 清水渉 : 3) 遺伝性不整脈. 7-4 循環器疾患と遺伝子異常. 7. 循環器系の疾患 (分担), 内科学 [第11版] (矢崎義雄総編集), p423-427, 朝倉書店, 2017.
 
3) 清水渉 : 4) 突然死. 7-6 不整脈. 7. 循環器系の疾患 (分担), 内科学 [第11版] (矢崎義雄総編集), p508-510, 朝倉書店, 2017.
 
4) Shimizu W, et al : Mechanisms of disease : current understanding and future challenges in Brugada syndrome. Nat Clin Pract Cardiovasc Med 2 : 408-414, 2005.
PubMed
5) Aiba T, et al : Cellular basis for trigger and maintenance of ventricular fibrillation in the Brugada syndrome model : high-resolution optical mapping study. J Am Coll Cardiol 47 : 2074-2085, 2006.
PubMed
6) Priori SG, et al : HRS/EHRA/APHRS expert consensus statement on the diagnosis and management of patients with inherited primary arrhythmia syndromes : document endorsed by HRS, EHRA, and APHRS in May 2013 and by ACCF, AHA, PACES, and AEPC in June 2013. Heart Rhythm 10 : 1932-1963, 2013.
PubMed
7) Antzelevitch C, et al : J-Wave syndromes expert consensus conference report : Emerging concepts and gaps in knowledge. J Arrhythm 32 : 315-339, 2016.
PubMed
8) 日本循環器学会, ほか : 遺伝性不整脈の診療に関するガイドライン (2017年改訂版), 2018.
 
9) Yamagata K, et al : Genotype-Phenotype Correlation of SCN5A Mutation for the Clinical and Electrocardiographic Characteristics of Probands With Brugada Syndrome : A Japanese Multicenter Registry. Circulation 135 : 2255-2270, 2017.
PubMed
10) Ohgo T, et al : Acute and chronic management in patients with Brugada syndrome associated with electrical storm of ventricular fibrillation. Heart Rhythm 4 : 695-700, 2007.
PubMed
11) Kamakura S, et al : Long-term prognosis of probands with Brugada-pattern ST elevation in leads V1-V3. Circ Arrhythm Electrophysiol 2 : 495-503, 2009.
PubMed
12) Takagi M, et al : The prognostic value of early repolarization (J wave) and ST-segment morphology after J wave in Brugada syndrome : multicenter study in Japan. Heart Rhythm 10 : 533-539, 2013.
PubMed
13) Sacher F, et al : Syncope in Brugada syndrome patients : prevalence, characteristics, and outcome. Heart Rhythm 9 : 1272-1279, 2012.
PubMed
P.211 掲載の参考文献
1) Haissaguerre M, et al : Sudden cardiac arrest associated with early repolarization. N Engl J Med 358 : 2016-2023, 2008.
PubMed
2) Macfarlane PW, et al : The Early Repolarization Pattern : A Consensus Paper. J Am Coll Cardiol 66 : 470-477, 2015.
 
3) Kamakura T, et al : Significance of Coronary Artery Spasm Diagnosis in Patients With Early Repolarization Syndrome. J Am Heart Assoc 7. pii : e007942, 2018.
 
4) Antzelevitch C, et al : J-Wave syndromes expert consensus conference report : Emerging concepts and gaps in knowledge. J Arrhythm 32 : 315-339, 2016.
PubMed
5) Tikkanen JT, et al : Long-term outcome associated with early repolarization on electrocardiography. N Engl J Med 361 : 2529-2537, 2009.
PubMed
6) Tikkanen JT, et al : Eariy repolarization : electrocardiographic phenotypes associated with favorable long-term outcome. Circulation 123 : 2666-2673, 2011.
 
7) Haissaguerre M, et al : Depolarization versus repolarization abnormality underlying inferolateral J-wave syndromes : New concepts in sudden cardiac death with apparently normal hearts. Heart Rhythm 16 : 781-790, 2019.
PubMed
8) Kamakura T, et al : Differences in the onset mode of ventricular tachyarrhythmia between patients with J wave in anterior leads and those with J wave in inferolateral leads. Heart Rhythm 14 : 553-561, 2017.
 
9) Aizawa Y, et al : Electrical storm in idiopathic ventricular fibrillation is associated with early repolarization. J Am Coll Cardiol 62 : 1015-1019, 2013.
PubMed
10) Kamakura T, et al : Significance of non-type l anterior early repolarization in patients with inferolateral early repolarization syndrome. J Am Coll Cardiol 62 : 1610-1618, 2013.
 
11) Naruse Y, et al : Early repolarization is an independent predictor of occurrences of ventricular fibrillation in the very early phase of acute myocardial infarction. Circ Arrhythm Electrophysiol 5 : 506-513, 2012.
PubMed
12) Tokioka K, et al : Electrocardiographic parameters and fatal arrhythmic events in patients with Brugada syndrome : combination of depolarization and repolarization abnormalities. J Am Coll Cardiol 63 : 2131-2138, 2014.
PubMed
13) Wu SH, et al : Early repolarization pattern and risk for arrhythmia death : a meta-analysis. J Am Coll Cardiol 61 : 645-650, 2013.
 
14) Haissaguerre M, et al : Characteristics of recurrent ventricular fibrillation associated with inferolateral early repolarization role of drug therapy. J Am Coll Cardiol 53 : 612-619, 2009.
PubMed
P.216 掲載の参考文献
1) Gussak I, et al : Idiopathic short QT interval : a new clinical syndrome? Cardiology 94 : 99-102, 2000.
PubMed
2) Levine SA, Woodworth CR : Congenital deaf-mutism, prolonged QT interval, syncopal attacks and sudden death. N Engl J Med 259 : 412-417, 1958.
PubMed
3) Mason JW, et al : Electrocardiographic reference ranges derived from 79,743 ambulatory subjects. J Electrocardiol 40 : 228-234, 2007.
PubMed
4) Anttonen O, et al : Prevalence and prognostic significance of short QT interval in a middle-aged Finnish population. Circulation 116 : 714-720, 2007.
 
5) Mazzanti A, et al : Novel insight into the natural history of short QT syndrome. J Am Coll Cardiol 63 : 1300-1308, 2014.
PubMed
6) Thorsen K, et al : Loss-of-activity-mutation in the cardiac chloride-bicarbonate exchanger AE3 causes short QT syndrome. Nat Commun 8 : 1696, 2017.
PubMed
7) Giustetto C, et al : Long-term follow-up of patients with short QT syndrome. J Am Coll Cardiol 58 : 587-595, 2011.
PubMed
8) Villafane J, et al : Long-term follow-up of a pediatric cohort with short QT syndrome. J Am Coll Cardiol 61 : 1183-1191, 2013.
PubMed
9) Priori SG, et al : HRS/EHRA/APHRS expert consensus statement on the diagnosis and management of patients with inherited primary arrhythmia syndromes : document endorsed by HRS, EHRA, and APHRS in May 2013 and by ACCE AHA, PACES, and AEPC in June 2013. Heart Rhythm 10 : 1932-1963, 2013.
 
10) Priori SG, et al : 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death : The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC). Endorsed by : Association for European Paediatric and Congenital Cardiology (AEPC). Eur Heart J 36 : 2793-2867, 2015.
 
11) Gollob MH, et al : The short QT syndrome : proposed diagnostic criteria. J Am Coll Cardiol 57 : 802-812, 2011.
PubMed
12) Giustetto C, et al : Usefulness of exercise test in the diagnosis of short QT syndrome. Europace 17 : 628-634, 2015.
PubMed
13) Patel C, et al : Short QT syndrome : from bench to bedside. Circ Arrhythm Electrophysiol 3 : 401-408, 2010.
PubMed
14) Gaita F, et al : Short QT syndrome : pharmacological treatment. J Am Coll Cardiol 43 : 1494-1499, 2004.
PubMed
15) Wolpert C, et al : Further insights into the effect of quinidine in short QT syndrome caused by a mutation in HERG. J Cardiovasc Electrophysiol 16 : 54-58, 2005.
PubMed
P.222 掲載の参考文献
1) Jervell A, Lange-Nielsen F : Congenital deaf-mutism, functional heart disease with prolongation of the Q-T interval and sudden death. Am Heart J 54 : 59-68, 1957.
 
2) Itoh H, et al : The genetics underlying acquired long QT syndrome : impact for genetic screening. Eur Heart J 37 : 1456-1464, 2016.
PubMed
3) Yoshinaga M, et al : Probability of diagnosing long QT syndrome in children and adolescents according to the criteria of the HRS/EHRA/APHRS expert consensus statement. Eur Heart J 37 : 2490-2497, 2016.
 
4) Schwartz PJ, et al : Prevalence of the congenital long-QT syndrome. Circulation 120 : 1761-1767, 2009.
PubMed
5) Saarnivaara L, Simola M : Effects of four anticholinesterase-anticholinergic combinations and tracheal extubation on QTc interval of the ECG, heart rate and arterial pressure. Acta Anaesthesiol Scand 42 : 460-463, 1998.
PubMed
6) Shimizu W, et al : Association of Genetic and Clinical Aspects of Congenital Long QT Syndrome With Life-Threatening Arrhythmias in Japanese Patients. JAMA Cardiol 4 : 246-254, 2019.
 
7) Priori SG, Blomstrom-Lundqvist C : 2015 European Society of Cardiology Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death summarized by co-chairs. Eur Heart J 36 : 2757-2759, 2015.
 
8) Priori SG, et al : Risk stratification in the long-QT syndrome. N Engl J Med 348 : 1866-1874, 2003.
 
9) Schwartz PJ, Crotti L : QTc behavior during exercise and genetic testing for the long-QT syndrome. Circulation 124 : 2181-2184, 2011.
 
10) 日本循環器学会, ほか : 遺伝性不整脈の診療に関するガイドライン (2017年改訂版), 2018.
 
11) Shimizu W, et al : Genotype-phenotype aspects of type 2 long QT syndrome. J Am Coll Cardiol 54 : 2052-2062, 2009.
PubMed
12) Priori SG, et al : HRS/EHRA/APHRS expert consensus statement on the diagnosis and management of patients with inherited primary arrhythmia syndromes : document endorsed by HRS, EHRA, and APHRS in May 2013 and by ACCF, AHA, PACES, and AEPC in June 2013. Heart Rhythm 10 : 1932-1963, 2013.
PubMed
13) Abu-Zeitone A, et al : Efficacy of different beta-blockers in the treatment of long QT syndrome. J Am Coll Cardiol 64 : 1352-1358, 2014.
PubMed
14) Ishibashi K, et al : Arrhythmia risk and β-blocker therapy in pregnant women with long QT syndrome. Heart 103 : 1374-1379, 2017.
 
P.229 掲載の参考文献
1) Roden DM, et al : Incidence and clinical features of the quinidine-associated long QT syndrome : implications for patient care. Am Heart J 111 : 1088-1093, 1986.
PubMed
2) Itoh H, et al : The genetics underlying acquired long QT syndrome : impact for genetic screening. Eur Heart J 37 : 1456-1464, 2016.
PubMed
3) Selzer A, Wray HW : Quinidine Syncope. Paroxysmal Ventricular Fibrillation Occurring During Treatment of Chronic Atrial Arrhythmias. Circulation 30 : 17-26, 1964.
PubMed
4) Ficker E, et al : Mechanisms of arsenic-induced prolongation of cardiac repolarization. Mol Pharmacol 66 : 33-44. 2004.
PubMed
5) Anson BD, et al : Blockade of HERG channels by HIV protease inhibitors. Lancet 365 : 682-686, 2005.
PubMed
6) Haraoka K, et al : Fragmented QRS is associated with torsades de pointes in patients with acquired long QT syndrome. Heart Rhythm 7 : 1808-1814, 2010.
PubMed
7) Aiba T, et al : Cellular and ionic mechanism for drug-induced long QT syndrome and effectiveness of verapamil. J Am Coll Cardiol 45 : 300-307, 2005.
PubMed
8) Noda T, et al : Classification and mechanism of Torsade de Pointes initiation in patients with congenital long QT syndrome. Eur Heart J 25 : 2149-2154, 2004.
PubMed
9) Ohe T, et al : Electrocardiographic and electrophysiologic studies in patients with torsades de pointe-role of monophasic action potentials. Jpn Circ J 54 : 1323-1330, 1990.
PubMed
10) Kurita T, et al : Bradycardia-induced abnormal QT prolongation in patients with complete atrioventricular block with torsades de pointes. Am J Cardiol 69 : 628-633, 1992.
PubMed
11) Kurita T, et al : Early afterdepolarizationlike activity in patients with class IA induced long QT syndrome and torsades de pointes. Pacing Clin Electrophysiol 20 : 695-705, 1997.
PubMed
12) Dote K, et al : [Myocardial stunning due to simultaneous multivessel coronary spasms : a review of 5 cases]. J Cardiol 21 : 203-214, 1991.
 
13) Pant S, et al : Burden of arrhythmias in patients with Takotsubo cardiomyopathy (apical ballooning syndrome). Int J Cardiol 170 : 64-68, 2013.
PubMed
14) Maekawa Y, et al : Direct comparison of Takotsubo cardiomyopathy between Japan and USA : 3-year follow-up study. Intern Med 51 : 257-262, 2012.
PubMed
15) Isogai T, et al : Apical Takotsubo syndrome versus anterior acute myocardial infarction : findings from the Tokyo Cardiovascular Care Unit network registry. Eur Heart J Acute Cardiovasc Care 8 : 86-95, 2019.
 
16) Nakamura K, et al : Anti-KCNH2 antibody-induced long QT syndrome : novel acquired form of long QT syndrome. J Am Coll Cardiol 50 : 1808-1809, 2007.
PubMed
P.234 掲載の参考文献
1) 消防庁 : 平成5～14年版 救急救助の現況, 1993～2002.
 
2) Bayes de Luna A, et al : Ambulatory sudden cardiac death : mechanisms of production of fatal arrhythmia on the basis of data from 157 cases. Am Heart J 117 : 151-159, 1989.
PubMed
3) 八木繁 (監) : Case Studies. ホルター心電図記録中の急死例. Proc of the Meeting for Case Studies of Sudden Death during Holter ECG Recording. Excerpta Medica, Tokyo, 1990.
 
4) ホルター記録中の突然死調査委員会および研究グループ : ホルター記録中の突然死について : ホルター記録中の突然死調査委員会の集計報告 (第1報). 心電図 28 : 243-250, 2008.
 
5) Shimizu A, et al : Actual conditions of implantable defibrillation therapy over 5 years in Japan. J Arrhythm 28 : 263-272, 2012.
 
6) Zipes DP, et al : ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death : a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (writing committee to develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death) : developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Circulation 114 : e385-484, 2006.
 
7) Dec GW, Fuster V : Idiopathic dilated cardiomyopathy. N Engl J Med 331 : 1564-1575, 1994.
PubMed
8) 日本循環器学会, ほか : 循環器病の診断と治療に関するガイドライン (2009年度合同研究班報告). 心臓突然死の予知と予防法のガイドライン (2010年改訂版), 2010.
 
9) Sumitomo N, et al : Catecholaminergic polymorphic ventricular tachycardia : electrocardiographic characteristics and optimal therapeutic strategies to prevent sudden death. Heart 89 : 66-70, 2003.
PubMed
10) Haissaguerre M, et al : Sudden cardiac arrest associated with early repolarization. N Engl J Med 358 : 2016-2023, 2008.
PubMed
11) Priori SG, et al : 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death : The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC). Endorsed by : Association for European Paediatric and Congenital Cardiology (AEPC). Eur Heart J 36 : 2793-2867, 2015.
 
12) Bardy GH, et al : Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 352 : 225-237, 2005.
 
13) Packer M, et al : The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U. S. Carvedilol Heart Failure Study Group. N Engl J Med 334 : 1349-1355, 1996.
 
14) Moss AJ, et al : Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction, N Engl J Med 346 : 877-883, 2002.
PubMed
15) Kober L, et al : Defibrillator Implantation in Patients with Nonischemic Systolic Heart Failure. N Engl J Med 375 : 1221-1230, 2016.
PubMed
P.239 掲載の参考文献
1) Watanabe E, et al : Sudden cardiac arrest recorded during Holter monitoring : prevalence, antecedent electrical events, and outcomes. Heart Rhythm 11 : 1418-1425, 2014.
PubMed
2) Kitamura T, et al : Nationwide improvements in survival from out-of-hospital cardiac arrest in Japan. Circulation 126 : 2834-2843, 2012.
PubMed
3) Hayashi M, et al : The spectrum of epidemiology underlying sudden cardiac death. Circ Res 116 : 1887-1906, 2015.
PubMed
4) Bigger JT, et al : Ventricular arrhythmias in ischemic heart disease : mechanism, prevalence, significance, and management. Prog Cardiovasc Dis 19 : 255-300. 1977.
 
5) Tabereaux PB, et al : Activation patterns of Purkinje fibers during long-duration ventricular fibrillation in an isolated canine heart model. Circulation 116 : 1113-1119, 2007.
 
6) Nishizaki M : Life-threatening arrhythmias leading to syncope in patients with vasospastic angina. J Arrhythm 33 : 553-561, 2017.
PubMed
7) Mentias A, et al : Late Gadolinium Enhancement in Patients With Hypertrophic Cardiomyopathy and Preserved Systolic Function. J Am Coll Cardiol 72 : 857-870, 2018.
PubMed
8) Gulati A, et al : Association of fibrosis with mortality and sudden cardiac death in patients with nonischemic dilated cardiomyopathy. JAMA 309 : 896-908, 2013.
PubMed
9) Patel AR, Kramer CM : Role of Cardiac Magnetic Resonance in the Diagnosis and Prognosis of Nonischemic Cardiomyopathy. JACC Cardiovasc Imaging 10 : 1180-1193, 2017.
PubMed
10) Connolly SJ, et al : Comparison of beta-blockers, amiodarone plus beta-blockers, or sotalol for prevention of shocks from implantable cardioverter defibrillators : the OPTIC Study : a randomized trial. JAMA 295 : 165-171, 2006.
PubMed
11) Bardy GH, et al : Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 352 : 225-237, 2005.
 
12) Suzuki M, et al : A multicenter observational study of the effectiveness of antiarrhythmic agents in ventricular arrhythmias : Apropensity-score adjusted analysis. J Arrhythm 32 : 186-190, 2016.
 
13) Connolly SJ, et al : Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials. AVID, CASH and CIDS studies. Antiarrhythmics vs Implantable Defibrillator study. Cardiac Arrest Study Hamburg. Canadian Implantable Defibrillator Study. Eur Heart J 21 : 2071-2078, 2000.
PubMed
14) Tanno K, et al : Are the MADIT II criteria for ICD implantation appropriate for Japanese patients? Circ J 69 : 19-22, 2005.
 
15) Satake H, et al : Current status of primary prevention of sudden cardiac death with implantable cardioverter defibrillator in patients with chronic heart failure-a report from the CHART-2 Study. Circ J 79 : 381-390, 2015.
PubMed
16) Kober L, et al : Defibrillator Implantation in Patients with Nonischemic Systolic Heart Failure. N Engl J Med 375 : 1221-1230, 2016.
PubMed
17) Elming MB, et al : Age and Outcomes of Primary Prevention Implantable Cardioverter-Defibrillators in Patients With Nonischemic Systolic Heart Failure. Circulation 136 : 1772-1780, 2017.
PubMed
18) Reddy VY, et al : Prophylactic catheter ablation for the prevention of defibrillator therapy. N Engl J Med 357 : 2657-2665, 2007.
PubMed
19) Kuck KH, et al : Catheter ablation of stable ventricular tachycardia before defibrillator implantation in patients with coronary heart disease (VTACH) : a multicentre randomised controlled trial. Lancet 375 : 31-40, 2010.
PubMed
20) Sapp JL, et al : Ventricular Tachycardia Ablation versus Escalation of Antiarrhythmic Drugs. N Engl J Med 375 : 111-121, 2016.
PubMed
21) Tilz RR, et al : Rationale and design of BERLIN VT study : a multicenter randomised trial comparing Preventive versus deferred ablation of ventricular tachycardia. BMJ Open 9 : e022910, 2019.
PubMed
22) Rao MP, et al : Sudden Cardiac Death in Patients With Ischemic Heart Failure Undergoing Coronary Artery Bypass Grafting : Results From the STICH Randomized Clinical Trial (Surgical Treatment for Ischemic Heart Failure). Circulation 135 : 1136-1144, 2017.
PubMed
P.246 掲載の参考文献
1) Cronin EM, et al : 2019 HRS/EHRA/APHRS/LAHRS expert consensus statement on catheter ablation of ventricular arrhythmias. Heart Rhythm, pii : S1547-5271 (19) 30210-3. doi : 10.1016/j.hrthm.2019.03.002. [Epub ahead of print]
 
2) Lerman BB, et al : Mechanism of repetitive monomorphic ventricular tachycardia. Circulation 92 : 421-429, 1995.
PubMed
3) Nogami A, Tada H : Ablation of idiopathic left and right ventricular and fascicular tachycardias. In : Catheter Ablation of Cardiac Arrhythmias, 4th ed (ed by Huang SK, Miller JM), p467-509, Elsevier/Saunders, Philadelphia, 2019.
 
4) Komatsu Y, et al : Fascicular ventricular tachycardia originating from papillary muscles : Purkinje network involvement in the reentrant circuit. Circ Arrhythm Electrophysiol 10. pii : e004549, 2017.
 
5) Talib AK, et al : Non-reentrant fascicular tachycardia : Clinical and electrophysiological characteristics of a distinct type of idiopathic ventricular tachycardia. Circ Arrhythm Electrophysiol 9. pii : e004177, 2016.
 
6) Tchou P, et al : Bundle branch reentry ventricular tachycardia. Pacing Clin Electrophysiol 18 : 1427-1437, 1995.
PubMed
P.250 掲載の参考文献
1) 日本循環器学会, ほか : 循環器病の診断と治療に関するガイドライン (2008年度合同研究班報告). 不整脈薬物治療に関するガイドライン (2009年改訂版), 2009.
 
2) Ganz LI : Sustained monomorphic ventricular tachycardia : Clinical manifestation, diagnosis, and evaluation. UpToDate, 2019.
 
3) Stevenson WG, et al : Identification of reentry circuit sites during catheter mapping and radiofrequency ablation of ventricular tachycardia late after myocardial infarction. Circulation 88 : 1647-1670, 1993.
PubMed
4) Akhtar M : Clinical spectrum of ventricular tachycardia. Circulation 82 : 1561-1573, 1990.
PubMed
5) Goldenberg I, et al : Long QT syndrome. J Am Coll Cardiol 51 : 2291-2300, 2008.
PubMed
6) Brugada P, et al : Right bundle branch block, persistent ST segment elevation and sudden cardiac death : a distinct clinical and electrocardiographic syndrome. A multicenter report. J Am Coll Cardiol 20 : 1391-1396, 1992.
PubMed
7) Leenhardt A, et al : Catecholaminergic polymorphic ventricular tachycardia in children. A 7-year follow-up of 21 patients. Circulation 91 : 1512-1519, 1995.
PubMed
8) Bigger JT Jr, et al : Ventricular arrhythmias in ischemic heart disease : mechanism, prevalence, significance, and management. Prog Cardiovasc Dis 19 : 255-300, 1977.
 
9) Patel AR, Kramer CM : Role of Cardiac Magnetic Resonance in the Diagnosis and Prognosis of Nonischemic Cardiomyopathy. JACC Cardiovasc Imaging : 10 : 1180-1193, 2017.
PubMed
10) Akhtar M, et al : Wide QRS complex tachycardia. Reappraisal of a common clinical problem. Ann Intern Med 109 : 905-912, 1988.
PubMed
11) Wellens HJ, et al : The value of the electrocardiogram in the differential diagnosis of a tachycardia with a widened QRS complex. Am J Med 64 : 27-33, 1978.
PubMed
12) Reddy GV, et al : Standard limb lead QRS concordance during wide QRS tachycardia. A new surface ECG sign of ventricular tachycardia. Chest 92 : 763-765, 1987.
PubMed
13) Ishida N, et al : Noninfarcted myocardium : correlation between dynamic first-pass contrastenhanced myocardial MR imaging and quantitative coronary angiography. Radiology 229 : 209-216, 2003.
PubMed
14) 日本循環器学会, ほか : 日本循環器学会/日本不整脈心電学会合同ガイドライン. 不整脈非薬物治療ガイドライン (2018年改訂版), 2019.
 
15) 日本循環器学会, ほか : 循環器病の診断と治療に関するガイドライン (2011年度合同研究班報告). QT延長症候群 (先天性・二次性) とBrugada症候群の診療に関するガイドライン (2012年改訂版), 2012.
 
P.257 掲載の参考文献
1) Tanaka Y, et al : Gender and age differences in candidates for radiofrequency catheter ablation of idiopathic ventricular arrhythmias. Circ J 75 : 1585-1591, 2011.
PubMed
2) Komatsu Y, et al : Fascicular Ventricular Tachycardia Originating From Papillary Muscles : Purkinje Network Involvement in the Reentrant Circuit. Circ Arrhythm Electrophysiol 10 : 2017.
PubMed
3) Aiba T, et al : The role of Purkinje and pre-Purkinje potentials in the reentrant circuit of verapamil-sensitive idiopathic LV tachycardia. Pacing Clin Electrophysiol 24 : 333-344, 2001.
PubMed
4) Brugada P, et al : a new approach to the differential diagnosis of a regular tachycardia with a wide QRS complex. Circulation 83 : 1649-1659, 1991.
 
5) Wellens HJ : Electrophysiology : Ventricular tachycardia : diagnosis of broad QRS complex tachycardia. Heart 86 : 579-585, 2001.
PubMed
6) Ouyang F, et al : Repetitive monomorphic ventricular tachycardia originating from the aortic sinus cusp : electrocardiographic characterization for guiding catheter ablation. J Am Coll Cardiol 39 : 500-508, 2002.
PubMed
7) Al'Aref SJ, et al : Differentiation of papillary muscle from fascicular and mitral annular ventricular arrhythmias in patients with and without structural heart disease. Circ Arrhythm Electrophysiol 8 : 616-624, 2015.
PubMed
8) Nakagawa H, et al : Radiofrequency catheter ablation of idiopathic left ventricular tachycardia guided by a Purkinje potential. Circulation 88 : 2607-2617, 1993.
PubMed
9) Nogami A, et al : Demonstration of diastolic and presystolic Purkinje potentials as critical potentials in a macroreentry circuit of verapamil-sensitive idiopathic left ventricular tachycardia. J Am Coll Cardiol 36 : 811-823, 2000.
 
10) Kumagai K, et al : Idiopathic left ventricular tachycardia originating from the mitral annulus. J Cardiovasc Electrophysiol 16 : 1029-1036, 2005.
PubMed
11) Yamada T, et al : Idiopathic ventricular arrhythmias originating from the papillary muscles in the left ventricle : prevalence, electrocardiographic and electrophysiological characteristics, and results of the radiofrequency catheter ablation. J Cardiovasc Electrophysiol 21 : 62-69, 2010.
PubMed
P.262 掲載の参考文献
1) Lerman BB : Mechanism of outflow tract tachycardia. Heart Rhythm 4 : 973-976, 2007.
PubMed
2) Kobayashi Y : Idiopathic ventricular premature contraction and ventricular tachycardia : Distribution of the origin, diagnostic algorithm, and catheter ablation. J Nippon Med Sch 85 : 87-94, 2018.
PubMed
3) Sekiguchi Y, et al : Electrocardiographic and electrophysiologic characteristics of ventricular tachycardia originating within the pulmonary artery. J Am Coll Cardiol 45 : 887-895, 2005.
PubMed
4) Tada H, et al : Idiopathic ventricular arrhythmias originating from the tricuspid annulus : Prevalence, electrocardiographic characteristics, and results of radiofrequency catheter ablation. Heart Rhythm 4 : 7-16, 2007.
PubMed
5) 日本循環器学会, ほか : 日本循環器学会/日本不整脈心電学会合同ガイドライン. 不整脈非薬物治療ガイドライン (2018年改訂版), 2019. [http://www.j-circ.or.jp/guideline/pdf/JCS2018_kurita_nogami.pdf]
 
6) Betensky BP, et al : The V (2) transition ratio : a new electrocardiographic criterion for distinguishing left from right ventricular outflow tract tachycardia origin. J Am Coll Cardiol 57 : 2255-2262, 2011.
 
7) Yoshida N, et al : A novel electrocardiographic criterion for differentiating a left from right ventricular outflow tract tachycardia origin : the V2S/V3R index. J Cardiovasc Electrophysiol 25 : 747-753, 2014.
PubMed
P.267 掲載の参考文献
1) 日本循環器学会, ほか : 遺伝性不整脈の診療に関するガイドライン (2017年改訂版), 2018.
 
2) 日本循環器学会, ほか : 日本循環器学会, 日本心不全学会合同ガイドライン. 心筋症診療ガイドライン (2018年改訂版), 2019.
 
3) Marcus FI, et al : Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia : proposed modification of the task force criteria. Circulation 121 : 1533-1541, 2010.
PubMed
4) Ohno S : The genetic background of arrhythmogenic right ventricular cardiomyopathy. J Arrhythm 32 : 398-403, 2016.
PubMed
5) 市田蕗子 : 心筋緻密化障害. 日本内科学会雑誌 103 : 327-335, 2014.
 
6) 日本循環器学会, ほか : 日本循環器学会/日本不整脈心電学会合同ガイドライン. 不整脈非薬物治療ガイドライン (2018年改訂版), 2019.
 
7) 日本循環器学会, ほか : 循環器病の診断と治療に関するガイドライン (2008年度合同研究班報告). 不整脈薬物治療に関するガイドライン (2009年改訂版), 2009.
 
P.271 掲載の参考文献
1) Leenhardt A, et al : Catecholaminergic polymorphic ventricular tachycardia in children. A 7-year follow-up of 21 patients. Circulation 91 : 1512-1519, 1995.
PubMed
2) Priori SG, et al : HRS/EHRA/APHRS expert consensus statement on the diagnosis and management of patients with inherited primary arrhythmia syndromes : document endorsed by HRS, EHRA, and APHRS in May 2013 and by ACCF, AHA, PACES, and AEPC in June 2013. Heart Rhythm 10 : 1932-1963, 2013.
PubMed
3) Ohno S, et al : Gender Differences in the Inheritance Mode of RYR2 Mutations in Catecholaminergic Polymorphic Ventricular Tachycardia Patients. PLoS ONE 10 : e0131517, 2015.
PubMed
4) Priori SG, et al : Mutations in the cardiac ryanodine receptor gene (hRyR2) underlie catecholaminergic polymorphic ventricular tachycardia. Circulation 103 : 196-200, 2001.
PubMed
5) Sumitomo N : Current topics in catecholaminergic polymorphic ventricular tachycardia. J Arrhythm 32 : 344-351, 2016.
PubMed
6) van der Werf C, et al : Familial evaluation in catecholaminergic polymorphic ventricular tachycardia : disease penetrance and expression in cardiac ryanodine receptor mutationcarrying relatives. Circ Arrhythm Electrophysiol 5 : 748-756, 2012.
PubMed
7) Sy RW, et al : Arrhythmia characterization and long-term outcomes in catecholaminergic olymorphic ventricular tachycardia. Heart Rhythm 8 : 864-871, 2011.
 
8) Marjamaa A, et al : Intravenous epinephrine infusion test in diagnosis of catecholaminergic polymorphic ventricular tachycardia. J Cardiovasc Electrophysiol 23 : 194-199, 2012.
PubMed
9) Priori SG, et al : 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death : The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC). Endorsed by : Association for European Paediatric and Congenital Cardiology (AEPC). Eur Heart J 36 : 2793-2867, 2015.
 
10) Tester DJ, et al : Genotypic heterogeneity and phenotypic mimicry among unrelated patients referred for catecholaminergic polymorphic ventricular tachycardia genetic testing. Heart Rhythm 3 : 800-805, 2006.
PubMed
11) Roux-Buisson N, et al : Prevalence and significance of rare RYR2 variants in arrhythmogenic right ventricular cardiomyopathy/dysplasia : results of a systematic screening. Heart Rhythm 11 : 1999-2009, 2014.
PubMed
12) Roston TM, et al : Catecholaminergic polymorphic ventricular tachycardia in children : analysis of therapeutic strategies and outcomes from an international multicenter registry. Circ Arrhythm Electrophysiol 8 : 633-642, 2015.
PubMed
13) Swan H, et al : Calcium channel antagonism reduces exercise-induced ventricular arrhythmias in catecholaminergic polymorphic ventricular tachycardia patients with RyR2 mutations. J Cardiovasc Electrophysiol 16 : 162-166, 2005.
PubMed
14) Wilde AA, et al : Left cardiac sympathetic denervation for catecholaminergic polymorphic ventricular tachycardia. N Engl J Med 358 : 2024-2029, 2008.
PubMed
P.277 掲載の参考文献
1) 櫻田春水 : 脚枝間リエントリー性心室頻拍の臨床的, 電気生理学的特徴. 不整脈 18 : 7-17, 2002.
 
2) Nishizaki M, et al : Bundle Branch Reentrant Ventricular Tachycardia. In : Catheter Ablation (ed by Hirao K), p325-334, Springer, Singapore, 2018.
 
3) Blanck Z, et al : Bundle branch reentrant ventricular tachycardia : cumulative experience in 48 patients. J Cardiovasc Electrophysiol 4 : 253-262, 1993.
PubMed
4) Narasimhan C, et al : Ventricular tachycardia in valvular heart disease : facilitation of sustained bundle-branch reentry by valve surgery. Circulation 96 : 4307-4313, 1997.
PubMed
5) Chen H, et al : Electrophysiological Characteristics of Bundle Branch Reentry Ventricular Tachycardia in Patients Without Structural Heart Disease. Circ Arrhythm Electrophysiol 11 : e006049, 2018.
PubMed
6) Caceres J, et al : Sustained bundle branch reentry as a mechanism of clinical tachycardia. Circulation 79 : 256-270, 1989.
PubMed
7) Mizusawa Y, et al : Characteristics of bundle branch reentrant ventricular tachycardia with a right bundle branch block configuration : feasibility of atrial pacing. Europace 11 : 1208-1213, 2009.
PubMed
8) Merino JL, et al : Bundle-branch reentry and the postpacing interval after entrainment by right ventricular apex stimulation : a new approach to elucidate the mechanism of wide-QRS-complex tachycardia with atrioventricular dissociation. Circulation 103 : 1102-1108, 2001.
PubMed
9) Balasundaram R, et al : Catheter ablation of bundle branch reentrant ventricular tachycardia. Heart Rhythm 5 : S68-72, 2008.
PubMed
10) Tchou P, et al : Transcatheter electrical ablation of right bundle branch. A method of treating macroreentrant ventricular tachycardia attributed to bundle branch reentry. Circulation 78 : 246-257, 1988.
 
11) Pathak RK, et al : Long-Term Outcome of Catheter Ablation for Treatment of Bundle Branch Re-Entrant Tachycardia. JACC Clin Electrophysiol 4 : 331-338, 2018.
PubMed
P.282 掲載の参考文献
1) Vedel J, et al : [Recurrent ventricular tachycardia and parchlnent right ventricie in the adult. Anatomical and clinical report of 2 cases]. Arch Mal Coeur Vaiss 71 : 973-9. 81, 1978.
 
2) Marcus FI, et al : Right ventricular dysplasia : a report of 24 adult cases. Circulation 65 : 384-398, 1982.
PubMed
3) Richardson P, et al : Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of cardiomyopathies. Circulation 93 : 841-842, 1996.
PubMed
4) McKenna WJ, et al : Diagnosis of arrhythmogenic right ventricular dysplasia/cardiomyopathy. Task Force of the Working Group Myocardial and Pericardial Disease of the European Society of Cardiology and of the Scierltific Council on Cardiomyopathies of the International Society and Federation of Cardiology. Br Heart J 71 : 215-218, 1994.
 
5) Marcus FI, et al : Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia : proposed modification of the Task Force Criteria. Eur Heart J 31 : 806-814, 2010.
PubMed
6) Marcus FI, et al : Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia : proposed modification of the task force criteria. Circulation 121 : 1533-1541, 2010.
PubMed
7) Bhonsale A, et al : Impact of genotype on clinical course in arrhythmogenic right ventricular dysplasia/cardiomyopathy-associated mutation carriers. Eur Heart J 36 : 847-855, 2015.
PubMed
8) te Riele AS, et al : Approach to family screening in arrhythmogenic right ventricular dysplasia/cardiomyopathy. Eur Heart J 37 : 755-763, 2016.
PubMed
9) Romero J, et al : Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC/D) : A Systematic Literature Review. Clin Med Insights Cardiol 7 : 97-114, 2013.
 
10) Protonotarios A, et al : Arrhythmic risk assessment in genotyped families with arrhythmogenic right ventricular cardiomyopathy. Europace 18 : 610-616, 2016.
PubMed
11) Dalal D, et al : Clinical features of arrhythmogenic right ventricular dysplasia/cardiomyopathy associated with mutations in plakophilin-2. Circulation 113 : 1641-1649, 2006.
PubMed
12) James CA, et al : Exercise increases age-related penetrance and arrhythmic risk in arrhythmogenic right ventricular dysplasia/cardiomyopathy-associated desmosomal mutation carriers. J Am Coll Cardiol 62 : 1290-1297, 2013.
PubMed
13) Ruwald AC, et al : Association of competitive and recreational sport participation with cardiac events in patients with arrhythmogenic right ventricular cardiomyopathy : results from the North American multidisciplinary study of arrhythmogenic right ventricular cardiomyopathy. Eur Heart J 36 : 1735-1743, 2015.
PubMed
14) Corrado D, et al : Treatment of arrhythmogenic right ventricular cardiomyopathy/dysplasia : an international task force consensus statement. Eur Heart J 36 : 3227-3237, 2015.
PubMed
15) Rigato I, et al : Pharmacotherapy and other therapeutic modalities for managing Arrhythmogenic Right Ventricular Cardiomyopathy. Cardiovasc Drugs Ther 29 : 171-177, 2015.
PubMed
16) Corrado D, et al : Spectrum of clinicopathologic manifestations of arrhythmogenic right ventricular cardiomyopathy/dysplasia : a multicenter study. J Am Coll Cardiol 30 : 1512-1520, 1997.
PubMed
P.287 掲載の参考文献
1) Selzer A, Wray HW : Quinidine Syncope. Paroxysmal Ventricular Fibrillation Occurring During Treatment of Chronic Atrial Arrhythmias. Circulation 30 : 17-26, 1964.
PubMed
2) Dessertenne F : [Ventricular tachycardia with 2 variable opposing foci]. Arch Mal Coeur Vaiss 59 : 263-272, 1966.
PubMed
3) Yu H, et al : Acquired long QT syndrome in hospitalized patients. Heart Rhythm 14 : 974-978, 2017.
PubMed
4) Straus SMJM, et al : Non-cardiac QTc-prolonging drugs and the risk of sudden cardiac death. Eur Heart J 26 : 2007-2012, 2005.
PubMed
5) Hravnak M, et al : Elevated cardiac troponin I and relationship to persistence of electrocardiographic and echocardiographic abnormalities after aneurysmal subarachnoid hemorrhage. Stroke 40 : 3478-3484, 2009.
PubMed
6) Shimizu W, et al : Effects of verapamil and propranolol on early afterdepolarizations and entricular arrhythmias induced by epinephrine in congenital long QT syndrome. J Am Coll Cardiol 26 : 1299-1309, 1995.
 
7) Shimizu W, et al : Early afterdepolarizations induced by isoproterenol in patients with congenital long QT syndrome. Circulation 84 : 1915-1923, 1991.
PubMed
8) Tisdale JE : Drug-induced QT interval prolongation and torsades de pointes : Role of the pharmacist in risk assessment, prevention and management. Can Pharm J (Ott) 149 : 139-152, 2016.
PubMed
9) Tzivoni D, et al : Treatment of torsade de pointes with magnesium sulfate. Circulation 77 : 392-397, 1988.
PubMed
10) Hoshino K, et al : Successful uses of magnesium sulfate for torsades de pointes in children with long QT syndrome. Pediatr Int 48 : 112-117, 2006.
PubMed
11) Oka Y, et al : Atrioventricular block-induced Torsades de Pointes with clinical and molecular backgrounds similar to congenital long QT syndrome. Circ J 74 : 2562-2571, 2010.
PubMed
12) Monnig G, et al : Role of implantable cardioverter defibrillator therapy in patients with acquired long QT syndrome : a long-term follow-up. Europace 14 : 396-401, 2012.
PubMed
13) Itoh H, et al : The genetics underlying acquired long QT syndrome : impact for genetic screening. Eur Heart J 37 : 1456-1464, 2016.
PubMed
P.292 掲載の参考文献
1) Krummen DE, et al : Ventricular fibrillation : triggers, mechanisms and therapies. Future Cardiol 12 : 373-390, 2016.
PubMed
2) Boukens BJ, et al : Imaging of Ventricular Fibrillation and Defibrillation : The Virtual Electrode Hypothesis. Adv Exp Med Biol 859 : 343-365, 2015.
PubMed
3) 日本循環器学会, ほか : 循環器病の診断と治療に関するガイドライン (2009年度合同研究班報告), 心臓突然死の予知と予防法のガイドライン (2010年改訂版), 2010.
 
4) ホルター記録中の突然死調査委員会および研究グループ : ホルター記録中の突然死について ホルター記録中の突然死調査委員会の集計報告 (第1報). 心電図 28 : 243-250, 2008.
 
5) Baron-Esquivias G, et al : Prognosis of patients with syncope seen in the emergency room department : an evaluation of four different risk scores recommended by the European Society of Cardiology guidelines. Eur J Emerg Med 24 : 428-434, 2017.
 
6) 総務省消防庁 : 平成30年版 救急救助の現況, 2019.
 
7) 原山信也, ほか : 電気ショック抵抗性心室細動に対する薬物治療-ニフェカラントとアミオダロンの効果比較からみえるもの. J UOEH (産業医科大学雑誌) 38 : 35-46, 2016.
 
8) Khan SU, et al : Amiodarone, lidocaine, magnesium or placebo in shock refractory ventricular arrhythmia : A Bayesian network meta-analysis. Heart Lung 46 : 417-424, 2017.
PubMed
9) Nogami A : Trigger elimination of polymorphic ventricular tachycardia and ventricular fibrillation by catheter ablation : trigger and substrate modification. J Biomed Res 29 : 44-51, 2015.
PubMed
10) Brugada J, et al : Brugada Syndrome Phenotype Elimination by Epicardial Substrate Ablation. Circ Arrhythm Electrophysiol 8 : 1373-1381, 2015.
PubMed
P.297 掲載の参考文献
1) an der Weg K, et al : Editor's Choice-Reperfusion cardiac arrhythmias and their relation to reperfusion-induced cell death. Eur Heart J Acute Cardiovasc Care 8 : 142-152, 2019.
 
2) Majidi M, et al : Reperfusion ventricular arrhythmia 'bursts' in TIMI 3 flow restoration with primary angioplasty for anterior ST-elevation myocardial infarction : amore precise definition of reperfusion arrhythmias. Europace 10 : 988-997, 2008.
 
3) Henriques JP, et al : Ventricular fibrillation in acute myocardial infarction before and during primary PCI. Int J Cardiol 105 : 262-266, 2005.
PubMed
4) Podolecki T, et al : Prognostic Significance of Complex Ventricular Arrhythmias Complicating ST-Segment Elevation Myocardial Infarction. Am J Cardiol 121 : 805-809, 2018.
PubMed
5) 日本循環器学会, ほか : 急性冠症候群ガイドライン (2018年改訂版), 2019.
 
6) Burjorjee JE, et al : Propofol for electrical storm ; acase report of cardioversion and suppression of ventricular tachycardia by propofol. Can J Anaesth 49 : 973-977, 2002.
 
7) Kurisu S, et al : Temporary overdriving pacing as an adjunct to antiarrhythrnic drug therapy for electrical storm in acute myocardial infarction. Circ J 69 : 613-616, 2005.
PubMed
8) Bansch D, et al : Successful catheter ablation of electrical storm after myocardial infarction. Circulation 108 : 3011-3016, 2003.
PubMed
9) Komatsu Y, et al : Catheter Ablation of Refractory Ventricular Fibrillation Storm After Myocardial Infarction. Circulation 139 : 2315-2325, 2019.
PubMed
P.304 掲載の参考文献
1) Maeno Y, et al : Fetal arrhythmia : prenatal diagnosis and perinatal management. J Obstet Gynaecol Res 35 : 623-629, 2009.
PubMed
2) Strasburger JF, et al : Perinatal arrhythmias : diagnosis and management. Clin Perinatol 34 : 627-652, vii-viii, 2007.
 
3) Peleg D, et al : The relationship between maternal serum thyroid-stimulating immunoglobulin and fetal and neonatal thyrotoxicosis. Obstet Gynecol 99 : 1040-1043, 2002.
PubMed
4) Naheed ZJ, et al : Fetal tachycardia : mechanisms and predictors of hydrops fetalis. J Am Coll Cardiol 27 : 1736-1740, 1996.
PubMed
5) Miyoshi T, et al : Antenatal antiarrhythmic treatment for fetal tachyarrhythmias : a study protocol for a prospective multicentre trial. BMJ Open 7 : e016597, 2017.
PubMed
6) Horigome H, et al : Clinical characteristics and genetic background of congenital long-QT syndrome diagnosed in fetal, neonatal, and infantile life : a nationwide questionnaire survey in Japan. Circ Arrhythm Electrophysiol 3 : 10-17, 2010.
PubMed
7) Miyake A, et al : Successful prenatal management of ventricular tachycardia and seconddegree atrioventricular block in fetal long QT syndrome. HeartRhythm Case Rep 3 : 53-57, 2017.
PubMed
8) Zhao H, et al : Electrophysiological characteristics of fetal atrioventricular block. J Am Coll Cardiol 51 : 77-84, 2008.
PubMed
9) Groves AM, et al : Therapeutic trial of sympathomimetics in three cases of complete heart block in the fetus. Circulation 92 : 3394-3396, 1995.
PubMed
10) Copel JA, et al : Successful in utero therapy of fetal heart block. Am J Obstet Gynecol 173 : 1384-1390, 1995.
 
P.309 掲載の参考文献
1) 長嶋正實 : 小児の不整脈の特徴. 小児不整脈 [改訂第2版] (長嶋正實ほか編), p2-3, 診断と治療社, 2011.
 
2) Drago F, et al : Neonatal and Pediatric Arrhythmias : Clinical and Electrocardiographic Aspects. Card Electrophysiol Clin 10 : 397-412, 2018.
PubMed
3) 日本循環器学会, 日本小児循環器学会 : 日本循環器学会/日本小児循環器学会合同ガイドライン. 2016年版 学校心臓検診のガイドライン, 2016.
 
4) Wilders R : Cardiac ion channelopathies and the sudden infant death syndrome. ISRN Cardiol 2012 : 846171, 2012.
PubMed
5) 立野滋 : 成人先天性心疾患にみられる不整脈. 小児・成育循環器学 (日本小児循環器学会編), p673-675, 診断と治療社, 2018.
 
6) 加藤愛章 : 成人先天性心疾患の不整脈. 日本小児循環器学会雑誌 33 : 385-394, 2017
Medical*Online
7) Brugada J, et al : Pharmacological and non-pharmacological therapy for arrhythmias in the pediatric population : EHRA and AEPC-Arrhythmia Working Group joint consensus statement. Europace 15 : 1337-1382, 2013.
 
8) Hernandez-Madrid A, et al : Arrhythmias in congenital heart disease : aposition paper of the European Heart Rhythm Association (EHRA), Association for European Paediatric and Congenital Cardiology (AEPC), and the European Society of Cardiology (ESC) Working Group on Grown-up Congenital heart disease, endorsed by HRS, PACES, APHRS, and SOLAECE. Europace 20 : 1719-1753, 2018.
 
9) Hu F, et al : Ventricular arrhythmia as an initial sign in acute Kawasaki disease : A case report. Medicine (Baltimore) 97 : e0641, 2018.
PubMed
10) Oztunc F, et al : Everolimus treatment of a newborn with rhabdomyoma causing severe arrhythmia. Cardiol Young 25 : 1411-1414, 2015.
PubMed
11) 堀米仁志, 吉永正夫 : 乳児期発症先天性QT延長症候群 (LQTS) と乳児突然死症候群にみられるLQTS関連遺伝子変異の比較. 循環器専門医 26 : 64-69, 2018.
 
12) Pediatric and Congenital Electrophysiology Society (PACES), et al : PACES/HRS expert consensus statement on the management of the asymptomatic young patient with a Wolff-Parkinson-White (WPW, ventricular preexcitation) electrocardiographic pattern : developed in partnership between the Pediatric and Congenital Electrophysiology Society (PACES) and the Heart Rhythm Society (HRS). Endorsed by the governing bodies of PACES, HRS, the American College of Cardiology Foundation (ACCF), the American Heart Association (AHA), the American Academy of Pediatrics (AAP), and the Canadian Heart Rhythm Society (CHRS). Heart Rhythm 9 : 1006-1024, 2012.
 
13) 日本小児循環器学会 : 小児不整脈の診断・治療ガイドライン, 2010.
 
14) 日本循環器学会, ほか : 日本循環器学会/日本不整脈心電学会合同ガイドライン. 不整脈非薬物治療ガイドライン (2018年改訂版), 2019.
 
15) 宮崎文 : 小児循環器領域の植え込み型心臓電気デバイス : ペースメーカ, 植え込み型除細動器, 心臓再同期療法. 日本小児循環器学会雑誌 34 : 172-181, 2018.
Medical*Online
P.314 掲載の参考文献
1) Ko JK, et al : Supraventricular tachycardia mechanisms and their age distribution in pediatric patients. Am J Cardiol 69 : 1028-1032, 1992.
PubMed
2) Perry JC, Garson A Jr : Supraventricular Tachycardia due to Wolff-Parkinson-White Syndrome in Children : Early Disappearance and Late Recurrence. J Am Coll Cardiol 16 : 1215-1220, 1990.
PubMed
3) Asakai H, Kirsh JA : Optimizing outcomes of catheter ablation in infants and toddlers. Expert Rev Cardiovasc Ther 13 : 333-340, 2015.
PubMed
4) Pediatric and Congenital Electrophysiology Society (PACES), et al : PACES/HRS expert consensus statement on the management of the asymptomatic young patient with a Wolff-Parkinson-White (WPW, ventricular preexcitation) electrocardiographic pattern : developed in partnership between the Pediatric and Congenital Electrophysiology Society (PACES) and the Heart Rhythm Society (HRS). Endorsed by the governing bodies of PACES, HRS, the American College of Cardiology Foundation (ACCF), the American Heart Association (AHA), the American Academy of Pediatrics (AAP), and the Canadian Heart Rhythm Society (CHRS). Heart Rhythm 9 : 1006-1024, 2012.
 
5) 小児循環器学会「小児不整脈の診断・治療に関する検討委員会」 : 小児不整脈の診断・治療ガイドライン, 2010.
 
6) Groves AMM, et al : Outcome of isolated congenital complete heart block diagnosed in utero. Heart 75 : 190-194, 1996.
 
7) Jaeggi ET, et al : Outcome of children with fetal, neonatal or childhood diagnosis of isolated congenital atrioventricular block. A single institution's experience of 30 years. J Am Coll Cardiol 39 : 130-137, 2002.
 
8) Bordachar P, et al : Pathophysiology, clinical course, and management of congenital complete atrioventricular block. Heart Rhythm 10 : 760-766, 2013.
PubMed
9) Ozawa Y, et al : Cardiac Rhythm Disturbances in Heterotaxy Syndrome. Pediatr Cardiol 40 : 909-913, 2019.
PubMed
P.319 掲載の参考文献
1) Maisel WH, et al : Atrial fibrillation after cardiac surgery. Ann Intern Med 135 : 1061-1073, 2001.
PubMed
2) Kalman JM, et al : Ablation of 'incisional' reentrant atrial tachycardia complicating surgery for congenital heart disease. Use of entrainment to define a critical isthmus of conduction. Circulation 93 : 502-512, 1996.
PubMed
3) Mariscalco G, et al : Bedside tool for predicting the risk of postoperative atrial fibrillation after cardiac surgery : the POAF score. J Am Heart Assoc 3 : e000752, 2014.
 
4) Ascione R, et al : Predictors of atrial fibrillation after conventional and beating heart coronary surgery : A prospective, randomized study. Circulation 102 : 1530-1535, 2000.
PubMed
5) 今井克彦, ほか : 開心術後上室性不整脈の発症様式～バックマン束持続モニターからの検討～. 心臓 36 (Suppl 5) : 11-12, 2004.
 
6) Markowitz SM, et al : Lesional tachycardias related to mitral valve surgery. J Am Coll Cardiol 39 : 1973-1983, 2002.
PubMed
7) Takeshita M, et al : Sinus node function after mitral valve surgery via the transseptal superior approach. Eur J Cardiothorac Surg 12 : 341-344, 1997.
PubMed
8) Mohr FW, et al : The German Aortic Valve Registry : 1-year results from 13,680 patients with aortic valve disease. Eur J Cardiothorac Surg 46 : 808-816, 2014.
PubMed
9) van Hemel NM, et al : Long-term follow-up of corridor operation for lone atrial fibrillation : evidence for progression of disease? J Cardiovasc Electrophysiol 8 : 967-973, 1997.
 
10) Imai K, et al : Clinical analysis of results of a simple left atrial procedure for chronic atrial fibrillation. Ann Thorac Surg 71 : 577-581, 2001.
PubMed
11) Ferrer MI : The sick sinus syndrome in atrial disease. JAMA 206 : 645-646, 1968.
PubMed
12) Delaney JW, et al : Early postoperative arrhythmias after pediatric cardiac surgery. J Thorac Cardiovasc Surg 131 : 1296-1300, 2006.
PubMed
13) Mitchell LB, et al : Prophylactic oral amiodarone for the prevention of arrhythmias that begin early after revascularization, valve replacement, or repair : PAPABEAR : a randomized controlled trial. JAMA 294 : 3093-3100, 2005.
PubMed
14) Wiesbauer F, et al : Perioperative beta-blockers for preventing surgery-related mortality and morbidity : asystematic review and meta-analysis. Anesth Analg 104 : 27-41, 2007.
 
P.324 掲載の参考文献
1) Nakai S, et al : Overview of regular dialysis treatment in Japan as of 31 December 2006. Ther Apher Dial 12 : 428-456, 2008.
PubMed
2) Bleyer AJ, et al : Characteristics of sudden death in hemodialysis patients. Kidney Int 69 : 2268-2273, 2006.
PubMed
3) Vazquez E, et al : Atrial fibrillation in incident dialysis patients. Kidney Int 76 : 324-330, 2009.
PubMed
4) Genovesi S, et al : Prevalence of atrial fibrillation and associated factors in a population of long-term hemodialysis patients. Am J Kidney Dis 46 : 897-902, 2005.
 
5) Vazquez E, et al : Comparison of prognostic value of atrial fibrillation versus sinus rhythm in patients on long-term hemodialysis. Am J Cardiol 92 : 868-871, 2003.
PubMed
6) Cice G, et al : Carvedilol increases two-year survivalin dialysis patients with dilated cardiomyopathy : aprospective, placebo-controlled trial. J Am Coll Cardiol 41 : 1438-1444, 2003.
 
7) Herzog CA, et al : Survival of dialysis patients after cardiac arrest and the impact of implantable cardioverter defibrillators. Kidney Int 68 : 818-825, 2005.
PubMed
8) Chao TF, et al : Incidence and prediction of ischemic stroke among atrial fibrillation patients with end-stage renal disease requiring dialysis. Heart Rhythm 11 : 1752-1759, 2014.
PubMed
9) 社団法人日本透析医学会「血液透析患者における心血管合併症の評価と治療に関するガイドライン」. 日本透析医学会雑誌 44 : 337-425, 2011.
 
10) Chan KE, et al : Warfarin use associates with increased risk for stroke in hemodialysis patients with atrial fibrillation. J Am Soc Nephrol 20 : 2223-2233, 2009.
PubMed
11) 日本循環器学会, ほか : 循環器病の診断と治療に関するガイドライン (2012年度合同研究班報告). 心房細動治療 (薬物) ガイドライン (2013年改訂版), 2013.
 
12) Takigawa M, et al : The impact of haemodialysis on the outcomes of catheter ablation in patients with paroxysmal atrial fibrillation. Europace 16 : 327-334, 2014.
PubMed
P.328 掲載の参考文献
1) Kerin NZ, Somberg J : Proarrhythmia : definition, risk factors, causes, treatment, and controversies. Am Heart J 128 : 575-585, 1994.
PubMed
2) Roden DM : Taking the "idio" out of "idiosyncratic" : predicting torsades de pointes. Pacing Clin Electrophysiol 21 : 1029-1034, 1998.
PubMed
3) Yang P, et al : Allelic variants in long-QT disease genes in patients with drug-associated torsades de pointes. Circulation 105 : 1943-1948, 2002.
PubMed
4) Itoh H, et al : Latent genetic backgrounds and molecular pathogenesis in drug-induced long-QT syndrome. Circ Arrhythm Electrophysiol 2 : 511-523, 2009.
PubMed
5) Morganroth J : Risk factors for the development of proarrhythmic events. Am J Cardiol 59 : 32E-37E, 1987.
PubMed
6) Tzivoni D, et al : Magnesium therapy for torsades de pointes. Am J Cardiol 53 : 528-530, 1984.
PubMed
P.334 掲載の参考文献
1) 日本循環器学会, ほか : 日本循環器学会/日本不整脈心電学会合同ガイドライン. 不整脈非薬物治療ガイドライン (2018年改訂版), 2019.
 
2) Sharma PS, et al : Permanent His-bundle pacing as an alternative to biventricular pacing for cardiac resynchronization therapy : a multicenter experience. Heart Rhythm 15 : 413-420, 2018.
PubMed
3) Reynolds D, et al : A Leadless Intracardiac Transcatheter Pacing System. N Engl J Med 374 : 533-541, 2016.
 
4) Echt DS, et al : Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial. N Engl J Med 324 : 781-788, 1991.
 
5) Curtis AB, et al : Biventricular pacing for atrioventricular block and systolic dysfunction. N Engl J Med 368 : 1585-1593, 2013.
PubMed
6) Link MS, et al : Part 7 : Adult Advanced Cardiovascular Life Support : 2015 American Heart Association Guidelines Update for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Circulation 132 : S444-464, 2015.
PubMed
7) Sweeney MO, et al : Differences in effects of electrical therapy type for ventricular arrhythmias on mortality in implantable cardioverter-defibrillator patients. Heart Rhythm 7 : 353-360, 2010.
PubMed
8) Bradfield JS, et al : Mechanisms and management of refractory ventricular arrhythmias in the age of autonomic modulation. Heart Rhythm 15 : 1252-1260, 2018.
PubMed
9) Burke MC, et al : Safety and Efficacy of the Totally Subcutaneous Implantable Defibrillator : 2-Year Results From a Pooled Analysis of the IDE Study and EFFORTLESS Registry. J Am Coll Cardiol 65 : 1605-1615, 2015.
PubMed
10) Kutyifa V, et al : Use of the wearable cardioverter defibrillator in high-risk cardiac patients : data from the Prospective Registry of Patients Using the Wearable Cardioverter Defibrillator (WEARIT-II Registry). Circulation 132 : 1613-1619, 2015.
PubMed
P.340 掲載の参考文献
1) Mitsui T, et al : Atrial rate as an indicator for optimal pacing rate and the pacemaking syndrome. Ann Cardiol Angeiol (Paris) 20 : 371-379, 1971.
PubMed
2) 八木哲夫 : ペースメーカ症候群 : 定義. 症候と予防策. ペースメーカ・ICD・CRT/CRT-D (奥村謙編), p146-151, メジカルビュー社, 2012.
 
3) 内藤滋人 : ペースメーカ症候群. 症候群ハンドブック (井村裕夫, ほか編), p182, 中山書店, 2011.
 
4) Ausubel K, Furman S : The pacemaker syndrome. Ann Inter Medicine 130 : 420-429, 1985.
 
5) Link MS, et al : High incidence of pacemaker syndrome in patients with sinus node dysfunction treated with ventricular-based pacing in the Mode Selection Trial (MOST). J Am Coll Cardiol 43 : 2066-2071, 2004.
 
6) Opie LH : Mechanism of Cardiac Contraction and Relaxation. In : Braunwald's Heart Disease : A Textbook of Cardiovascular Medicine, 8th ed (ed by Libby P, et al), p509-540, Saunders, Philadelphia, 2008.
 
7) Nielsen JC, et al : A randomized comparison of atrial and dual-chamber pacing in 177 consecutive patients with sick sinus syndrome : echocardiographic and clinical outcome. J Am Coll Cardiol 42 : 614-623, 2003.
PubMed
P.350 掲載の参考文献
1) Luceri RM, et al : The arrhythmias of dual-chamber cardiac pacemakers and their management. Ann Intern Med 99 : 354-359, 1983.
PubMed
2) Link MS, et al : High incidence of pacemaker syndrome in patients with sinus node dysfunction treated with ventricular-based pacing in the Mode Selection Trial (MOST). J Am Coll Cardiol 43 : 2066-2071, 2004.
 
3) Mitsui T, et al : The "pacemaking syndrome". In : Proceedings of the Eighth Annual International Conference on Medical and Biological Engineering (ed by Jacobs JE), p29-33, Association for the Advancement of Medical Instrumentation, Chicago, 1969.
 
4) 石川利之, ほか : 心房細動の発生および心房負荷から見たペーシング・モードの適応. 心臓ペーシング 8 : 455-459, 1992.
 
5) Levine PA : Postventricular atrial refractory periods and pacemaker-mediated tachycardia. Clin Prog Pacing Electrophysiol 1 : 394-401, 1983.
 

X 突然死

P.357 掲載の参考文献
1) 河合忠一 : 突然死の調査研究. 昭和62年度厚生省循環器病研究委託費による研究報告集, 1987.
 
2) Myerburg RJ, Castellanos A : Cardiac arrest and sudden cardia death, Chapter 24. In : Heart Disease : A Textbook of Cardiovascular Medicine, 5th ed (ed by Braunwald E), vol 2, WB Saunders, Philadelphia, 1997.
 
3) American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (ACC/AHA/HRS Writing Committee to Develop Data Standards on Electrophysiology), et al : ACC/AHA/HRS 2006 key data elements and definitions for electrophysiological studies and procedures : a report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (ACC/AHA/HRS Writing Committee to Develop Data Standards on Electrophysiology). Circulation 114 : 2534-2570, 2006.
 
4) 日本循環器学会, ほか : 循環器病の診断と治療に関するガイドライン (2009年度合同研究班報告). 心臓突然死の予知と予防法のガイドライン (2010年改訂版), 2010. [http://www.j-circ.or.jp/guideline/pdf/JCS2010aizawa.h.pdf] (2019年10月閲覧)
 
5) Toyoshima H, et al : Sudden death of adults in Japan. Nagoya J Med Sci 59 : 81-95, 1996.
PubMed
6) Nagata M, et al : Temporal trends in sudden unexpected death in a general population : the Hisayama study. Am Heart J 165 : 932-938.e1, 2013.
 
7) Zheng ZJ, et al : Sudden cardiac death in the United States, 1989 to 1998. Circulation 104 : 2158-2163, 2001.
PubMed
8) Hayashi M, et al : The spectrum of epidemiology underlying sudden cardiac death. Circ Res 116 : 1887-1906, 2015.
PubMed
9) 総務省消防庁 : 平成30年版消防白書, 2019. [https://www.fdma.go.jp/publication/hakusho/h30/46816.html] (2019年10月閲覧)
 
10) 総務省消防庁 : 平成29年版消防白書. 心肺機能停止傷病者の救命率等の状況, 2018 [https://www.fdma.go.jp/publication/hakusho/h29/chapter2/section5/2371.html] (2019年10月閲覧)
 
11) 徳留省悟 : 剖検よりみた突然死. 日本医師会雑誌 106 : 1344-1348, 1991.
 
12) 上田一雄 : 脳血管障害における突然死の実態. Cardiac Practice 6 : 281-285, 1995.
 
13) Nakahara S, et al : Association of Bystander Interventions With Neurologically Intact Survival Among Patients With Bystander-Witnessed Out-of-Hospital Cardiac Arrest in Japan. JAMA 314 : 247-254, 2015.
PubMed
P.362 掲載の参考文献
1) 日本循環器学会, ほか : 循環器病の診断と治療に関するガイドライン (2009年度合同研究班報告). 心臓突然死の予知と予防法のガイドライン (2010年改訂版), 2010.
 
2) The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II) : a randomised trial. Lancet 353 : 9-13, 1999.
 
3) Schneider JF, et al : Comparative features of newly acquired left and right bundle branch block in the general population : the Framingham study. Am J Cardiol 47 : 931-940, 1981.
PubMed
4) Maggioni AP, et al : Prevalence and prognostic significance of ventricular arrhythmias after acute myocardial infarction in the fibrinolytic era. GISSI-2 results. Circulation 87 : 312-322, 1993.
PubMed
5) Olivotto I, et al : Prognostic value of systemic blood pressure response during exercise in a community-based patient population with hypertrophic cardiomyopathy. J Am Coll Cardiol 33 : 2044-2051, 1999.
 
6) Hohnloser SH, et al : Evidence regarding clinical use of microvolt T-wave alternans. Heart Rhythm 6 : S36-44, 2009.
PubMed
7) Ozawa Y, et al : Prospective study of late potentials to predict cardiac sudden death and ventricular tachycardias in patients with myocardial infarction surviving over 4 weeks. Jpn Circ J 54 : 1304-1314, 1990.
PubMed
8) Wolf MM, et al : Sinus arrhythmia in acute myocardial infarction. Med J Aust 2 : 52-53, 1978.
PubMed
9) Schmidt G, et al : Heart-rate turbulence after ventricular premature beats as a predictor of mortality after acute myocardial infarction. Lancet 353 : 1390-1396, 1999.
PubMed
10) La Rovere MT, et al : Baroreflex sensitivity and heart-rate variability in prediction of total cardiac mortality after myocardial infarction. ATRAMI (Autonomic Tone and Reflexes After Myocardial Infarction) Investigators. Lancet 351 : 478-484, 1998.
PubMed
11) Buxton AE, et al : Electrophysiologic testing to identify patients with coronary artery disease who are at risk for sudden death. Multicenter Unsustained Tachycardia Trial Investigators. N Engl J Med 342 : 1937-1945, 2000.
 
12) Daubert JP, et al : Predictive value of ventricular arrhythmia inducibility for subsequent ventricular tachycardia or ventricular fibrillation in Multicenter Automatic Defibrillator Implantation Trial (MADIT) II patients. J Am Coll Cardiol 47 : 98-107, 2006.
PubMed
13) Edvardsson N, et al : Use of an implantable loop recorder to increase the diagnostic yield in unexplained syncope : results from the PICTURE registry. Europace 13 : 262-269, 2011.
PubMed
14) 日本循環器学会, ほか : 遺伝性不整脈の診療に関するガイドライン (2017年改訂版), 2018.
 
P.367 掲載の参考文献
1) JCS Joint Working Group : Guidelines for Non-Pharmacotherapy of Cardiac Arrhythmias (JCS 2011). Circ J 77 : 249-274, 2013.
 
2) 日本循環器学会, ほか : 日本循環器学会/日本不整脈心電学会合同ガイドライン. 不整脈非薬物治療ガイドライン (2018年改訂版), 2019. [http://www.j-circ.or.jp/guideline/pdf/JCS2018_kurita_nogami.pdf] (2019年10月閲覧)
 
3) January CT, et al : 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation : a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society. Circulation 130 : e199-267, 2014.
 
4) Priori SG, et al : 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death : The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC). Endorsed by : Association for European Paediatric and Congenital Cardiology (AEPC). Eur Heart J 36 : 2793-2867, 2015.
 
5) Shiga T, et al : Sudden cardiac death and left ventricular ejection fraction during long-term follow-up after acute myocardial infarction in the primary percutaneous coronary intervention era : results from the HIJAMI-II registry. Heart 95 : 216-220, 2009.
PubMed
6) Tanno K, et al : Are the MADIT II criteria for ICD implantation appropriate for Japanese patients? Circ J 69 : 19-22, 2005.
 
7) Moss AJ, et al : Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators. N Engl J Med 335 : 1933-1940, 1996.
 
8) Moss AJ, et al : Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 346 : 877-883, 2002.
PubMed
9) Kadish A, et al : Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy. N Engl J Med 350 : 2151-2158, 2004.
PubMed
10) Bardy GH, et al : Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 352 : 225-237, 2005.
 
11) Shiba N, et al : Trend of westernization of etiology and clinical characteristics of heart failure patients in Japan-first report from the CHART-2 study. Circ J 75 : 823-833, 2011.
PubMed
12) Takada T, et al : Impact of elevated heart rate on clinical outcomes in patients with heart failure with reduced and preserved ejection fraction : a report from the CHART-2 Study. Eur J Heart Fail 16 : 309-316, 2014.
PubMed
13) Tsuji K, et al ; CHART-2 Investigators : Characterization of heart failure patients with midrange left ventricular ejection fraction-a report from the CHART-2 Study. Eur J Heart Fail 19 : 1258-1269, 2017.
 
14) Ushigome R, et al : Temporal trends in clinical characteristics, management and prognosis of patients with symptomatic heart failure in Japan-report from the CHART Studies. Circ J 79 : 2396-2407, 2015.
PubMed
15) Satake H, et al : Current status of primary prevention of sudden cardiac death with implantable cardioverter defibrillator in patients with chronic heart failure-a report from the CHART-2 Study. Circ J 79 : 381-390, 2015.
PubMed
P.374 掲載の参考文献
1) Bardy GH, et al : Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 352 : 225-237, 2005.
 
2) Kennedy HL, et al : Beta-blocker therapy in the Cardiac Arrhythmia Suppression Trial. CAST Investigators. Am J Cardiol 74 : 674-680, 1994.
PubMed
3) Boutitie F, et al : Amiodarone interaction with beta-blockers : analysis of the merged EMIAT (European Myocardial Infarct Amiodarone Trial) and CAMIAT (Canadian Amiodarone Myocardial Infarction Trial) databases. The EMIAT and CAMIAT Investigators. Circulation 99 : 2268-2275, 1999.
PubMed
4) 和田暢, 草野研吾 : 心臓突然死の予知と予防法のガイドライン : 薬物治療の役割. 医学と薬学 71 : 2057-2063, 2014.
Medical*Online
5) Domanski MJ, et al : Effect of angiotensin converting enzyme inhibition on sudden cardiac death in patients following acute myocardial infarction. A meta-analysis of randomized clinical trials. J Am Coll Cardiol 33 : 598-604, 1999.
PubMed
6) Heart Outcomes Prevention Evaluation Study Investigators, et al : Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. N Engl J Med 342 : 145-153, 2000.
PubMed
7) Garg R, Yusuf S : Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure. Collaborative Group on ACE Inhibitor Trials. JAMA 273 : 1450-1456, 1995.
 
8) Pitt B, et al : Randomised trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE). Lancet 349 : 747-752, 1997.
PubMed
9) Pitt B, et al : Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure : randomised trial-the Losartan Heart Failure Survival Study ELITE II. Lancet 355 : 1582-1587, 2000.
PubMed
10) Solomon SD, et al : Effect of candesartan on cause-specific mortality in heart failure patients : the Candesartan in Heart failure Assessment of Reduction in Mortality and morbidity (CHARM) program. Circulation 110 : 2180-2183, 2004.
 
11) Pitt B, et al : The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. N Engl J Med 341 : 709-717, 1999.
 
12) Pitt B, et al : Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med 348 : 1309-1321, 2003.
PubMed
13) Albert CM, et al : Blood levels of long-chain n-3 fatty acids and the risk of sudden death. N Engl J Med 346 : 1113-1118, 2002.
PubMed
14) Rizos EC, et al : Association between omega-3 fatty acid supplementation and risk of major cardiovascular disease events : a systematic review and meta-analysis. JAMA 308 : 1024-1033, 2012.
PubMed
15) Vyas AK, et al : Reduction in ventricular tachyarrhythmias with statins in the Multicenter Automatic Defibrillator Implantation Trial (MADIT) -II. J Am Coll Cardiol 47 : 769-773, 2006.
 
16) Rahimi K, et al : Effect of statins on ventricular tachyarrhythmia, cardiac arrest, and sudden cardiac death : a meta-analysis of published and unpublished evidence from randomized trials. Eur Heart J 33 : 1571-1581, 2012.
PubMed
17) Schwartz PJ, et al : Genotype-phenotype correlation in the long-QT syndrome : gene-specific triggers for life-threatening arrhythmias, Circulation 103 : 89-95, 2001.
 
18) Abu-Zeitone. A, et al : Efficacy of different beta-blockers in the treatment of long QT syndrome. J Am Coll Cardiol 64 : 1352-1358, 2014.
PubMed
19) Watanabe H, et al : Flecainide prevents catecholaminergic polymorphic ventricular tachycardia in mice and humans. Nat Med 15 : 380-383, 2009.
PubMed
20) Miyamoto K, et al : Efficacy and safety of flecainide for ventricular arrhythmias in patients with Andersen-Tawil syndrome with KCNJ2 mutations. Heart Rhythm 12 : 596-603, 2015.
PubMed
P.380 掲載の参考文献
1) O'Mahony C, et al : A novel clinical risk prediction model for sudden cardiac death in hypertrophic cardiomyopathy (HCM risk-SCD). Eur Heart J 35 : 2010-2020, 2014.
 
2) Corrado D, et al : Treatment of Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia : An International Task Force Consensus Statement. Circulation 132 : 441-453, 2015.
PubMed
3) Link MS, et al : Ventricular arrhythmias in the North American multidisciplinary study of ARVC : predictors, characteristics, and treatment. J Am Coll Cardiol 64 : 119-125, 2014.
PubMed
4) Makimoto H, et al : Clinical impact of the number of extrastimuli in programmed electrical stimulation in patients with Brugada type l electrocardiogram. Heart Rhythm 9 : 242-248, 2012.
 
5) Sroubek J, et al : Programmed ventricular stimulation for risk stratification in the Brugada syndrome : apooled analysis. Circulation 133 : 622-630, 2016.
PubMed
6) Yamagata K, et al : Genotype-Phenotype Correlation of SCN5A Mutation for the Clinical and Electrocardiographic Characteristics of Probands With Brugada Syndrome : A Japanese Multicenter Registry. Circulation 135 : 2255-2270, 2017.
PubMed
7) Chue CD, et al : Efficacy and safety of the subcutaneous implantable cardioverter defibrillator : a systematic review. Heart 103 : 1315-1322, 2017.
PubMed
P.389 掲載の参考文献
1) 日本循環器学会, ほか : 循環器病の診断と治療に関するガイドライン (2011年度合同研究班報告). 失神の診断・治療ガイドライン (2012年改訂版), 2012. [http://www.j-circ.or.jp/guideline/pdf/JCS2012_inoue_h.pdf] (2019年10月閲覧)
 
2) Task Force for the Diagnosis and Management of Syncope, et al : Guidelines for the diagnosis and management of syncope (version 2009). Eur Heart J 30 : 2631-2671, 2009.
PubMed
3) Savage DD, et al : Epidemiologic features of isolated syncope : the Framingham Study. Stroke 16 : 626-629, 1985.
PubMed
4) Soteriades ES, et al : Incidence and prognosis of syncope. N Engl J Med 347 : 878-885, 2002.
PubMed
5) Ganzeboom KS, et al : Prevalence and triggers of syncope in medical students. Am J Cardiol 91 : 1006-1008, A8, 2003.
PubMed
6) Ganzeboom KS, et al : Lifetime cumulative incidence of syncope in the general population : a study of 549 Dutch subjects aged 35-60 years. J Cardiovasc Electrophysiol 17 : 1172-1176, 2006.
PubMed
7) Serletis A, et al : Vasovagal syncope in medical students and their first-degree relatives. Eur Heart J 27 : 1965-1970, 2006.
PubMed
8) Ammirati F, et al : Diagnosing syncope in clinical practice. Implementation of a simplified diagnostic algorithm in a multicentre prospective trial-the OESIL 2 study (Osservatorio Epidemiologico della Sincope nel Lazio). Eur Heart J 21 : 935-940, 2000.
 
9) 鈴木昌, ほか : 東京都内の救急部における循環器救急疾患の疫学的検討. 日本救急医学会雑誌 15 : 169-174, 2004.
 
10) 藤沼好克, ほか : 神経内科外来における失神診療の現状 : 103例における検討. 自律神経 46 : 589-594, 2009.
Medical*Online
11) Tanimoto K, et al : Usefulness of brain natriuretic peptide as a marker for separating cardiac and noncardiac causes of syncope. Am J Cardiol 93 : 228-230, 2004.
PubMed
12) Hayes DL : Cardiac pacemakers and cardioverter defibrillators. In : Braunwald's Heart Disease : A Textbook of Cardiovascular Medicine, 8th ed (ed by Libby P, et al), p831-861, Saunders, Philadelphia, 2008.
 
13) James TN, et al : Sudden death in young athletes. Ann Intern Med 67 : 1013-1021, 1967.
PubMed
14) Rubenstein JJ, et al : Clinical spectrum of the sick sinus syndrome. Circulation 46 : 5-13, 1972.
PubMed
15) 日本循環器学会, ほか : 日本循環器学会/日本不整脈心電学会合同ガイドライン. 不整脈非薬物治療ガイドライン (2018年改訂版), 2019. [http://www.j-circ.or.jp/guideline/pdf/JCS2018_kurita_nogami.pdf] (2019年10月閲覧)
 
16) Brodsky M, et al : Arrhythmias documented by 24 hour continuous electrocardiographic monitoring in 50 male medical students without apparent heart disease. Am J Cardiol 39 : 390-395, 1977.
PubMed
17) Narula OS, Samet P : Wenckebach and Mobitz type II A-V block due to block within the His bundle and bundle branches. Circulation 41 : 947-965, 1970.
 
18) Wilde AA, et al : Proposed diagnostic criteria for the Brugada syndrome : consensus report. Circulation 106 : 2514-2519, 2002.
PubMed
19) Schwartz PJ, et al : Diagnostic criteria for the long QT syndrome. An update. Circulation 88 : 782-784, 1993.
 
20) Corrado D, et al : Clinical diagnosis and management strategies in arrhythmogenic right ventricular cardiomyopathy. J Electrocardiol 33 (Suppl) : 49-55, 2000.
PubMed
21) Kishida H, et al : Significant characteristics of variant angina patients with associated syncope. Jpn Heart J 37 : 317-326, 1996.
PubMed
22) Hattori R, et al : Diffuse triple-vessel coronary artery spasm complicated by idioventricular rhythm and syncope. Chest 92 : 183-185, 1987.
PubMed
23) Elliott PM, et al : Sudden death in hypertrophic cardiomyopathy : identification of high risk patients. J Am Coll Cardiol 36 : 2212-2218, 2000.
PubMed
24) Kofflard MJ, et al : Hypertrophic cardiomyopathy in a large community-based population : clinical outcome and identification of risk factors for sudden cardiac death and clinical deterioration. J Am Coll Cardiol 41 : 987-993, 2003.
 
25) 河合忠一, ほか : 特発性心筋症の診断基準について-アンケート第2次集計報告. 厚生省特定疾患特発性心筋症調査研究班 昭和50年度研究報告集, p88-99, 1976.
 
26) Yano K, et al : Simultaneous monitoring of electrocardiogram and arterial blood pressure during exercise-induced syncope in a patient with severe aortic stenosis-a case report. Angiology 40 : 143-148, 1989.
 
P.394 掲載の参考文献
1) Konstantinides SV, et al : Management of Pulmonary Embolism : An Update. J Am Coll Cardiol 67 : 976-990, 2016.
PubMed
2) Nakamura M, et al : Current management of venous thromboembolism in Japan : Current epidemiology and advances in anticoagulant therapy. J Cardiol 66 : 451-459, 2015.
PubMed
3) Shirakawa T, et al : Watching Television and Risk of Mortality From Pulmonary Embolism Among Japanese Men and Women : The JACC Study (Japan Collaborative Cohort). Circulation 134 : 355-357, 2016.
PubMed
4) Cannegieter SC, et al : Travel-related venous thrombosis : results from a large population-based case control study (MEGA study). PLoS Med 3 : e307, 2006.
PubMed
5) Sueta D, et al : Venous Thromboembolism Caused by Spending a Night in a Vehicle After an Earthquake (Night in a Vehicle After the 2016 Kumamoto Earthquake). Can J Cardiol 34 : 813.e9-813.e10, 2018.
 
6) Pollack CV, et al : Clinical characteristics, management, and outcomes of patients diagnosed with acute pulmonary embolism in the emergency department : initial report of EMPEROR (Multicenter Emergency Medicine Pulmonary Embolism in the Real World Registry). J Am Coll Cardiol 57 : 700-706, 2011.
PubMed
7) 肺血栓塞栓症/深部静脈血栓症 (静脈血栓塞栓症) 予防ガイドライン作成委員会 : 肺血栓塞栓症/深部静脈血栓症 (静脈血栓塞栓症) 予防ガイドライン (ダイジェスト版). Medical Front International Limited, 2004.
 
8) 榛沢和彦 : 新潟県中越地震時における急性肺・静脈血栓塞栓症. 心臓 39 : 104-109, 2007.
Medical*Online
9) Konstantinides SV, et al : 2014 ESC guidelines on the diagnosis and management of acute pulmonary embolism. Eur Heart J 35 : 3033-3069, 3069a-3069k, 2014.
 
10) Hendriksen JM, et al : Diagnostic prediction models for suspected pulmonary embolism : systematic review and independent external validation in primary care. BMJ 351 : h4438, 2015.
PubMed
11) Jimenez D, et al : Simplification of the pulmonary embolism severity index for prognostication in patients with acute symptomatic pulmonary embolism. Arch Intern Med 170 : 1383-1389, 2010.
PubMed
12) Ota M, et al : Prognostic significance of early diagnosis in acute pulmonary thromboembolism with circulatory failure. Heart Vessels 17 : 7-11, 2002.
PubMed
13) De Backer D, et al : Comparison of dopamine and norepinephrine in the treatment of shock. N Engl J Med 362 : 779-789, 2010.
 
14) Kearon C, et al : Antithrombotic Therapy for VTE Disease : CHEST Guideline and Expert Panel Report. Chest 149 : 315-352, 2016.
 
15) Klok FA, et al : Prediction of bleeding events in patients with venous thromboembolism on stable anticoagulation treatment. Eur Respir J 48 : 1369-1376, 2016.
PubMed
P.399 掲載の参考文献
1) Maron BJ, et al : Blunt impact to the chest leading to sudden death from cardiac arrest during sports activities. N Engl J Med 333 : 337-342, 1995,
 
2) Maron BJ, et al : Clinical profile and spectrum of commotio cordis. JAMA 287 : 1142-1146, 2002.
PubMed
3) 堀進悟 : Commotio cordis : スポーツ中の胸部打撲による突然死. 臨床スポーツ医学 19 : 891-897, 2002.
Medical*Online
4) 輿水健治 : 若年者の突然死 心臓震盪. 蘇生 28 : 87-94, 2009.
Medical*Online
5) 輿水健治, ほか : 心臓震盪 update-国内例の状況と予後, 今後の対策-. 臨床スポーツ医学 35 : 574-577, 2018.
Medical*Online
6) Link MS, et al : An experimental model of sudden death due to low-energy chest-wall impact (commotio cordis). N Engl J Med 338 : 1805-1811, 1998.
PubMed
7) Link MS, et al : Selective activation of the K(+) (ATP) channel is a mechanism by which sudden death is produced by low-energy chest-wall impact (Commotio cordis). Circulation 100 : 413-418, 1999.
 
8) Link MS, et al : Impact directly over the cardiac silhouette is necessary to produce ventricular fibrillation in an experimental model of commotio cordis. J Am Coll Cardiol 37 : 649-654, 2001.
 
9) Maron BJ : Sudden death in young athletes. N Engl J Med 349 : 1064-1075, 2003.
PubMed
10) Maron BJ, et al : Commotio cordis. N Engl J Med 362 : 917-927, 2010.
PubMed
11) Miyazaki T, et al : An autopsy case of commotio cordis from a motor scooter accident. Leg Med (Tokyo) 10 : 264-267, 2008.
PubMed
12) Maron BJ, et al : Increasing survival rate from commotio cordis. Heart Rhythm 10 : 219-223, 2013.
PubMed
13) 輿水健治 : 心臓震盪の現状と対策-少年野球を中心に-. トレーニング科学 30 : 231-236, 2019.
 
14) Kumar K, et al : Development of a Chest Wall Protector Effective in Preventing Sudden Cardiac Death by Chest Wall Impact (Commotio Cordis). Clin J Sport Med 27 : 26-30, 2017.
PubMed
15) Link MS, et al : Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities : Task Force 13 : Commotio Cordis : A Scientific Statement From the American Heart Association and American College of Cardiology. J Am Coll Cardiol 66 : 2439-2443, 2015.
 
P.404 掲載の参考文献
1) Negovsky VA : The second step in resuscitation-the treatment of the 'post-resuscitation disease'. Resuscitation 1 : 1-7, 1972.
PubMed
2) Neumar RW, et al : Post-cardiac arrest syndrome : epidemiology, pathophysiology, treatment, and prognostication. A consensus statement from the International Liaison Committee on Resuscitation (American Heart Association, Australian and New Zealand Council on Resuscitation, European Resuscitation Council, Heart and Stroke Foundation of Canada, InterAmerican Heart Foundation, Resuscitation Council of Asia, and the Resuscitation Council of Southern Africa) ; the American Heart Association Emergency Cardiovascular Care Committee ; the Council on Cardiovascular Surgery and Anesthesia ; the Council on Cardiopulmonary, Perioperative, and Critical Care ; the Council on Clinical Cardiology ; and the Stroke Council. Circulation 118 : 2452-2483, 2008.
 
3) Stiell IG, et al : Advanced cardiac life support in out-of-hospital cardiac arrest. N Engl J Med 351 : 647-656, 2004.
PubMed
4) Keenan SP, et al : Variation in length of intensive care unit stay after cardiac arrest : where you are is as important as who you are. Crit Care Med 35 : 836-841, 2007.
PubMed
5) Mashiko K, et al : An outcome study of out-of-hospital cardiac arrest using the Utstein template-a Japanese experience. Resuscitation 55 : 241-246, 2002.
PubMed
6) Iwami T, et al : Continuous improvements in "chain of survival" increased survival after out-of-hospital cardiac arrests : a large-scale population-based study. Circulation 119 : 728-734, 2009.
PubMed
7) Nadkarni VM, et al : First documented rhythm and clinical outcome from in-hospital cardiac arrest among children and adults. JAMA 295 : 50-57, 2006.
PubMed
8) Neumar RW : Molecular mechanisms of ischemic neuronal injury. Ann Emerg Med 36 : 483-506, 2000.
PubMed
9) Lipton P : Ischemic cell death in brain neurons. Physiol Rev 79 : 1431-1568, 1999.
PubMed
10) Sundgreen C, et al : Autoregulation of cerebral blood flow in patients resuscitated from cardiac arrest. Stroke 32 : 128-132, 2001.
PubMed
11) Pulsinelli WA : Selective neuronal vulnerability : morphological and molecular characteristics. Prog Brain Res 63 : 29-37, 1985.
PubMed
12) Snyder JV, et al : Global ischemia in dogs : intracranial pressures, brain blood flow and metabolism. Stroke 6 : 21-27, 1975.
PubMed
13) Sakabe T, et al : Intracranial pressure following cardiopulmonary resuscitation. Intensive Care Med 13 : 256-259, 1987.
PubMed
14) Morimoto Y, et al : Acute brain swelling after out-of-hospital cardiac arrest : pathogenesis and outcome. Crit Care Med 21 : 104-110, 1993.
PubMed
15) Sugita A, et al : Systemic impact on secondary brain aggravation due to ischemia/reperfusion injury in post-cardiac arrest syndrome : a prospective observational study using high-mobility group box 1 protein. Crit Care 21 : 247, 2017.
PubMed
16) Royl G, et al : Hypothermia effects on neurovascular coupling and cerebral metabolic rate of oxygen. Neuroimage 40 : 1523-1532, 2008.
PubMed
17) Meybohm P, et al : Mild hypothermia alone or in combination with anesthetic post-conditioning reduces expression of inflammatory cytokines in the cerebral cortex of pigs after cardiopulmonary resuscitation. Crit Care 14 : R21, 2010.
 
18) Motamedi GK, et al : Therapeutic brain hypothermia, its mechanisms of action, and its prospects as a treatment for epilepsy. Epilepsia 54 : 959-970, 2013.
PubMed
19) Tang ZR, et al : Effects of hypothermia on brain injury assessed by magnetic resonance imaging after cardiopulmonary resuscitation in a porcine model of cardiac arrest. Am J Emerg Med 31 : 86-93, 2013.
 
20) Ji XF, et al : Impaired β-adrenergic receptor signalling in post-resuscitation myocardial dysfunction. Resuscitation 83 : 640-644, 2012.
 
21) Laurent I, et al : Reversible myocardial dysfunction in survivors of out-of-hospital cardiac arrest. J Am Coll Cardiol 40 : 2110-2116, 2002.
PubMed
22) Zobel C, et al : Mild therapeutic hypothermia in cardiogenic shock syndrome. Crit Care Med 40 : 1715-1723, 2012.
PubMed
23) Schmidt-Schweda S, et al : Moderate hypothermia for severe cardiogenic shock (COOL Shock Study I & II). Resuscitation 84 : 319-325, 2013.
 
24) Aibiki M, et al : Does therapeutic hypothermia improve depressed cardiac functions in postcardiac arrest patients? Crit Care Med 42 : e315-316, 2014.
PubMed
25) Aibiki M, et al : Is hypothermia beneficial even for the depressed heart after the resumption of spontaneous circulation (ROSC) from out-of-hospital cardiac arrest (OHCA)? Resuscitation 85 : e93-94, 2014.
PubMed
26) Arola O, et al : Inhaled Xenon Attenuates Myocardial Damage in Comatose Survivors of Out-of-Hospital Cardiac Arrest : The Xe-Hypotheca Trial. J Am Coll Cardiol 70 : 2652-2660, 2017.
 
27) Shoemaker WC, et al : Tissue oxygen debt as a determinant of lethal and nonlethal postoperative organ failure. Crit Care Med 16 : 1117-1120, 1988.
PubMed
28) Adrie C, et al : Successful cardiopulmonary resuscitation after cardiac arrest as a "sepsis-like" syndrome. Circulation 106 : 562-568, 2002.
PubMed
29) Adrie C, et al : Coagulopathy after successful cardiopulmonary resuscitation following cardiac arrest : implication of the protein C anticoagulant pathway. J Am Coll Cardiol 46 : 21-28, 2005.
PubMed
30) Bottiger BW, et al : TROICA Trial Investigators ; European Resuscitation Council Study Group : Thrombolysis during resuscitation for out-of-hospital cardiac arrest. N Engl J Med 359 : 2651-2662, 2008.
 
31) Wada T, et al : Coagulofibrinolytic changes in patients with disseminated intravascular coagulation associated with post-cardiac arrest syndrome-fibrinolytic shutdown and insufficient activation of fibrinolysis lead to organ dysfunction. Thromb Res 132 : e64-69, 2013.
PubMed
32) Spaulding CM, et al : Immediate coronary angiography in survivors of out-of-hospital cardiac arrest. N Engl J Med 336 : 1629-1633, 1997.
PubMed
33) Anyfantakis ZA, et al : Acute coronary angiographic findings in survivors of out-of-hospital cardiac arrest. Am Heart J 157 : 312-318, 2009.
PubMed
34) Larsen JM, Ravkilde J : Acute coronary angiography in patients resuscitated from out-of-hospital cardiac arrest-a systematic review and meta-analysis. Resuscitation 83 : 1427-1433, 2012.
PubMed
35) Callaway CW, et al : Early coronary angiography and induced hypothermia are associated with survival and functional recovery after out-of-hospital cardiac arrest. Resuscitation 85 : 657-663, 2014.
PubMed
36) Dumas F, et al : Emergency Percutaneous Coronary Intervention in Post-Cardiac Arrest Patients Without ST-Segment Elevation Pattern : Insights From the PROCAT II Registry. JACC Cardiovasc Interv 9 : 1011-1018, 2016.
PubMed
37) Bernard SA, et al : Treatment of comatose survivors of out-of-hospital cardiac arrest with induced hypothermia. N Engl J Med 346 : 557-563, 2002.
PubMed
38) Hypothermia after Cardiac Arrest Study Group : Mild therapeutic hypothermia to improve the neurologic outcome after cardiac arrest. N Engl J Med 346 : 549-556, 2002.
 
39) Sunde K, et al : Implementation of a standardised treatment protocol for post resuscitation care after out-of-hospital cardiac arrest. Resuscitation 73 : 29-39, 2007.
PubMed
40) Yokoyama H, et al : Impact of therapeutic hypothermia in the treatment of patients with out-of-hospital cardiac arrest from the J-PULSE-HYPO study registry. Circ J 75 : 1063-1070, 2011.
 
41) Nielsen N, et al : Targeted temperature management at 33℃ versus 36℃ after cardiac arrest. N Engl J Med 369 : 2197-2206, 2013.
 
42) JRC蘇生ガイドライン 2015 (日本蘇生協議会監), 医学書院, 2016.
 
43) Kirkegaard H, et al : Targeted Temperature Management for 48 vs 24 Hours and Neurologic Outcome After Out-of-Hospital Cardiac Arrest : A Randomized Clinical Trial. JAMA 318 : 341-350, 2017.
PubMed
44) Aibiki M, et al : Serious concerns on TTM trials by the Japanese Association of Brain Hypothermia : "Letter to the Editor" in Ther Hypothermia Temp Manag 4 : 104, 2014.
 
45) Aibiki M : Editorial for a paper of Dr. Hans Kirkegaard et al : JAMA 2017 ; 318 : 341-350, J Emerg Crit Care Med 1 : 39, 2017. [http://dx.doi.org/10.21037/jeccm.2017.11.02]
 
46) Bray JE, et al : Changing target temperature from 33℃ to 36℃ in the ICU management of out-of-hospital cardiac arrest : A before and after study. Resuscitation 113 : 39-43, 2017.
 
P.411 掲載の参考文献
1) 日本循環器学会, ほか : 循環器病の診断と治療に関するガイドライン (2009年度合同研究班報告), 2010 心臓突然死の予知と予防法のガイドライン (2010年改訂版).
 
2) Guidelines for risks and prevention of sudden cardiac death (JCS2010) : -digest versionr Circ J 76 : 489-507, 2012.
 
3) Al-Khatib SM, et al : 2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death. Circulation 138 : e272-e391, 2018.
PubMed
4) 日本循環器学会, ほか : 循環器病の診断と治療に関するガイドライン (2011年度合同研究班報告), 2012 失神の診断・治療ガイドライン (2012年改訂版).
 
5) Bayes de Luna A, et al : Ambulatory sudden cardiac death : mechanisms of production of fatal arrhythmia on the basis of data from 157 cases. Am Heart J 117 : 151-159, 1989.
PubMed
6) Olshausen KV, et al : Sudden cardiac death while wearing a Holter monitor. Am J Cardiol 67 : 381-386, 1991.
 
7) Nishizaki M, et al : Polymorphic ventricular tachycardia in patients with vasospastic angina-clinical and electrocardiographic characteristics and long-term outcome. Jpn Circ J 65 : 519-525, 2001.
PubMed
8) 日本循環器学会, ほか : 遺伝性不整脈の診療に関するガイドライン (2017年改訂版) (2016-2017年度活動), 2018.
 
9) Nishizaki M : Life-threatening arrhythmias leading to syncope in patients with vasospastic angina. J Arrhythm 33 : 553-561, 2017.
PubMed
10) Matsue Y, et al : Clinical implications of an implantable cardioverter-defibrillator in patients with vasospastic angina and lethal ventricular arrhythmia. J Am Coll Cardiol 60 : 908-913, 2012.
PubMed
11) Kapa S, et al : Fascicular Ventricular Arrhythmias : Pathophysiologic Mechanisms, Anatomical Constructs, and Advances in Approaches to Management. Circ Arrhythm Electrophysiol 10 : 2017.
PubMed
P.415 掲載の参考文献
1) Cobb LA, et al : Changing incidence of out-of-hospital ventricular fibrillation, 1980-2000. JAMA 288 : 3008-3013, 2002.
PubMed
2) Nichol G, et al : Regional variation in out-of-hospital cardiac arrest incidence and outcome. JAMA 300 : 1423-1431, 2008.
PubMed
3) Weisfeldt ML, et al : Ventricular tachyarrhythmias after cardiac arrest in public versus at home. N Engl J Med 364 : 313-321, 2011.
PubMed
4) Goto Y, et al : Neurological outcomes in patients transported to hospital without a prehospital return of spontaneous circulation after cardiac arrest. Crit Care 17 : R274, 2013.
PubMed
5) Fukuda T, et al : Association of initial rhythm with neurologically favorable survival in non-shockable out-of-hospital cardiac arrest without a bystander witness or bystander cardiopulmonary resuscitation. Eur J Intern Med 30 : 61-67, 2016.
PubMed
6) Littmann L, et al : A simplified and structured teaching tool for the evaluation and management of pulseless electrical activity. Med Princ Pract 23 : 1-6, 2014.
PubMed
7) American Heart Association : ACLS EPマニュアル・リソーステキスト (日本ACLS協会監), シナジー, 2014.
 
8) Wu C, et al : The predictive value of bedside ultrasound to restore spontaneous circulation in patients with pulseless electrical activity : A systematic review and meta-analysis. PLoS ONE 13 : e0191636, 2018.
PubMed
P.422 掲載の参考文献
1) Exner DV, et al : Electrical storm presages nonsudden death : the antiarrhythmics versus implantable defibrillators (AVID) trial. Circulation 103 : 2066-2071, 2001.
PubMed
2) Noda T, et al : Significant impact of electrical storm on mortality in patients with structural heart disease and an implantable cardiac defibrillator. Int J Cardiol 255 : 85-91, 2018.
 
3) Braunschweig F, et al : Management of patients receiving implantable cardiac defibrillator shocks : recommendations for acute and long-term patient management. Europace 12 : 1673-1690, 2010.
PubMed
4) Gao D, et al : Electrical storm : definitions, clinical importance, and treatment. Curr Opin Cardiol 28 : 72-79, 2013.
PubMed
5) 栗田隆志, ほか : 静注III群薬 (nifekalant hydrochloride) をどう使うか. 内科 94 : 630-635, 2004.
 
6) 栗田隆志 : ニフェカラント静注薬の利点と欠点. リドカイン・ニフェカラント・アミオダロン静注薬の使い方-重症心室不整脈への対策 [循環器薬物治療実践シリーズ VIII] (日本心電学会学術諮問委員会編), p41-47, ライフメディコム, 2009.
 
7) 志賀剛 : 重症心室不整脈に対するアミオダロン静注薬の利点と欠点. リドカイン・ニフェカラント・アミオダロン静注薬の使い方-重症心室不整脈への対策 [循環器薬物治療実践シリーズ VIII] (日本心電学会学術諮問委員会編), p47-60, ライフメディコム, 2009.
 
8) Kotake Y, et al : Intravenous amiodarone homogeneously prolongs ventricular repolarization in patients with life-threatening ventricular tachyarrhythmia. J Cardiol 66 : 161-167, 2015.
PubMed
9) Miwa Y, et al : Effects of landiolol, an ultra-short-acting beta1-selective blocker, on electrical storm refractory to class III antiarrhythmic drugs. Circ J 74 : 856-863, 2010.
PubMed
10) Stevenson WG, et al : Irrigated radiofrequency catheter ablation guided by electroanatomic mapping for recurrent ventricular tachycardia after myocardial infarction : the multicenter thermocool ventricular tachycardia ablation trial. Circulation 118 : 2773-2782, 2008.
PubMed
11) Bansch D, et al : Successful catheter ablation of electrical storm after myocardial infarction. Circulation 108 : 3011-3016, 2003.
PubMed
12) Bourke T, et al : Neuraxial modulation for refractory ventricular arrhythmias : value of thoracic epidural anesthesia and surgical left cardiac sympathetic denervation. Circulation 121 : 2255-2262, 2010.
PubMed
13) 清水渉, ほか : 先天性QT延長症候群におけるelectrical stormに対するCa拮抗薬の使い方. 心電図 30 : 55-62, 2010.
Medical*Online
14) Ohgo T, et al : Acute and chronic management in patients with Brugada syndrome associated with electrical storm of ventricular fibrillation. Heart Rhythm 4 : 695-700, 2007.
PubMed
15) 栗田隆志, 奥村謙 : 不整脈薬物療法における患者フォローと病診連携のポイント-副作用マネジメントから考える抗不整脈薬の選択-. PROGRESS IN MEDICINE 30 : 1629-1632, 2010.
Medical*Online
16) Kurita T, et al : Cardiac resynchronization therapy to prevent life-threatening arrhythmias in patients with congestive heart failure. J Electrocardiol 44 : 736-741, 2011.
PubMed
P.427 掲載の参考文献
1) Stevenson WG, et al : Ventricular arrhythmias in heart failure. In : Cardiac Electrophysiology : From Cell to Bedside, 2nd ed (ed by Zipes DP, Jalife J), p848, WB Saunders, Philadelphia, 1995.
 
2) Coronel R, et al : Electrophysiological changes in heart failure and their implications for arrhythmogenesis. Biochim Biophys Acta 1832 : 2432-2441, 2013.
PubMed
3) Reiter MJ : The role of ventricular dilatation in ventricular fibrillation. In : Atrial and Ventricular Fibrillation : Mechanisms and Device Therapy (ed by Allessie MA, Fromer M), p93, Futura, Armonk, 1997.
 
4) Roberts WC, et al : Idiopathic dilated cardiomyopathy : Analysis of 152 necropsy patients. Am J Cardiol 60 : 1340-1355. 1987.
PubMed
5) Basso C, et al : Arrhythmogenic right ventricular cardiomyopathy. Lancet 373 : 1289-1300, 2009.
PubMed
6) Ott P, Reiter MJ : Effect of ventricular dilatation on defibrillation threshold in the isolated perfused rabbit heart. J Cardiovasc Electrophysiol 8 : 1013-1019, 1997.
 
7) Franz MR, et al : Electrophysiological effects of myocardial stretch and mechanical determinants of stretch-activated arrhythmias. Circulation 86 : 968-978, 1992.
PubMed
8) Vermeulen JT, et al : Triggered activity and automaticity in ventricular trabeculae of failing human and rabbit hearts. Cardiovasc Res 28 : 1547-1554, 1994,
PubMed
9) Boyden PA, Jeck CD : Ion channel function in disease. Cardiovasc Res 29 : 312-318, 1995.
PubMed
10) Bailly P, et al : Regional alteration of the transient outward current in human left ventricular septum during compensated hypertrophy. Circulation 96 : 1266-1274, 1997.
PubMed
11) Nuss HB, Houser SR : T-type Ca2+ current is expressed in hypertrophied adult feline left ventricular myocytes. Circ Res 73 : 777-782, 1993,
PubMed
12) Tomaselli GF, et al : Sudden cardiac death in heart failure. The role of abnormal repolarization. Circulation 90 : 2534-2539, 1994.
PubMed
13) Beuckelmann DJ, et al : Intracellular calcium handling in isolated ventricular myocytes from patients with terminal heart failure. Circulation 85 : 1046-1055, 1992.
PubMed
14) Sipido KR, et al : Altered Na/Ca exchange activity in cardiac hypertrophy and heart failure : a new target for therapy? Cardiovasc Res 53 : 782-805, 2002.
PubMed
15) Meredith IT, et al : Evidence of a selective increase in cardiac sympathetic activity in patients with sustained ventricular arrhythmias. N Engl J Med 325 : 618-624, 1991.
PubMed
16) Sabbah HN, et al : Spontaneous and inducible ventricular arrhythmias in a canine model of chronic heart failure : relation to haemodynamics and sympathoadrenergic activation. Eur Heart J 13 : 1562-1572, 1992.
 
17) Orchard CH, Cingolani HE : Acidosis and arrhythmias in cardiac muscle. Cardiovasc Res 28 : 1312-1319, 1994.
PubMed
18) Orchard CH, et al : Mechanical alternans during acidosis in ferret heart muscle. Circ Res 68 : 69-76, 1991.
PubMed
19) Effect of metoprolol CR/XL in chronic heart failure : Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF). Lancet 353 : 2001-2007, 1999.
PubMed
20) The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II) : a randomised trial. Lancet 353 : 9-13, 1999.
 
21) Shen L, et al : Declining Risk of Sudden Death in Heart Failure. N Engl J Med 377 : 41-51, 2017.
PubMed
22) Shiga T, Kasanuki H : Drug therapy for ventricular tachyarrhythmia in heart failure. Circ J 71 (Suppl A) : A90-96, 2007.
 
P.432 掲載の参考文献
1) Tofler GH, et al : Prognosis after cardiac arrest due to ventricular tachycardia or ventricular fibrillation associated with acute myocardial infarction (the MILIS Study). Multicenter Investigation of the Limitation of Infarct Size. Am J Cardiol 60 : 755-761, 1987.
PubMed
2) Volpi A, et al : In-hospital prognosis of patients with acute myocardial infarction complicated by primary ventricular fibrillation. N Engl J Med 317 : 257-261, 1987.
PubMed
3) Behar S, et al : Prognosis of acute myocardial infarction complicated by primary ventricular fibrillation. Principal Investigators of the SPRINT Study. Am J Cardiol 66 : 1208-1211, 1990.
PubMed
4) Volpi A, et al : One-year prognosis of primary ventricular fibrillation complicating acute myocardial infarction. The GISSI (Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto miocardico) investigators. Am J Cardiol 63 : 1174-1178, 1989.
PubMed
5) Volpi A, et al : Incidence and prognosis of secondary ventricular fibrillation in acute myocardial infarction. Evidence for a protective effect of thrombolytic therapy. GISSI Investigators. Circulation 82 : 1279-1288, 1990.
PubMed
6) Behar S, et al : Frequency and prognostic significance of secondary ventricuiar fibrillation complicating acute myocardial infarction. SPRINT Study Group. Am J Cardiol 71 : 152-156, 1993.
 
7) O'Doherty M, et al : Five hundred patients with myocardial infarction monitored within one hour of symptoms. Br Med J (Clin Res Ed) 286 : 1405-1408, 1983.
PubMed
8) Gheeraert PJ, et al : Risk factors for primary ventricular fibrillation during acute myocardial infarction : a systematic review and meta-analysis. Eur Heart J 27 : 2499-2510, 2006.
PubMed
9) Bigger JT Jr, et al : Ventricular arrhythmias in ischemic heart disease : mechanism, prevalence, significance, and management. Prog Cardiovasc Dis 19 : 255-300, 1977.
 
10) McMurray J, et al : Antiarrhythmic effect of carvedilol after acute myocardial infarction : results of the Carvedilol Post-Infarct Survival Control in Left Ventricular Dysfunction (CAPRICORN) trial. J Am Coll Cardiol 45 : 525-530, 2005.
 
11) Piccini JP, et al : Relation of mortality to failure to prescribe beta blockers acutely in patients with sustained ventricular tachycardia and ventricular fibrillation following acute myocardial infarction (from the VALsartan In Acute myocardial iNfarcTion trial [VALIANT] Registry). Am J Cardiol 102 : 1427-1432, 2008.
PubMed
12) MacMahon S, et al : Effects of prophylactic lidocaine in suspected acute myocardial infarction. An overview of results from the randomized, controlled trials. JAMA 260 : 1910-1916, 1988.
PubMed
13) Elizari MV, et al : Morbidity and mortality following early administration of amiodarone in acute myocardial infarction. GEMICA study investigators, GEMA Group, Buenos Aires, Argentina. Grupo de Estudios Multicentricos en Argentina. Eur Heart J 21 : 198-205, 2000.
 
14) Goldberg RJ, et al : Prognosis of acute myocardial infarction complicated by complete heart block (the Worcester Heart Attack Study). Am J Cardiol 69 : 1135-1141, 1992.
PubMed
15) Berger PB, Ryan TJ : Inferior myocardial infarction. High-risk subgroups. Circulation 81 : 401-411, 1990.
PubMed
16) Pappas PJ, et al : Ventricular free-wall rupture after myocardial infarction. Treatment and outcome. Chest 99 : 892-895, 1991.
PubMed
17) Becker AE, van Mantgem Jp : Cardiac tamponade. A study of 50 hearts. Eur J Cardiol 3 : 349-358, 1975.
PubMed
18) Shozawa T, et al : Classification of cardiac rupture complicated in myocardial infarction. Pathological study of 32 cases. Acta Pathol Jpn 37 : 871-886, 1987.
PubMed
19) Hohnloser SH, et al : Prophylacticuse of an implantable cardioverter-defibrillator after acute myocardial infarction. N Engl J Med 351 : 2481-2488, 2004.
PubMed
20) Steinbeck G, et al : Defibrillator implantation early after myocardial infarction. N Engl J Med 361 : 1427-1436, 2009.
PubMed
21) Santangeli P, et al : Comparative effectiveness of antiarrhythmic drugs and catheter ablation for the prevention of recurrent ventricular tachycardia in patients with implantable cardioverter-defibrillators : A systematic review and meta-analysis of randomized controlled trials. Heart Rhythm 13 : 1552-1559, 2016.
PubMed
22) Moss AJ, et al : Reduction in inappropriate therapy and mortality through ICD programming. N Engl J Med 367 : 2275-2283, 2012.
PubMed
23) Connolly SJ, et al : Comparison of beta-blockers, amiodarone plus beta-blockers, or sotalol for prevention of shocks from implantable cardioverter defibrillators : the OPTIC Study : a randomized trial. JAMA 295 : 165-171, 2006.
PubMed
24) Sapp JL, et al : Ventricular Tachycardia Ablation versus Escalation of Antiarrhythmic Drugs. N Engl J Med 375 : 111-121, 2016.
PubMed
P.438 掲載の参考文献
1) 日本循環器学会, ほか : 日本循環器学会/日本心不全学会合同ガイドライン. 心筋症診療ガイドライン (2018年改訂版), 2019.
 
2) Kubo T, et al : Patients' Characteristics and Clinical Course of Hypertrophic Cardiomyopathy in a Regional Japanese Cohort-Results From Kochi RYOMA Study. Circ J 82 : 824-830, 2018.
 
3) Maron BJ, et al : Epidemiology of hypertrophic cardiomyopathy-related death : revisited in a large non-referral-based patient population. Circulation 102 : 858-864, 2000.
 
4) O'Mahony C, et al : The long-term survivai and the risks and benefits of implantable cardioverter defibrillators in patients with hypertrophic cardiomyopathy. Heart 98 : 116-125, 2012.
 
5) Cecchi F, et al : The Italian Registry for hypertrophic cardiomyopathy : a nationwide survey. Am Heart J 150 : 947-954, 2005.
PubMed
6) Mitchell LB : Clinical trials of antiarrhythmic drugs in patients with sustained ventricular tachyarrhythmias. Curr Opin Cardiol 12 : 33-40, 1997.
PubMed
7) Desai AS, et al : Implantable defibrillators for the prevention of mortality in patients with nonischemic cardiomyopathy : a meta-analysis of randomized controlled trials. JAMA 292 : 2874-2879, 2004.
PubMed
8) Ban JE, et al : Electrocardiographic and electrophysiological characteristics of premature ventricular complexes associated with left ventricular dysfunction in patients without structural heart disease. Europace 15 : 735-741, 2013.
PubMed
9) Marcus FI, et al : Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia : proposed modification of the task force criteria. Circulation 121 : 1533-1541, 2010.
PubMed
10) Tabib A, et al : Undetected cardiac lesions cause unexpected sudden cardiac death during occasional sport activity. A report of 80 cases. Eur Heart J 20 : 900-903, 1999.
PubMed
11) Corrado D, et al : Molecular biology and clinical management of arrhythmogenic right ventricular cardiomyopathy/dysplasia. Heart 97 : 530-539, 2011.
PubMed
12) 日本循環器学会, ほか : 日本循環器学会/日本不整脈心電学会合同ガイドライン. 不整脈非薬物治療ガイドライン (2018年改訂版), 2019.
 
13) Fabritz L, et al : Load-reducing therapy prevents development of arrhythmogenic right ventricular cardiomyopathy in plakoglobin-deficient mice. J Am Coll Cardiol 57 : 740-750, 2011.
PubMed
14) Ammash NM, et al : Clinical profile and outcome of idiopathic restrictive cardiomyopathy. Circulation 101 : 2490-2496, 2000.
PubMed
15) Hirota Y, et al : Spectrum of restrictive cardiomyopathy : report of the national survey in Japan. Am Heart J 120 : 188-194, 1990.
PubMed
P.444 掲載の参考文献
1) Lubitz SA, et al : Sudden cardiac death in infiltrative cardiomyopathies : sarcoidosis, scleroderma, amyloidosis, hemachromatosis. Prog Cardiovasc Dis 51 : 58-73, 2008.
PubMed
2) Bernstein M, et al : Boeck's sarcoid : report of a case with visceral involvement. Arch Intern Med 44 : 721-734, 1929.
 
3) Yoshida Y, et al : Incidence of cardiac sarcoidosis in Japanese patients with high-degree atrioventricular block. Am Heart J 134 : 382-386, 1997.
PubMed
4) Uemura A, et al : Histologic diagnostic rate of cardiac sarcoidosis : evaluation of endomyocardial biopsies. Am Heart J 138 : 299-302, 1999.
PubMed
5) From AM, et al : Current status of endomyocardial biopsy. Mayo Clin Proc 86 : 1095-1102, 2011.
PubMed
6) 日本循環器学会, ほか (班長寺崎文生) : 2016年版 心臓サルコイドーシスの診療ガイドライン, 2017. [http://www.j-circ.or.jp/guideline/pdf/JCS2016_terasaki_h.pdf] (2019年9月閲覧)
 
7) Terasaki F, et al : Atrial arrhythmias and atrial involvement in cardiac sarcoidosis. Int Heart J 60 : 788-795, 2019.
PubMed
8) Roberts WC, et al : Sarcoidosis of the heart. A clinicopathologic study of 35 necropsy patients (group 1) and review of 78 previously described necropsy patients (group 11). Am J Med 63 : 86-108, 1977.
 
9) Sekhri V, et al : Cardiac sarcoidosis : a comprehensive review. Arch Med Sci 7 : 546-554, 2011.
PubMed
10) Uusimaa P, et al : Ventricular tachyarrhythmia as a primary presentation of sarcoidosis. Europace 10 : 760-766, 2008.
PubMed
11) Winters SL, et al : Sustained ventricular tachycardia associated with sarcoidosis : assessment of the underlying cardiac anatomy and the prospective utility of programmed ventricular stimulation, drug therapy and an implantable antitachycardia device. J Am Coll Cardiol 18 : 937-943, 1991.
 
12) Aizer A, et al : Usefulness of programmed ventricular stimulation in predicting future arrhythmic events in patients with cardiac sarcoidosis. Am J Cardiol 96 : 276-282, 2005.
PubMed
13) Mehta D, et al : Primary prevention of sudden cardiac death in silent cardiac sarcoidosis : role of programmed ventricular stimulation. Circ Arrhythm Electrophysiol 4 : 43-48, 2011.
PubMed
14) Kumar S, et al : Ventricular tachycardia in cardiac sarcoidosis : Characterization of ventricular substrate and outcomes of catheter ablation. Circ Arrhythm Electrophysiol 8 : 87-93, 2015.
PubMed
15) LUMB G, et al : Human cardiac conduction tissue lesions. Am J Pathol 36 : 411-429. 1960.
PubMed
16) 日野原重明 : Amyloidosisの臨床-心アミロイドーシス-. 最新医学 30 : 1550-1555, 1975.
Medical*Online
17) Wright JR, Calkins E : Clinical-pathologic differentiation of common amyloid syndromes. Medicine (Baltimore) 60 : 429-448, 1981.
PubMed
18) Mlcochova H, et al : Catheter ablation of ventricular fibrillation storm in patients with infiltrative amyloidosis of the heart. J Cardiovasc Electrophysiol 17 : 426-430, 2006.
 
P.451 掲載の参考文献
1) 日本循環器学会, ほか : 遺伝性不整脈の診療に関するガイドライン (2017年改訂版). 2018. [http://www.j-circ.or.jp/guideline/] (2019年8月閲覧)
 
2) Schwartz PJ, et al : Long-QT syndrome : from genetics to management. Circ Arrhythm Electrophysiol 5 : 868-877, 2012.
PubMed
3) Priori SG, et al : HRS/EHRA/APHRS expert consensus statement on the diagnosis and management of patients with inherited primary arrhythmia syndromes : document endorsed by HRS, EHRA, and APHRS in May 2013 and by ACCF, AHA, PACES, and AEPC in June 2013. Heart Rhythm 10 : 1932-1963, 2013.
PubMed
4) Priori SG, et al : Risk stratification in the long-QT syndrome. N Engl J Med 348 : 1866-1874, 2003.
 
5) Gollob MH, et al : The short QT syndrome : proposed diagnostic criteria. J Am Coll Cardiol 57 : 802-812, 2011.
PubMed
P.455 掲載の参考文献
1) Erlangsen A, et al : Cause-specific life-years lost in people with mental disorders : a nationwide, register-based cohort study. Lancet Psychiatry 4 : 937-945, 2017.
PubMed
2) Ray WA, et al : Atypical antipsychotic drugs and the risk of sudden cardiac death. N Engl J Med 360 : 225-235, 2009.
PubMed
3) Manu P, et al : Sudden deaths in psychiatric patients. J Clin Psychiatry 72 : 936-941, 2011.
PubMed
4) Yang C, et al : Does antipsychotic drug use increase the risk of long term mortality? A systematic review and meta-analysis of observational studies. Oncotarget 9 : 15101-15110, 2018.
PubMed
5) Taipale H, et al : Antipsychotics and mortality in a nationwide cohort of 29,823 patients with schizophrenia. Schizophr Res 197 : 274-280, 2018.
 
6) Sicouri S, Antzelevitch C : Sudden cardiac death secondary to antidepressant and antipsychotic drugs. Expert Opin Drug Saf 7 : 181-194, 2008.
PubMed
7) van Noord C, et al : Psychotropic drugs associated with corrected QT interval prolongation. J Clin Psychopharmacol 29 : 9-15, 2009.
PubMed
8) Ray WA, et al : Cyclic antidepressants and the risk of sudden cardiac death. Clin Pharmacol Ther 75 : 234-241, 2004.
PubMed
9) Whang W, et al : Depression and risk of sudden cardiac death and coronary heart disease in women : results from the Nurses' Health Study. J Am Coll Cardiol 53 : 950-958, 2009.
PubMed
10) Jolly K, et al : Sudden death in patients receiving drugs tending to prolong the QT interval. Br J Clin Pharmacol 68 : 743-751, 2009.
 
P.459 掲載の参考文献
1) The WHO Application of ICD-10 to deaths during pregnancy, childbirth and puerperium : ICD MM, World Health Organization, 2012. [https://www.mhlw.go.jp/toukei/kaisetu/index-hw.html]
 
2) 日本の妊産婦を救うために 2015 (石渡勇, 池田智明企画), 東京医学社, 2015.
 
3) Tanaka H, et al : The increase in the rate of maternal deaths related to cardiovascular disease in Japan from 1991-1992 to 2010-2012. J Cardiol 69 : 74-78, 2017.
PubMed
4) Krexi D, Sheppard MN : Cardiovascular causes of maternal sudden death. Sudden arrhythmic death syndrome is leading cause in UK. Euro J Obstet Gynecol 212 : 155-159, 2017.
 
5) Katsuragi S, et al : Pregnancy-associated aortic dilatation or dissection in Japanese women with Marfan syndrome. Circ J 75 : 2545-2551, 2011.
PubMed
6) Habashi JP, et al : Oxytocin antagonism prevents pregnancy-associated aortic dissection in a mouse model of Marfan syndrome. Sci Transl Med 11. pii : eaat4822, 2019.
 
7) Ruys TP, et al : Heart failure in pregnant women with cardiac disease : data from the ROPAC. Heart 100 : 231-238, 2014.
PubMed
8) Nakashima A, et al : Predicting postpartum cardiac events in pregnant women with complete atrioventricular block. J Cardiol 74 : 347-352, 2019.
PubMed
9) Seth R, et al : Long QT syndrome and pregnancy. J Am Coll Cardiol 49 : 1092-1098, 2007.
PubMed
10) Weiss BM, et al : Outcome of pulmonary vascular disease in pregnancy : asystematic overview from 1978 through 1996. J Am Coll Cardiol 31 : 1650-1657, 1998.
 
11) Pieper PG, et al : Pregnancy and pulmonary hypertension. Best Pract Res Clin Obstet Gynecol 28 : 579-591, 2014.
 
12) Silversides CK, et al : Pregnancy Outcomes in Women With Heart Disease : The CARPREG II Study. J Am Coll Cardiol 71 : 2419-2430, 2018.
PubMed
13) Kamiya CA, et al : Different characteristics of peripartum cardiomyopathy between patients complicated with and without hypertensive disorders. -Results from the Japanese Nationwide survey of peripartum cardiomyopathy-. Circ J 75 : 1975-1981, 2011.
PubMed
P.463 掲載の参考文献
1) 金古善明 : 薬剤性QT延長症候群とその対処法. 月刊薬事 55 : 1369-1373, 2013.
Medical*Online
2) Tisdale JE : Drug-induced QT interval prolongation and torsades de pointes : Role of the pharmacist in risk assessment, prevention and management. Can Pharm J (Ott) 149 : 139-152, 2016.
PubMed
3) 一瀬白帝 : 薬剤が発症に関与する血栓塞栓症. 医学のあゆみ 251 : 901-907, 2014.
Medical*Online
4) 向井幹夫 : がん治療における血栓塞栓症 腫瘍循環器 (Onco-Cardiology) における診断と治療. 心臓 49 : 816-821, 2017.
Medical*Online
5) 堀川達弥 : 薬剤によるアナフィラキシー. アレルギー 65 : 1171-1177, 2016.
Medical*Online
P.469 掲載の参考文献
1) Sonoda K, et al : High Frequency of Early Repolarization and Brugada-Type Electrocardiograms in Hypercalcemia. Ann Noninvasive Electrocardiol 21 : 30-40, 2016.
PubMed
2) Freeman K, et al : Effects of presentation and electrocardiogram on time to treatment of hyperkalemia. Acad Emerg Med 15 : 239-249, 2008.
PubMed
3) Redman J, Worthley LI : Antiarrhythmic and haemodynamic effects of the commonly used intravenous electrolytes. Crit Care Resusc 3 : 22-34, 2001.
PubMed
4) Maciejewski P, et al : Acute coronary syndrome : potassium, magnesium and cardiac arrhythmia. Kardiol Pol 59 : 402-407, 2003.
PubMed
5) Crowley R, Gittoes N : How to approach hypercalcaemia. Clin Med (Lond) 13 : 287-290, 2013.
PubMed
6) Minato N, et al : Perioperative coronary artery spasm in off-pump coronary artery bypass grafting and its possible relation with perioperative hypomagnesemia. Ann Thorac Cardiovasc Surg 12 : 32-36, 2006.
PubMed
7) Shechter M : Does magnesium have a role in the treatment of patients with coronary artery disease? Am J Cardiovasc Drugs 3 : 231-239, 2003.
PubMed
8) Bashir H, et al : Cisplatin-induced hypomagnesemia and cardiac dysrhythmia. Pediatr Blood Cancer 49 : 867-869, 2007.
PubMed
9) Elliott MJ, et al : Management of patients with acute hyperkalemia. CMAJ 182 : 1631-1635, 2010.
PubMed
10) Vijayakumar S, et al : New treatments for hyperkalaemia : clinical use in cardiology. Eur Heart J Suppl 21 (Suppl A) : A41-A47, 2019.
PubMed
11) Kelly A, Levine MA : Hypocalcemia in the critically ill patient. J Intensive Care Med 28 : 166-177, 2013.
 
P.472 掲載の参考文献
1) Vakil K, et al : Incidence, predictors, and temporal trends of sudden cardiac death after heart transplantation, Heart Rhythm 11 : 1684-1690, 2014.
PubMed
2) Alba AC, et al : Incidence and predictors of sudden cardiac death after heart transplantation : A systematic review and meta-analysis. Clin Transplant 32 : e13206, 2018.
PubMed
3) Alba AC, et al : Impact of Cardiac Allograft Vasculopathy and Treated Rejection on Sudden Cardiac Death in Patients Receiving a Cardiac Transplant. An Analysis of the ISHLT Registry Data. J Heart Lung Transplant 36 (Suppl) : S154, 2017.
 
4) Daly KP, et al : Pediatric Heart Transplant Study Investigators : Sudden death after pediatric heart transplantation : analysis of data from the Pediatric Heart Transplant Study Group. J Heart Lung Transplant 30 : 1395-1402, 2011.
 
5) Chang HY, et al : The utilization of twelve-lead electrocardiography for predicting sudden cardiac death after heart transplantation. Int J Cardiol 168 : 2665-2672, 2013.
PubMed
6) Alba AC, et al : The evolving risk of sudden cardiac death after heart transplant. An analysis of the ISHLT Thoracic Transplant Registry. Clin Transplant 33 : e13490. 2019.
PubMed
7) Coutance G, et al : Late antibody-mediated rejection after heart transplantation : Mortality, graft function, and fulminant cardiac allograft vasculopathy. J Heart Lung Transplant 34 : 1050-1057, 2015.
PubMed
8) Chantranuwat C, et al : Sudden, unexpected death in cardiac transplant recipients : an autopsy study. J Heart Lung Transplant 23 : 683-689, 2004.
PubMed
9) Kim M, et al : Early aspirin use and the development of cardiac allograft vasculopathy. J Heart Lung Transplant 36 : 1344-1349, 2017.
PubMed
10) Bertic M, et al : Coronary Vasospasm Following Heart Transplantation : Rapid Progression to Aggressive Cardiac Allograft Vasculopathy. Can J Cardiol 34 : 1687.e9-1687.e11, 2018.
 
11) Cantillon DJ, et al : Long-term outcomes and clinical predictors for pacemaker-requiring brady arrhythmias after cardiac transplantation : analysis of the UNOS/OPTN cardiac transplant database. Heart Rhythm 7 : 1567-1571, 2010.
 
12) Scott CD, et al : Bradyarrhythmias requiring pacemaker implantation after orthotopic heart transplantation : association with rejection. J Heart Lung Transplant 12 : 534-536, 1993.
PubMed
13) Vaseghi M, et al : Mode and mechanisms of death after orthotopic heart transplantation. Heart Rhythm 6 : 503-509, 2009.
PubMed
14) Buendia-Fuentes F, et al : Sympathetic reinnervation l year after heart transplantation, as sessed using iodine-123 metaiodobenzylguanidine imaging. Transplant Proc 43 : 2247-2248, 2011.
 
P.478 掲載の参考文献
1) Ramesh S, et al : Incidence of sudden cardiac death in adults with end-stage renal disease : a systematic review and meta-analysis. BMC Nephrol 17 : 78, 2016.
PubMed
2) Moroi M, et al : Association between abnormal myocardial fatty acid metabolism and cardiacderived death among Patients undergoing hemodialysis : results from a cohort study in Japan. Am J Kidney Dis 61 : 466-475, 2013.
PubMed
3) Takeda K, et al : Sudden death in chronic dialysis patients. Nephrol Dial Transplant 12 : 952-955, 1997.
PubMed
4) Bleyer AJ, et al : Characteristics of sudden death in hemodialysis patients. Kidney Int 69 : 2268-2273, 2006.
PubMed
5) Wong MCG, et al : Bradycardia and asystole is the predominant mechanism of sudden cardiac death in patients with chronic kidney disease. J Am Coll Cardiol 65 : 1263-1265, 2015.
PubMed
6) Roberts PR, et al : Monitoring of arrhythmia and sudden death in a hemodialysis population : The CRASH-ILR Study. PLoS ONE 12 : e0188713, 2017.
 
7) Davis TR, et al : Outcome of cardiac arrests attended by emergency medical services staff at community outpatient dialysis centers. Kidney Int 73 : 933-939, 2008.
PubMed
8) Silva RT, et al : Predictors of Arrhythmic Events Detected by Implantable Loop Recorders in Renal Transplant Candidates. Arq Bras Cardiol 105 : 493-502, 2015.
PubMed
9) Kerns ES, et al : Obstructive Sleep Apnea Increases Sudden Cardiac Death in Incident Hemodialysis Patients. Am J Nephrol 48 : 147-156, 2018.
PubMed
10) Sarnak MJ, et al : Kidney disease as a risk factor for development of cardiovascular disease : a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Circulation 108 : 2154-2169, 2003.
PubMed
11) Genovesi S, et al : Electrolyte concentration during haemodialysis and QT interval prolongation in uraemic patients. Europace 10 : 771-777, 2008.
PubMed
12) Pun PH, et al : Dialysate calcium concentration and the risk of sudden cardiac arrest in hemodialysis patients. Clin J Am Soc Nephrol 8 : 797-803, 2013.
PubMed
13) Cice G, et al : Carvedilol increases two-year survlvalin dialysis patients with dilated cardiomyopathy : a prospective, placebo-controlled trial. J Am Coll Cardiol 41 : 1438-1444, 2003.
 
14) Matsue Y, et al : β-blocker prevents sudden cardiac death in patients with hemodialysis. Int J Cardiol 165 : 519-522, 2013.
 
15) El-Chami MF, et al : Long-term survival of implantable cardioverter defibrillator recipients with end-stage renal disease. J Arrhythm 33 : 459-462, 2017.
PubMed
P.484 掲載の参考文献
1) Huikuri HV, et al : Sudden death due to cardiac arrhythmias. N Engl J Med 345 : 1473-1482, 2001.
PubMed
2) Ackerman MJ : The long QT syndrome : ion channel diseases of the heart. Mayo Clin Proc 73 : 250-269, 1998.
 
3) Basilico FC : Cardiovascular disease in athletes. Am J Sports Med 27 : 108-121, 1999.
PubMed
4) Futterman LG, et al : Sudden death in athletes : an update. Sports Med 26 : 335-350, 1998.
PubMed
5) Drezner JA : Prevention of sudden cardiac death in young athletes. In : Preventing Sudden Death in Sport and Physical Activity (ed by Casa DJ), p15-31, Jones & Bartlett Learning, Sudbury, 2011.
 
6) Maron BJ, et al : Sudden deaths in young competitive athletes : analysis of l866 deaths in the United States, 1980-2006. Circulation 119 : 1085-1092, 2009.
 
7) 武者春樹 : スポーツ関連の突然死. 心臓性突然死 (村山正博, 笠貫宏編), p62-70, 医学書院, 1997.
 
8) 村山正博 : 本邦成人におけるスポーツ中の突然死の実態と発生機序に関する研究. DMW (日本語翻訳版) 15 : 43-60, 1993.
 
9) 真鍋知宏 : スポーツ現場における心停止とその救命. 医学のあゆみ 262 : 1093-1097, 2017.
Medical*Online
10) Harmon KG, et al : Incidence of sudden cardiac death in National Collegiate Athletic Association athletes. Circulation 123 : 1594-1600, 2011.
PubMed
11) Maron BJ : Sudden death in young athletes. N Engl J Med 349 : 1064-1075, 2003.
PubMed
12) Van Camp SP, et al : Nontraumatic sports death in high school and college athletes. Med Sci Sports Exerc 27 : 641-647, 1995.
PubMed
13) Maron BJ, et al : Sudden death in young competitive athletes. Clinical, demographic, and pathological profiles. JAMA 276 : 199-204, 1996.
PubMed
14) Corrado D, et al : Does sports activity enhance the risk of sudden death in adolescents and young adults? J Am Coll Cardiol 42 : 1959-1963, 2003.
 
15) 鮎沢衛, 伊東三吾 : 学校管理下における心臓・大血管系運動関連突然死例に関する検討. 日本臨床スポーツ医学会誌 19 : 125, 2011.
Medical*Online
P.488 掲載の参考文献
1) Mitani Y, et al : Public access defibrillation improved the outcome after out-of-hospital cardiac arrest in school-age children : a nationwide, population-based, Utstein registry study in Japan. Europace 15 : 1259-1266, 2013.
PubMed
2) Ackerman M, et al : Sudden Cardiac Death in the Young. Circulation 133 : 1006-1026, 2016.
 
3) Schmied C, Borjesson M : Sudden cardiac death in athletes. J Intern Med 275 : 93-103, 2014.
PubMed
4) Mitani Y, et al : Circumstances and outcomes of out-of-hospital cardiac arrest in elementary and middle school students in the era of public-access defibrillation. Circ J 78 : 701-707, 2014.
PubMed
5) Murakami Y, et al : Outcomes of out-of-hospital cardiac arrest by public location in the public-access defibrillation era. J Am Heart Assoc 3 : e000533, 2014.
PubMed
6) Marijon E, et al : Survival from sports-related sudden cardiac arrest : In sports facilities versus outside of sports facilities. Am Heart J 170 : 339-345.e1, 2015.
 
7) Smith CM, Colquhoun MC : Out-of-hospital cardiac arrest in schools : A systematic review. Resuscitation 96 : 296-302, 2015.
 
8) 学校における心肺蘇生とAEDに関する調査報告書 (公益財団法人日本学校保健会 学校における心肺蘇生 (AED) 支援委員会), 2018. [https://www.gakkohoken.jp/book/ebook/ebook_H300010/data/213/src/H300010.pdf?d=1553295793703] (2019年8月閲覧)
 
9) 日本循環器学会AED検討委員会, 日本心臓財団 : AEDの具体的設置・配置基準に関する提言. 心臓 44 : 392-402, 2012.
Medical*Online
10) Mitamura H, et al : Aiming for Zero Deaths : Prevention of Sudden Cardiac Death in Schools-Statement From the AED Committee of the Japanese Circulation Society. Circ J 79 : 1398-1401, 2015.
PubMed
11) Sumitomo N, et al : Guidelines for Heart Disease Screening in Schools (JCS 2016/JSPCCS 2016) -Digest Version. Circ J 82 : 2385-2444, 2018.
PubMed
P.494 掲載の参考文献
1) ICD-11 for Mortality and Morbidity Statistics (Version : 04/2019) [https://icd.who.int/browse11/l-m/en] (2019年10月閲覧)
 
2) 独立行政法人日本スポーツ振興センター : 突然死の運用基準-突然死 (sudden death) について-. 学校における突然死予防必携 (改訂版), p94, 2011.
 
3) Egbe AC, et al : Cardiac Implantable Electronic Devices in Adults with Tetralogy of Fallot. Am J Cardiol 123 : 1999-2001, 2019.
PubMed
4) Sadoul N, et al : Prospective prognostic assessment of blood pressure response during exercise in patients with hypertrophic cardiomyopathy. Circulation 96 : 2987-2991, 1997.
PubMed
5) Webber BJ, et al : Prevalence of and risk factors for autopsy-determined atherosclerosis among US service members, 2001-2011. JAMA 308 : 2577-2583, 2012.
PubMed
6) Kobayashi T, et al : A new Z Score Curve of the Coronary Arterial Internal Diameter Using the Lambda-Mu-Sigma Method in a Pediatric Population. J Am Soc Echocardiogr 29 : 794-801.e29, 2016.
 
7) 日本循環器学会, ほか : 日本循環器学会/日本小児循環器学会合同ガイドライン (班長 : 住友直方). 2016年版 学校心臓検診のガイドライン, p75, 2016.
 
8) 国立大学法人保健管理施設協議会 : 学生の健康白書 2015, 2018. [http://jnuha.org/06_files/hakusyo2015.pdf] (2019年10月閲覧)
 
9) Van Camp SP, et al : Nontraumatic sports death in high school and college athletes. Med Sci Sports Exerc 27 : 641-647, 1995.
PubMed
10) 喜熨斗智也 : 救命救急情報 あなたも人助けができます. TOKYO MARATHON, 2020. [https://www.marathon.tokyo/about/medical/medical_criticalcare/index.html]
 
P.500 掲載の参考文献
1) 総務省消防庁 : 平成30年版 救急救助の現況. [https://www.fdma.go.jp/publication/rescue/post7.html]
 
2) Berdowski J, et al : Global incidences of out-of-hospital cardiac arrest and survival rates : Systematic review of 67 prospective studies. Resuscitation 81 : 1479-1487, 2010.
PubMed
3) Benjamin EJ, et al : Heart Disease and Stroke Statistics-2018 Update : A report From the American Heart Association. Circulation 137 : e67-e492, 2018.
PubMed
4) Kobayashi N, et al : Characteristics of patients with cardiac arrest caused by coronary vasospasm. Circ J 77 : 673-678, 2013.
PubMed
5) Kodama K, et al : Trend of coronary heart disease and its relationship to risk factors in a Japanese population : a 26-year follow-up, Hiroshima/Nagasaki study. Jpn Circ J 54 : 414-421, 1990.
 
6) Hata J, et al : Secular trends in cardiovascular disease and its risk factors in Japanese : half-century data from the Hisayama Study (1961-2009). Circulation 128 : 1198-1205, 2013.
PubMed
7) Rumana N, et al : Trend of increase in the incidence of acute myocardial infarction in a Japanese population : Takashima AMI Registry, 1990-2001. Am J Epidemiol 167 : 1358-1364, 2008.
 
8) Kitamura A, et al : Trends in the incidence of coronary heart disease and stroke and their risk factors in Japan, 1964 to 2003 : the Akita-Osaka study. J Am Coll Cardiol 52 : 71-79, 2008.
PubMed
9) Deo R, et al : Development and Validation of a Sudden Cardiac Death Prediction Model for the General Population. Circulation 134 : 806-816, 2016.
PubMed
10) Awamleh Garcia P, et al : Prevalence of Electrocardiographic Patterns Associated With Sudden Cardiac Death in the Spanish Population Aged 40 Years or Older. Results of the OFRECE Study. Rev Esp Cardiol (Engl Ed) 70 : 801-807, 2017.
PubMed
11) Maron BJ, et al : Sudden deaths in young competitive athletes : analysis of 1866 deaths in the United States, 1980-2006. Circulation 119 : 1085-1092, 2009.
PubMed
12) Reinier K, et al : Socioeconomic status and incidence of sudden cardiac arrest. CMAJ 183 : 1705-1712, 2011.
PubMed
13) Nishiyama C, et al : Association of out-of-hospital cardiac arrest with prior activity and ambient temperature. Resuscitation 82 : 1008-1012, 2011.
PubMed
14) Inamasu J, Miyatake S : Cardiac arrest in the toilet : clinical characteristics and resuscitation profiles. Environ Health Prev Med 18 : 130-135, 2013.
PubMed
15) Okabayashi S, et al : Outcomes of Patients 65 Years or Older After Out-of-Hospital Cardiac Arrest Based on Location of Cardiac Arrest in Japan. JAMA Netw Open 2 : e191011, 2019.
 
16) Stub D, et al : Post cardiac arrest syndrome : a review of therapeutic strategies. Circulation 123 : 1428-1435, 2011.
PubMed
17) Perman SM, et al ; American Heart Association's Get With the Guidelines-Resuscitation (formerly the National Registry of Cardiopulmonary Resuscitation) Investigators : Location of In-Hospital Cardiac Arrest in the United States-Variability in Event Rate and Outcomes. J Am Heart Assoc 5. pii : e003638, 2016.
 

XI 心臓腫瘍

P.508 掲載の参考文献
1) Reynen K : Frequencyof primary tumors of the heart. Am J Cardiol 77 : 107. 1996.
 
2) Bussami R. et al : Cardiac metastases. J Clin Pathol 60 : 27-34, 2007.
 
3) Burke A, Vermani R : Tumor of the Heart and Great Vessels : Atlas of tumor Pathology, 3rd Series, Fascicle 16, Armed Forces Institute of Pathology, Washington, DC, 1996.
 
4) McAllister HA Jr, Fenoglio JJ Jr : Tumors of the cardiovascular system. In : Atlas of Tumor Pathology, 2nd series, Fascicle 15, p1-3, Armed Forces Institute of Pathology, Washington, DC, 1978.
 
5) Amano J, et al : Clinical classification of cardiovascular tumors and tumor-like lesions, and its incidences. Gen Thorac Cardiovasc Surg 61 : 435-447, 2013.
PubMed
6) Araoz PA, et al : CT and MR imaging of benign primary cardiac neoplasms with echocardiographic correlation. Radiographics 20 : 1303-1319, 2000.
 
7) Reynen K : Cardiac myxomas. N Engl J Med 333 : 1610-1617, 1995.
 
8) Gowda RM, et al : Cardiac papillary fibroelastoma : a comprehensive analysis of 725 cases. Am Heart J 146 : 404-410, 2003.
PubMed
9) Best AK, et al : Best cases from the AFIP : cardiac angiosarcoma. Radiographics 23 (Spec No) : S141-145, 2003.
 
10) Villacampa VM, et al : Cardiac rhabdomyosarcoma : diagnosis by MR imaging. Eur Radiol 9 : 634-637, 1999.
PubMed
11) Ishikawa K, et al : Surgical treatment for primary cardiac leiomyosarcoma causing right ventricular outflow obstruction. Circ J 69 : 121-123, 2005.
PubMed
12) Cairns P, et al : Cardiac presentation of non-Hodgkin's lymphoma. Arch Pathol Lab Med 111 : 80-83, 1987.
PubMed
13) Mukai K, et al : The incidence of secondary tumors of the heart and pericardium : a 10-year study. Jpn J Clin Oncol 18 : 195-201, 1988.
PubMed
14) Butany J, et al : A 30-year analysis of cardiac neoplasms at autopsy. Can J Cardiol 21 : 675-680, 2005.
PubMed
P.512 掲載の参考文献
1) Reynen K : Frequency of primary tumors of the heart. Am J Cardiol 77 : 107, 1996.
PubMed
2) Uzun O, et al : Cardiac tumours in children. Orphanet J Rare Dis 2 : 11, 2007.
PubMed
3) Butany J, et al : Cardiac tumours : diagnosis and management. Lancet Oncol 6 : 219-228, 2005.
PubMed
4) Reynen K : Cardiac myxomas. N Engl J Med 333 : 1610-1617, 1995.
 
5) Dein JR, et al : Primary cardiac neoplasms. Early and late results of surgical treatment in 42 patients. J Thorac Cardiovasc Surg 93 : 502-511, 1987.
PubMed
P.516 掲載の参考文献
1) Reynen K : Frequency of primary tumors of the heart. Am J Cardiol 77 : 107, 1996.
PubMed
2) Sun JP, et al : Clinical and echocardiographic characteristics of papillary fibroelastomas : a retrospective and prospective study in 162 patients. Circulation 103 : 2687-2693, 2001.
PubMed
3) Gowda RM, et al : Cardiac papillary fibroelastoma : a comprehensive analysis of 725 cases. Am Heart J 146 : 404-410, 2003.
PubMed
4) Gorton ME, Soltanzadeh H : Mitral valve fibroelastoma. Ann Thorac Surg 47 : 605-607, 1989.
PubMed
5) Pepi M, et al : Recommendations for echocardiography use in the diagnosis and management of cardiac sources of embolism : European Association of Echocardiography (EAE) (a registered branch of the ESC). Eur J Echocardiogr 11 : 461-476, 2010.
PubMed
6) 鈴木仁之, ほか : 大動脈弁乳頭状弾性線維腫の1手術例. 日本心臓血管外科学会雑誌 30 : 143-145, 2001.
 
7) Katsurada E, et al : A Case of Papillary Fibroelastoma on the Tricuspid Valve Incidentally Detected by Echocardiography. IRYO 67 : 174-178, 2013. [Japanese]
 
8) 土肥薫 : 乳頭状線維弾性腫. 心エコー 16 : 118-123, 2015.
Medical*Online
9) 岡田大司, ほか : 5年間で腫瘍の増大が確認出来た僧帽弁乳頭状線維弾性腫の1例. 超音波医学 38 : 647-650, 2011.
Medical*Online
10) Grinda JM, et al : Cardiac valve papillary fibroelastoma : surgical excision for revealed or potential embolization. J Thorac Cardiovasc Surg 117 : 106-110, 1999.
PubMed
P.520 掲載の参考文献
1) Hugh D, et al : Cardiac tumors. In : Moss and Adams' Heart Disease in Infants, Children, and Adolescents : Including the Fetus and Young Adult, 8th ed, Vol 2, p1549-1564, Lippincott Williams & Wilkins, Philadelphia, 2013.
 
2) Bielefeld KJ, Moller JH : Cardiac tumors in infants and children : study of 120 operated patients. Pediatr Cardiol 34 : 125-128, 2013.
PubMed
3) Marx G, Fyler D : Cardiac tumors. In : Nadas' Pediatric Cardiology, 2nd ed, p825-832, Saunders Elsevier, Philadelphia, 2006.
 
4) 富松宏文, 西川俊郎 : 心臓腫瘍. 臨床発達心臓病学 [改訂3版] (高尾篤良, ほか編), p692-697, 中外医学社, 2001.
 
5) 渡部誠一 : 心臓腫瘍. 小児・成育循環器学 (日本小児循環器学会編), p623-626, 診断と治療社, 2018.
 
6) Northrup H, Krueger DA ; International Tuberous Sclerosis Complex Consensus Group : Tuberous sclerosis complex diagnostic criteria update : recommendations of the 2012 Iinternational Tuberous Sclerosis Complex Consensus Conference. Pediatr Neurol 49 : 243-254, 2013.
 
7) 金田眞理, ほか : 結節性硬化症の診断基準および治療ガイドライン. 日本皮膚科学会雑誌 118 : 1667-1676, 2008.
 
8) Chan JA, et al : Pathogenesis of tuberous sclerosis subependymal giant cell astrocytomas : biallelic inactivation of TSC1 or TSC2 leads to mTOR activation. J Neuropathol Exp Neurol 63 : 1236-1242, 2004.
PubMed
9) Krueger DA, et al : Everolimus for subependymal giant-cell astrocytomas in tuberous sclerosis. N Engl J Med 363 : 1801-1811, 2010.
PubMed
10) Shrivastava S, et al : Diffuse rhabdomyomatosis of the heart. Arch Pathol Lab Med 101 : 78-80, 1977.
PubMed
11) Wu SS, et al : Study of the regression process in cardiac rhabdomyomas. Pediatr Dev Pathol 5 : 29-36, 2002.
PubMed
12) Isaacs H : Fetal and neonatal cardiac tumors. Pediatr Cardiol 25 : 252-273, 2004.
PubMed
13) Smythe JF, et al : Natural history of cardiac rhabdomyoma in infancy and childhood. Am J Cardiol 66 : 1247-1249, 1990.
PubMed
14) Emmel M, et al : Radiofrequency catheter ablation of symptomatic neonatal rhabdomyoma. Cardiol Young 16 : 97-98, 2006.
PubMed
15) Tiberio D, et al : Regression of a cardiac rhabdomyoma in a patient receiving everolimus. Pediatrics 127 : e1335-e1337, 2011.
 
16) Aw F, et al : Accelerated Cardiac Rhabdomyoma Regression with Everolimus in Infants with Tuberous Sclerosis Complex. Pediatr Cardiol 38 : 394-400, 2017.
PubMed
17) 江原英治 : 結節性硬化症に伴う心臓横紋筋腫に対するEverolimusの有効性と今後の展望. 日本小児循環器学会雑誌 32 : 445-447, 2016.
Medical*Online
18) 細井創, 土井邦彦 : 横紋筋肉腫などの軟部組織腫瘍. 小児血液・腫瘍学 (日本小児血液・がん学会編), p557-561, 診断と治療社, 2015.
 
19) 片山雄三, 高梨秀一郎 : 横紋筋肉腫. 心臓腫瘍学 (天野純, ほか編), p225-230, 南山堂, 2011.
 
20) Castorino F, et al : Primary cardiac rhabdomyosarcoma of the left atrium : an unusual presentation. Tex Heart Inst J 27 : 206-208, 2000.
PubMed
21) Genaro A, Arbulu V : Cardiac Rhabdomyosarcoma. Argentine Journal of Cardiology 81 : 161-163, 2013.
 
P.526 掲載の参考文献
1) 天野純, ほか : 心臓腫瘍学, p8-18, 104-109, 196-202, 南山堂, 2011.
 
2) Kojima S, et al : Cardiac hemangioma : a report of two cases and review of the literature. Heart Vessels 18 : 153-156, 2003.
PubMed
3) Patel SD, et al : Primary cardiac angiosarcoma-a review. Med Sci Monit 20 : 103-109, 2014.
PubMed
4) Chen TW, et al : Primary cardiac sarcomas : A multi-national retrospective review. Cancer Med 8 : 104-110, 2019.
PubMed
5) Rettmar K, et al : Primary angiosarcoma of the heart. Report of a case and review of the literature. Jpn Heart J 34 : 667-683, 1993.
PubMed
6) Meng Q, et al : Echocardiographic and pathologic characteristics of primary cardiac tumors : a study of 149 cases. Int J Cardiol 84 : 69-75, 2002.
PubMed
7) Araoz PA, et al : CT and MR imaging of primary cardiac malignancies. Radiographics 19 : 1421-1434, 1999.
 
8) Young RJ, et al : Angiosarcoma. Lancet Oncol 11 : 983-991, 2010.
PubMed
9) Look Hong NJ, et al : Cardiac angiosarcorna management and outcomes : 20-year single-institution experience. Ann Surg Oncol 19 : 2707-2715, 2012.
 
10) Honda K, et al : Successful Treatment of Cardiac Angiosarcoma Associated with Disseminated Intravascular Coagulation with Nab-Paclitaxel : A Case Report and Review of the Literature. Case Rep Oncol 10 : 863-870, 2017.
PubMed
11) Kakizaki S, et al : Cardiac angiosarcoma responding to multidisciplinary treatment. Int J Cardiol 62 : 273-275, 1997.
PubMed
12) Agulnik M, et al : An open-label, multicenter, phase II study of bevacizumab for the treatment of angiosarcoma and epithelioid hemangioendotheliomas. Ann Oncol 24 : 257-263, 2013.
PubMed
13) Elsayad K, et al : Advances in Image-Guided Radiation Therapy for Primary Cardiac Angiosarcoma : The Role of PET-CT and MRI. Oncol Res Treat 39 : 290-294, 2016.
PubMed
14) Janigan DT, et al : Cardiac angiosarcomas. A review and a case report. Cancer 57 : 852-859, 1986.
 
P.529 掲載の参考文献
1) Feldman PS, Meyer MW : Fibroelastic hamartoma (fibroma) of the heart. Cancer 38 : 314-323, 1976.
PubMed
2) Witkin GB, Rosai J : Solitary fibrous tumor of the mediastinum. A report of 14 cases. Am J Surg Pathol 13 : 547-557, 1989.
PubMed
3) Segawa D, et al : Successful operation for solitary fibrous tumor of the epicardium. J Thorac Cardiovasc Surg 109 : 1246-1248, 1995.
PubMed
4) Weidner N : Solitary fibrous tumor of the mediastinum. Ultrastruct Pathol 15 : 489-492, 1991.
PubMed
5) Briselli M, et al : Solitary fibrous tumors of the pleura : eight new cases and review of 360 cases in the literature. Cancer 47 : 2678-2689, 1981.
PubMed
6) Gonzalez-Crussi F, et al : Congenital fibrous hamartoma of the heart. Arch Pathol Lab Med 102 : 491-493, 1978.
PubMed
7) Bianchi G, et al : Giant solitary fibrous tumor of the epicardium causing reversible heart failure. Ann Thorac Surg 96 : e49-51, 2013.
PubMed
8) Luciano C, et al : CT signs, patterns and differential diagnosis of solitary fibrous tumors of the pleura. J Thorac Dis 2 : 21-25, 2010.
PubMed
9) Rosado-de-Christenson ML, et al : From the archives of the AFIP : Localized fibrous tumor of the pleura. Radiographics 23 : 759-783, 2003.
PubMed
10) Aliperta A, et al : [Double cardiac fibroma in a newborn infant]. Minerva Cardioangiol 44 : 623-629, 1996.
 
11) Moran CA, Suster S : Tumors of the lung and pleura. In : Diagnostic Histopathology of Tumors, 2nd ed (ed by Fletcher CDM), Volume 1, p171-208, Churchill Livingstone, Edinburgh, 2000.
 
12) Doyle LA, et al : Nuclear expression of STAT6 distinguishes solitary fibrous tumor from histologic mimics. Mod Pathol 27 : 390-395, 2014.
PubMed
13) Elbardissi AW, et al : Survival after resection of primary cardiac tumors : a 48-year experience. Circulation 118 : S7-15, 2008.
PubMed
14) Cuadrado M, et al : Cardiac intracavitary metastasis of a malignant solitary fibrous tumor : case report and review of the literature on sarcomas with left intracavitary extension. Cardiovasc Pathol 16 : 241-247, 2007.
PubMed
15) Zhao XG, et al : Malignant solitary fibrous tumor of the right atrium. Am J Med Sci 344 : 422-425, 2012.
PubMed
P.533 掲載の参考文献
1) 天野純 : 第2章 心臓腫瘍の疫学・頻度. 心臓腫瘍学 (天野純, ほか編), p8-18, 南山堂, 2011.
 
2) Taguchi S, Yozu R : Surgery for primary intrapericardial tumors in adults. J Card Surg 28 : 529-532, 2013.
PubMed
3) Burke A, Virmani R : Benign tumors of fatty tissue. Tumors of the heart and great vessels. In : Atlas of Tumor Pathology, 3rd Series, Fascicle 16 (ed by Burke A, Virmani R), p91-98, Armed Forces Institute of Pathology, Washington DC, 1996.
 
4) Yamamoto T, et al : A case of massive left atrial lipoma occupying Pericardial space. Jpn Heart J 45 : 715-721, 2004.
 
5) Grebenc ML, et al : Primary cardiac and pericardial neoplasms : radiologic-pathologic correlation. Radiographics 20 : 1073-1103 ; quiz 1110-1111, 1112, 2000.
 
6) Sun X, et al : Left ventricular lipoma resected using thoracoscope-assisted limited sternotomy : A case report and literature review. Medicine (Baltimore) 97 : e11436, 2018.
PubMed
7) Bath AS, et al : A right atrial fat ball : Rare case of cardiac lipoma. Clin Case Rep 7 : 1798-1799, 2019.
PubMed
8) Bayat F, et al : Asymptomatic Giant Lipoma of the Right Ventricular Outflow Tract : A Case Report. J Tehran Heart Cent 12 : 142-144, 2017.
PubMed
9) Sakamoto H, et al : Intramyocardial lipoma. J Card Surg 31 : 689, 2016.
PubMed
10) Naseerullah FS, et al : Cardiac Lipoma : An Uncharacteristically Large Intra-Atrial Mass Causing Symptoms. Case Rep Cardiol 2018 : 3531982, 2018.
PubMed
11) Liu Y, et al : A large left atrial lipoma combined with coronary artery disease. J Cardiothorac Surg 12 : 71, 2017.
 
12) Wang H, et al : An asymptomatic right atrial intramyocardial lipoma : a management dilemma. World J Surg Oncol 13 : 20, 2015.
 
13) 椎久哉良, ほか : 右房脂肪腫の1例. 胸部外科 68 : 218-220, 2015.
 
14) Roberts WC, et al : Lipoma of the Mitral Valve. Am J Cardiol 119 : 1121-1123, 2017.
PubMed
15) Luo GH, et al : Surgical treatment for primary mitral valve tumor : a 25-year single-center experience. Cardiology 119 : 81-87, 2011.
PubMed
16) Sadeghian H, et al : Lipomatous tumor of the tricuspid valve : report of a rare case. J Heart Valve Dis 18 : 720-722, 2009.
 
17) Fang L, et al : Infiltrating Lipoma of the Right Ventricle Involving the Interventricular Septum and Tricuspid Valve : Report of a Rare Case and Literature Review. Medicine (Baltimore) 95 : e2561, 2016.
PubMed
18) Shenthar J, et al : Infiltrating cardiac lipoma presenting as ventricular tachycardia in a young adult. Indian Heart J 67 : 359-361, 2015.
 
19) Anderson DR, Gray MR : Mitral incompetence associated with lipoma infiltrating the mitral valve. Br Heart J 60 : 169-171, 1988.
PubMed
20) Laura DM, et al : Lipomatous Atrial Septal Hypertrophy : A Review of Its Anatomy, Pathophysiology, Multimodality Imaging, and Relevance to Percutaneous Interventions. J Am Soc Echocardiogr 29 : 717-723, 2016.
PubMed
21) O'Connor S, et al : Lipomatous hypertrophy of the interatrial septum : an overview. Arch Pathol Lab Med 130 : 397-399, 2006.
PubMed
22) Shirani J, Roberts WC : Clinical, electrocardiographic and morphologic features of massive fatty deposits ("lipomatous hypertrophy") in the atrial septum. J Am Coll Cardiol 22 : 226-238, 1993.
PubMed
23) Becker AE : Tumors of the heart and pericardium. In : Diagnostic Histopathology of Tumors, 2nd ed (ed by Fletcher CDM), p7-26, Churchill Livingstone, London, 2000.
 
24) Burke AP, et al : Chapter 4 : Tumours of the heart. In : World Health Organization Classification of Tumours, Pathology and Genetics : Tumours of the Lung, Pleura, Thymus and Heart, 3rd ed (ed by Travis WD, et al), IARC Press, Lyon, 2004.
 
25) Azarine A, et al : Magnetic resonance imaging diagnosing a left ventricular lipoma in a patient with T wave changes on ECG. Heart 91 : 873, 2005.
 
26) Araoz PA, et al : CT and MR imaging of benign primary cardiac neoplasms with echocardiographic correlation. Radiographics 20 : 1303-1319, 2000.
 
27) 下条久志 : 各論 : 第1章 12 脂肪腫. 心臓腫瘍学 (天野純, ほか編), p135-138, 南山堂, 2011.
 
28) Zhu J, et al : A giant symptomatic cardiac lipoma recurring at the fifth year. Int J Clin Exp Med 8 : 14173-14175, 2015.
 
29) 増本純也 : 各論 : 第2章 10 脂肪肉腫. 心臓腫瘍学 (天野純, ほか編), p256-261, 南山堂, 2011.
 
30) Poterucha TJ, et al : Cardiac Tumors : Clinical Presentation, Diagnosis, and Management. Curr Treat Options Oncol 20 : 66, 2019.
PubMed
31) Kamiya H, et al : Surgical treatment of primary cardiac tumors : 28 years' experience in Kanazawa University Hospital. Jpn Circ J 65 : 315-319, 2001.
PubMed
32) Lau C, et al : A 20-Year Experience With Resection of Primary Cardiac Tumors and Metastatic Tumors of the Heart. Ann Thorac Surg 107 : 1126-1131, 2019.
 
P.537 掲載の参考文献
1) McAilister HA, Fenoglio LL : Tumors of the cardiovascular system. In : Atlas of Tumor Pathology, 2nd series, Fascicle 15, p40-46, Armed Forces Institute of Pathology, Washington DC, 1978.
 
2) O'Connor S, et al : Lipomatous hypertrophy of the interatrial septum : an overview. Arch Pathol Lab Med 130 : 397-399, 2006.
PubMed
3) Prior JT : Lipomatous hypertrophy of cardiac interatrial septum. A lesion resembling hibernoma, lipoblastomatosis and infiltrating lipoma. Arch Pathol 78 : 11-15, 1964.
PubMed
4) Heyer CM, et al : Lipomatous hypertrophy of the interatrial septum : a prospective study of incidence, imaging findings, and clinical symptoms. Chest 124 : 2068-2073, 2003.
PubMed
5) Pochis WT, et al : Usefulness of transesophageal echocardiography in diagnosing lipomatous hypertrophy of the atrial septum with comparison to transthoracic echocardiography. Am J Cardiol 70 : 396-398, 1992.
PubMed
6) Silverman PM, et al : Lipomatous hypertrophy of the atrial septum : diagnosis by combined two-dimensional echocardiography and computerized tomography. Am J Cardiol 54 : 1156-1157, 1984.
PubMed
7) Xanthopoulos A, et al : Lipomatous Hypertrophy of the Interatrial Septum : A Case Report and Review of the Literature. CASE (Phila) 1 : 182-189, 2017.
PubMed
8) Cheezum MK, et al : Lipomatous hypertrophy presenting as superior vena cava syndrome. J Cardiovasc Comput Tomogr 8 : 250-251, 2014.
PubMed
9) Dickerson JA, et al : Lipomatous hypertrophy of the intraatrial septum resulting in right atrial inflow obstruction and atrial flutter. Ann Thorac Surg 89 : 1647-1649, 2010.
PubMed
10) Cohn L, Bryne J : Cardiac Surgery in the Adult, 4th ed, p1245-1276, McGraw-Hill, New York, 2012.
 
11) Rocha RV, et al : Adipose tumors of the heart. J Card Surg 33 : 432-437, 2018.
 
12) Stephant E, et al : Images in cardiovascular medicine. Lipomatous hypertrophy of the interventricular septum : echocardiography, cardiac magnetic resonance, and multidetector computerized tomography imaging. Circulation 118 : e71-72, 2008.
PubMed
13) Ak K, et al : Large lipomatous hypertrophy of the interventricular septum. Tex Heart Inst J 41 : 231-233, 2014.
PubMed
14) Alesh I, et al : Lipomatous hypertrophy of the right ventricle and interventricular septum associated with ventricular arrhythmia. Int J Cardiovasc Imaging 32 : 449-450, 2016.
PubMed
15) Laura DM, et al : Lipomatous Atrial Septal Hypertrophy : A Review of Its Anatomy, Pathophysiology, Multimodality Imaging, and Relevance to Percutaneous Interventions. J Am Soc Echocardiogr 29 : 717-723, 2016.
PubMed
P.542 掲載の参考文献
1) Luc JGY, et al : Cystic tumor of the atrioventricular node : a review of the literature. J Thorac Dis 9 : 3313-3318, 2017.
PubMed
2) Kralstein J, Frishman WH : Malignant pericardial diseases : diagnosis and treatment. Cardiol Clin 5 : 583-589, 1987.
PubMed
3) Patel J, Sheppard MN : Primary malignant mesothelioma of the pericardium. Cardiovasc Pathol 20 : 107-109, 2011.
PubMed
4) Fujimoto N, et al : Clinical investigation of malignant mesothelioma in Japan. J Cancer Res Clin Oncol 136 : 1755-1759, 2010.
PubMed
5) Andersen JA, Hansen BF : Primary pericardial mesothelioma. Dan Med Bull 21 : 195-200, 1974.
PubMed
6) 齋藤希人, ほか : 原発性心膜悪性中皮腫の1例と本邦集計例 (118例) の検討. 心臓 35 : 611-620, 2003.
Medical*Online
7) Scherpereel A, et al : Guidelines of the European Respiratory Society and the European Society of Thoracic Surgeons for the management of malignant pleural mesothelioma. Eur Respir J 35 : 479-495, 2010.
PubMed
8) Butz T, et al : Primary malignant pericardial mesothelioma-a rare cause of pericardial effusion and consecutive constrictive pericarditis : a case report. J Med Case Rep 3 : 9256, 2009.
PubMed
9) Nilsson A, Rasmuson T : Primary Pericardial Mesothelioma : Report of a Patient and Literature Review. Case Rep Oncol 2 : 125-132, 2009.
PubMed
10) Mirabella F : [Pericardial mesothelioma. Evolution and update in the last decade]. Pathologica 85 : 377-386, 1993.
PubMed
11) 西英行, 清水信義 : 原発性悪性心膜中皮腫の検討. 日本呼吸器外科学会雑誌 28 : 842-847, 2014.
 
12) 八尾進太郎, ほか : 収縮性心外膜炎の一例. 東邦医学会雑誌 64 : 21-29, 2017.
 
13) Takeda K, et al : Pericardial mesothelioma : hyaluronic acid in pericardial fluid. Am Heart J 110 : 486-488, 1985.
PubMed
14) 加藤勝也, ほか : 心膜中皮腫17例における画像所見の検討. 肺癌 50 : 560, 2010.
Medical*Online
15) Kim JS, et al : A Case Report of Primary Pericardial Malignant Mesothelioma Treated with Pemetrexed and Cisplatin. J Korean Med Sci 32 : 1879-1884, 2017.
PubMed
P.547 掲載の参考文献
1) Goldberg AD, et al : Tumors metastatic to the heart. Circulation 128 : 1790-1794, 2013.
 
2) Al-Mamgani A, et al : Cardiac metastases. Int J Clin Oncol 13 : 369-372, 2008.
PubMed
3) Maeda M, et al : Myocardial metastasis from squamous cell carcinoma of the esophagus. Gen Thorac Cardiovasc Surg 57 : 440-445, 2009.
PubMed
4) Mukai K, et al : The incidence of secondary tumors of the heart and pericardium : a 10-year study. Jpn J Clin Oncol 18 : 195-201, 1988.
PubMed
5) Bussani R, et al : Cardiac metastases. J Clin Pathol 60 : 27-34, 2007.
PubMed
6) Wolver SE, et al : ST segment elevation and new right-bundle branch block : broadening the differential diagnosis. Int J Cardiol 114 : 247-248, 2007.
PubMed
7) 山崎一也, ほか : 食道癌心腔内転移の1手術例. 日本心臓血管外科学会雑誌 40 : 310-313, 2011.
 
P.551 掲載の参考文献
2) Oliveira GH, et al : Characteristics and survival of malignant cardiac tumors : a 40-year analysis of > 500 patients. Circulation 132 : 2395-2402, 2015.
PubMed
3) Burke A, et al : Cardiac tumours : an update : Cardiac tumours. Heart 94 : 117-123, 2008.
PubMed
4) Petrich A, et al : Primary cardiac lymphoma : an analysis of presentation, treatment, and outcome patterns. Cancer 117 : 581-589, 2011.
PubMed
5) Hoey ETD, et al : MRI and CT appearances of cardiac tumours in adults. Clin Radiol 64 : 1214-1230, 2009.
PubMed
6) Cheson BD, et al : Revised response criteria for malignant lymphoma. J Clin Oncol 25 : 579-586, 2007.
PubMed
7) 伊澤淳, ほか : 悪性リンパ腫. 心臓腫瘍学 (天野純, ほか編), p268-279, 南山堂, 2011.
 
8) Ito I, et al : Primary cardiac lymphoma : a lesson learned from an unsuccessful experience. Intern Med 57 : 3569-3574, 2018.
PubMed
Burazor I, et al : Primary malignancies of the heart and pericardium. Clin Cardiol 37 : 582-588, 2014.
PubMed
P.554 掲載の参考文献
1) Allen B, Renu V : Tumors of the Heart and Great Vessels. Atlas of Tumor Pathology, 3rd Series, Fascicle 16, DC, Armed Forces Institute of Pathology, Washington, 1995.
 
2) 厚生労働科学研究費補助金難治性疾患等政策研究事業 (難治性疾患政策研究事業) 「難治性血管腫・血管奇形についての調査研究班 患者実態調査および治療法の研究」班 (研究代表者 : 三村秀文), 平成25年度総括・分担研究報告書, 2014.
 
3) Ueno S, et al : Treatment of mediastinal lymphatic malformation in children : an analysis of a nationwide survey in Japan. Surg Today 48 : 716-725, 2018.
PubMed
4) Luks VL, et al : Lymphatic and other vascular malformative/overgrowth disorders are caused by somatic mutations in PIK3CA. J Pediatr 166 : 1048-1054.e1-5, 2015.
 
5) Kaji T, et al : Cardiac lymphangioma : case report and review of the literature. J Pediatr Surg 37 : E32, 2002.
PubMed
6) 血管腫・血管奇形・リンパ管奇形診療ガイドライン 2017 (第2版), 2017.
 
P.558 掲載の参考文献
1) Reynolds C, et al : Calcified amorphous tumor of the heart (cardiac CAT). Hum Pathol 28 : 601-606, 1997.
PubMed
2) de Hemptinne Q, et al : Cardiac calcified amorphous tumor : A systematic review of the literature. Int J Cardiol Heart Vasc 7 : 1-5, 2015.
PubMed
3) 小原浩, ほか : カルシウム代謝異常を有しないcalcified amorphous tumorの1例. 日本心エコー図学会学術集会抄録集, p180, 東京, 2010.
 
4) Kubota H, et al : Cardiac swinging calcified amorphous tumors in end-stage renal failure patients. Ann Thorac Surg 90 : 1692-1694, 2010.
PubMed
5) Yasui H, et al : Time-Course Changes of Cardiac-Specific Inflammation in a Patient With Left Ventricular Calcified Amorphous Tumor. Circ J 79 : 2069-2071, 2015.
 
6) Yilmaz R, et al : Cardiac calcified amorphous tumors : CT and MRI findings. Diagn Interv Radiol 22 : 519-524, 2016.
PubMed
7) Fealey ME, et al : Recurrent cardiac calcific amorphous tumor : the CAT had a kitten. Cardiovasc Pathol 16 : 115-118, 2007.
PubMed

書評

最近チェックした商品履歴

Loading...